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In  Escherichia  coli,  and  other  prokaryotes,  thiamine  (vitamin  B1)  is  assembled  by 
coupling  4-amino-5-hydroxymethyl-2-methylpyrimidine  pyrophosphate  (Hmp-PP) 
and  4-methyl-5-(β-hydroxyethyl)thiazole  phosphate  (Thz-P).  The  thiazole  moiety  is 
biosynthesised from 1-deoxyxylulose-5-phosphate, tyrosine, and cysteine, and at least 
six genes are required including thiH, thiG, thiS, and thiF. Whilst in aerobes, the C2-N3 
fragment of Thz-P derives from glycine in a reaction catalysed by the flavoenzyme 
ThiO, in anaerobes such as E. coli, dehydroglycine is formed from tyrosine in a ThiH 
dependent reaction. This biosynthetic step requires the cleavage of the Cα-Cβ bond of 
tyrosine and a release of an aromatic side chain. ThiH shows sequence similarity with 
the ‘radical S-adenosylmethionine’ (AdoMet) family of proteins, including conserved 
cysteine ligands to the essential [4Fe-4S] cluster and has been shown to form a complex 
with ThiG. With the purpose of studying the mechanistic enzymology by which Thz-P 
is assembled it was crucial to isolate ThiH in the holo-form. Several expression systems 
and purification methodologies were investigated. The optimisation of the purification 
method, together with in vitro chemical reconstitution with exogenous iron and sulfide 
allowed the successful isolation of holo-ThiH.  
 
To facilitate the mechanistic investigation of Thz-P biosynthesis, an in vitro assay was 
developed, and the reaction products formed in vitro were elucidated and quantified. 
The aromatic by-product derived from the side chain of tyrosine is p-cresol and the 
remaining fragment yields glyoxylate, a product of hydrolysis of dehydroglycine.   ii 
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CHAPTER 1 
Introduction 
 
1.1 Overview of Thiamine  
 
Thiamine  1,  also  known  as  vitamin  B1,  is  a  water  soluble  vitamin  and  a  essential 
component of human diet, with a recommended daily allowance of 1.4 mg1. The main 
biologically  active  form  of  thiamine  is  thiamine  pyrophosphate  2  (TPP).  TPP  is  an 
essential cofactor of several enzymes involved in important metabolic pathways. The 
biosynthesis  of  this  cofactor  occurs  in  most  microorganisms  and  higher  plants. 
Humans  are  not  able  to  produce  this  vitamin  and  its  deficiency  seriously  affects 
cardiovascular (wet beriberi) and nervous systems. The most devastating neurological 
disorder  known  to  be  caused  by  thiamine  deficiency  is  the  Wernicke-Korsakoff 
syndrome, an alcohol related illness, that is the third most common cause of dementia 
in  the  United  States1-3.  The  chemical  structures  of  thiamine  1  and  thiamine 
pyrophosphate 2 are shown in figure 1.1.  
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Figure 1.1 Structure of thiamine 1 and thiamine pyrophosphate 2. 
 
Thiamine  was  first  discovered  in  1910  by  Umetaro  Suzuki  in  Japan  while  he  was 
investigating  a  cure  for  beriberi.  At  the  time  he  did  not  determine  the  chemical 
constitution  of  thiamine  and  named  it  aberic  acid.  It  was  only  later,  in  1926,  that 
vitamin B1 was crystallised by Jansen and Donath4, two Dutch chemists, that at the   2 
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time published the wrong formula. Ten years later, Williams  5 finally elucidated the 
correct  formula  and  soon  after  that  the  first  chemical  synthesis  for  thiamine  was 
reported.  Thiamine  is  commercially  available  and  widely  used  as  a  nutritional 
supplement6.  
 
1.2 Thiamine pyrophosphate: importance and biochemical functions 
 
Thiamine pyrophosphate plays an important role in the cleavage of bonds adjacent to a 
carbonyl  group,  such  as  the  decarboxylation  of  α-keto  acids,  and  in  chemical 
rearrangements in which an activated aldehyde group is transferred from one carbon 
to another7 (table 1.1).  
 
Table 1.1 Examples of TPP-dependent reactions. Adapted from7. 
Enzyme  Pathway  Bond cleaved  Bond formed 
Pyruvate 
decarboxylases 
Alcohol fermentation 
 
 
Pyruvate 
dehydrogenase 
Synthesis of acetyl-
CoA 
   
α-Ketoglutarate 
dehydrogenase 
Citric acid cycle     
Transketolase 
Carbon-fixation 
reactions of 
photosynthesis 
   
Acetolactate 
synthase 
Valine, leucine 
biosynthesis 
   
    3 
In most TPP-dependent enzymes the loss of the proton at C-2 of the thiazole ring is the 
first step in the catalysis. This proton is relatively acidic [pKa of 17-198,9], due to the 
stabilisation  of  the  corresponding  carbanion  2a  by  the  adjacent  sulfur  and  by  the 
positive  charge  on  the  nitrogen10  (scheme  1.1).  This  carbanion  is  both  a  potent 
nucleophile and a good leaving group. The subsequent catalytic steps are characterised 
by the nucleophilic attack of 2a on the substrate, followed by cleavage of a C-C bond. 
This  cleavage  releases  the  first  product,  leaving  a  second,  resonance  stabilised 
carbanion (enamine). 
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Scheme 1.1 Formation of the stabilised carbanion of TPP. 
 
Pyruvate  dehydrogenase  and  α-ketoglutarate  dehydrogenase  are  two  important 
enzymes  in  the  Krebs  cycle.  The  E1  components  of  these  complexes,  catalyse  the 
decarboxylation  of  pyruvate  3  and  α-ketoglutarate  4,  respectively11,  through  the 
mechanism shown in scheme 1.2. The nucleophilic addition of the resonance stabilised 
thiazolium  carbanion  to  the  carbonyl  group  of  the  α-keto  acid,  followed  by 
protonation,  leads  to  the  formation  of  a  α-hydroxyacid  5.  This  adduct  readily 
undergoes decarboxylation producing hydroxyethylidene-TPP 6 (HE-TPP), stabilised 
by resonance. This hydroxyethylidene group is then oxidised and transferred as an 
acetyl into to the lipoamide prosthetic group of the pyruvate dehydrogenase and α-
ketoglutarate dehydrogenase E2 components, releasing 2a. The E2 components of the 
respective complexes then transfer the acetyl or succinyl groups to coenzyme A (CoA),   4 
with  the  oxidised  form  of  the  lipoamide  being  regenerated  by  the  E3  component, 
which  is  identical  in  the  two  dehydrogenases.  Decreased  activities  of  pyruvate 
dehydrogenase  and  α-ketoglutarate  dehydrogenase  reduces  adenosine  triphosphate 
(ATP) synthesis, and lower ATP levels have been found in brain regions damaged by 
thiamine deficiency1. 
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Scheme 1.2 Decarboxylation of α-keto acids catalysed by the TPP-dependent E1 components of 
pyruvate and α-ketoglutarate dehydrogenases. 
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Whilst  most  TPP  dependent  enzymes  follow  the  Breslow  mechanism12  for  TPP 
activation, the fate of the intermediate formed upon decarboxylation, HE-TPP 6, differs 
amongst  TPP  dependent  enzymes.  An  example  of  this  is  pyruvate  ferredoxin 
oxidoreductase  (PFOR),  a  thiamine  dependent  enzyme  that  catalyses  the  anaerobic 
oxidation  of  pyruvate  (with  CoA)  to  acetyl-CoA.  In  PFOR,  the  oxidation  of  this 
intermediate  is  associated  with  the  reduction  of  an  external  electron  acceptor,  for 
example, the clostridial ferredoxin, which contains three [4Fe-4S] clusters (cluster A, B 
and C)13. 
 
CoASH + pyruvate + ferredoxinox H3C - CO - SCoA + CO2 + ferredoxinred 
 
After the formation of HE-TPP, one electron is transferred to one of the three [4Fe-4S]2+ 
clusters, which generates a paramagnetic [4Fe-4S]1+ cluster and a HE-TPP radical14. A 
subsequent electron transfer from HE-TPP radical to cluster B ([4Fe-4S]2+) generates a 
second  [4Fe-4S]1+  cluster.  The  stability  of  the  HE-TPP  radical  is  dependent  on  the 
presence of CoA13. 
  
The subsequent steps upon formation of the HE-TPP radical intermediate were studied 
in detail by Furdui and Ragsdale14 and three mechanisms have been proposed (scheme 
1.3); (a) kinetic coupling mechanism: the nucleophilic attack by CoA thiolate on the 
HE-TPP radical generates an anion radical that transfers one electron to cluster B; (b) 
biradical mechanism: an electron transfers from CoA to cluster B generating a thiyl 
radical that combines with the HE-TPP radical; (c) wire mechanism: CoA induces an 
electron transfer pathways between the HE-TPP radical and cluster B14.     6 
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Scheme 1.3 Proposed mechanisms for the formation of the thiazole carbanion 2a via an HE-TPP 
radical intermediate; (a) kinetic coupling mechanism; (b) biradical mechanism; and (c) wire 
mechanism. Adapted from14. 
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1.3 Thiamine biosynthesis: prokaryotes and eukaryotes 
 
The  biosynthesis  of  thiamine  involves  the  separate  biosynthesis  and  subsequent 
coupling of 4-methyl-5-(β-hydroxyethyl) thiazole phosphate 7 (Thz-P) and 4-amino-5-
hydroxymethyl-2-methylpyrimidine  pyrophosphate  8  (Hmp-PP)  to  form  thiamine 
monophosphate 9 (TP). These two precursors are biosynthesised through independent 
pathways that are considerably different in prokaryotes and eukaryotes.  
 
All organisms able to produce thiamine first assemble thiamine monophosphate (TP), 
which  is  then  converted  to  thiamine  pyrophosphate  (TPP),  either  by  direct 
phosphorylation (in enteric bacteria) or by de-phosphorylation to thiamine followed by 
pyrophosphorylation (in aerobic bacteria and yeast) (scheme 1.4)6. 
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Scheme  1.4  Assembly  of  thiamine  pyrophosphate  from  Thz-P  7  and  Hmp-PP  8  in  enteric 
bacteria and aerobic bacteria and yeast. 
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In  prokaryotes  significant  progress  has  been  made  in  the  identification  of  the 
precursors and genes involved, comprehensive reviews of this topic are those by White 
and  Spenser6,15.  In  eukaryotes,  however,  the  details  have  only  recently  begun  to 
emerge. The following paragraphs summarise the biosynthesis of these two precursors 
in prokaryotes and eukaryotes, with particular emphasis on the biosynthesis of Thz-P.  
 
Biosynthesis of 4-amino-5-hydroxymethyl-2-methylpyrimidine pyrophosphate 
(Hmp-PP) 
 
Studies  on  the  prokaryotes  E.  coli  and  S.  typhimurium,  established  that  4-amino-5-
hydroxymethyl-2-methylpyrimidine  phosphate  10  (Hmp-P)  derives  from  5-
aminoimidazole  ribotide  11  (AIR)16-18.  It  is  still  unclear  if  the  direct  product  of  the 
pyrimidine-forming  reaction  is  Hmp  or  Hmp-P,  since  AIR  is  phosphorylated. 
However, because the enzyme ThiD can catalyse the phosphorylation of 4-amino-5-
hydroxymethyl-2-methylpyrimidine (Hmp) to Hmp-P and then on to Hmp-PP, Hmp is 
generally accepted to be the first product of the pyrimidine biosynthesis.  
 
This remarkable rearrangement of aminoimidazole ribonucleotide is catalysed by the 
ThiC gene product. Isotopic labelling studies (scheme 1.5) indicate that all the carbon 
and nitrogen atoms of Hmp derive from AIR, an intermediate in both de novo purine 
and histidine biosynthesis16,17,19,20. These studies suggest that the C5 of the pyrimidine 
derives from C4’ of AIR, the C2 methyl substituent originates from C2’ of AIR, and also 
that the nitrogens of the aminoimidazole are retained in the pyrimidine. Moreover, 
studies show that pyrimidine synthase activity is dependent on an iron sulfur cluster 
and  S-adenosyl  methionine  (AdoMet)  due  to  the  production  of  5-deoxyadenosine 
radical (Ado●), which suggests that this enzyme belongs to the ‘radical AdoMet’ family 
(discussed in detail in section 1.4). The mechanism of this rearrangement has not yet 
been elucidated21.  
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Scheme 1.5 Biosynthesis of Hmp-P 10 from AIR 11. 
 
The biosynthesis of the thiamine pyrimidine in S. cerevisiae, derives from histidine 12 
and pyridoxal-5’-phosphate 13 (PLP) in a reaction where the THI5 gene is involved. 
The mechanism for this rearrangement is not yet elucidated22. Scheme 1.6 summarises 
this conversion.  
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Scheme 1.6 Biosynthesis of Hmp-P 10 from histidine 12 and PLP 13.  
 
Zeidler  and  co-workers  used  incorporation  studies  with  13C,  15N  and  2H  labelled 
substrates,  with  subsequent  NMR  analysis  to  show  that  Hmp  originates  from  a 
NCHNH fragment that derives from histidine 12 (blue), and a CH3CNCHCCH2OPO32- 
fragment that derives from PLP 13 (red)22.  
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Biosynthesis of 4-methyl-5-(β-hydroxyethyl) thiazole phosphate  
(Thz-P) 
 
Considerable progress has been made recently on the elucidation of the biosynthetic 
pathway  by  which  4-methyl-5-(β-hydroxyethyl)  thiazole  phosphate  (Thz-P)  is 
assembled. This thiazole moiety, required for thiamine biosynthesis, has two different 
biosynthetic pathways in prokaryotes and eukaryotes. 
 
In  prokaryotes,  the  precursors  and  proteins  involved  differ  slightly  in  aerobic  and 
anaerobic  bacteria.  Common  to  both  are  the  precursors  1-deoxy-D-xylulose-5-
phosphate (Dxp), cysteine (Cys) and the proteins ThiF, ThiS, ThiI, ThiG and IscS. E. coli 
and other enteric bacteria depend on ThiH, an oxygen sensitive protein, which utilises 
tyrosine (Tyr) to provide the C2-N3 fragment of the thiazole23,24. B. subtilis, and other 
aerobes,  substitute  ThiH  with  ThiO,  an  oxygen  dependent  flavoenzyme,  that  uses 
glycine (Gly) to provide the C2-N3 unit25,26.  
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Scheme 1.7 Thz-P biosynthetic pathway in E. coli. Adapted from27. 
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IscS, an enzyme also involved in iron-sulfur cluster biosynthesis, catalyses the sulfur 
transfer from cysteine to ThiI to give ThiI-persulfide 17 (scheme 1.7)28,29. ThiF catalyses 
the adenylation of ThiS, at its carboxy terminus to give 16 and AMP is subsequently 
displaced by the ThiI-persulfide to give 18. Disulfide interchange, involving Cys184 on 
ThiF, generates the mixed acyl disulfide 19, which acts as a sulfur donor for thiazole 
formation29,30.  The intermediates 22  and  23  have  been  identified in studies using B. 
subtilis  but  are  thought  to  be  common  intermediates  in  Thz-P  in  E.  coli31.  The 
investigation of the mechanistic enzymology by which thiazole 7 is assembled from 
tyrosine 24 in E. coli is the main focus of this project.  
 
ThiS,  a  7.2  kDa  protein,  has  similar  structure  to  ubiquitin  and  MoaD32.  All  three 
proteins have a low degree of sequence similarity aside from the carboxy-terminal Gly-
Gly pair. ThiF, a 27 kDa protein, has similar structure to ubiquitin-like (Ubl) activating 
enzymes and also to the MoeB, a molybdopterin biosynthetic protein33-36. MoeB and 
MoaD, molybdopterin biosynthetic proteins, have similar function to those of the ThiF-
ThiS complex. MoeB uses ATP and catalyses the formation of MoaD-thiocarboxylate 
which acts as a sulfur source in molybdenum cofactor biosynthesis. The relationship 
between ThiF-ThiS complex with ubiquitin is less direct, as instead of formation of an 
acyl  disulfide,  ubiquitin  forms  a  thioester.  In  this  rearrangement,  the  ubiquitin-
activating enzyme E1 catalyses the formation of an acyl adenylate of ubiquitin, which 
reacts  with  the  cysteine  on  E1  to  form  a  thioester.  This  thioester  functions  as  an 
activated  ubiquitin  donor37,38.  The  functional  similarity  between  these  enzymes, 
ubiquitin-E1, ThiF-ThiS complex and MoaD-MoaB suggests that they share a common 
ancestor.  
 
Studies by Settembre31, elucidated the structure of the ThiG-ThiS complex and gave 
further  information  about  the  thiazole  synthase  active  site  and  also  about  the 
similarities  between  the  ThiG-ThiS  complex  and  the  ThiF-ThiS  complex.  ThiG-ThiS 
crystal structure indicates that the surface involved in the complex formation is the 
same  as  the  surface  suggested  being  involved  in  ThiS-ThiF  complex  formation36. 
Therefore, regardless of the structural difference existing between thiazole synthase 
and the proteins MoaE and E2-like proteins, a common binding motif is used for the   12 
formation of the complex of ThiS, MoaD, and ubiquitin with their respective partners. 
For clarity, table 1.2 summarises the protein systems related to thiazole biosynthesis.  
 
Table 1.2 Protein systems related to thiazole biosynthesis. 
pathway 
Ubiquitin 
homolog 
Activating enzyme 
(E1 homolog) 
Conjugating 
enzyme/synthase 
(E2 homolog) 
Thiamine biosynthesis  ThiS  ThiF  ThiG 
Molybdopterin biosynthesis  MoaD  MoeB  MoaE 
Protein degradation  Ubiquitin  UBA1 (E1)  UBC (E2) 
 
 
 
Figure 1.2 Putative active site of thiazole synthase. Thiazole synthase is shown as a surface 
representation, and ThiS is shown as a blue coil. Conserved residues with predicted functions 
are shown: Lys96 (blue), Glu98 (red), and Asp182 (yellow). Conserved residues without an 
assigned function are coloured in green, and an exposed hydrophobic surface is coloured in 
cyan. Phosphate is shown in red ball-and-stick representation. Adapted from31. 
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The location of the ThiG active site was deduced bearing in mind several factors (figure 
1.2): (a) thiazole synthase binding region was found to contain most of the conserved 
residues,  which  shows  similarities  to  the  thiamine  phosphate  synthase39;  (b)  a 
phosphate  ion  was  found  to  bind  to  the  region  that  contains  a  cluster  of  highly 
conserved residues; (c) Lys96, which forms an imine with Dxp, is closely positioned to 
the phosphate binding site; (d) the C-terminal appendage of ThiS extends to the region 
of  thiazole  synthase  where  Lys96  and  the  phosphate  binding  site  are  found.  This 
indicated that the phosphate of Dxp most likely binds in identical way to the bound 
phosphate in this structure. This binding site was found to contain a P-loop identical to 
that of thiamine phosphate synthase for the binding of the phosphate to its substrate31.  
 
Studies on the aerobe B. subtilis by Begley and co-workers have identified five enzymes 
involved in the formation of Thz-P, ThiS, ThiF, ThiG, ThiO and IscS. These studies 
have  further  elucidated  the  biosynthetic  pathway  by  which  Thz-P  is  assembled  in 
prokaryotes and a mechanism has been proposed (scheme 1.8)40.  
 
Dxp  21  forms  an  imine  with  Lys96  of  the  thiazole  synthase  (ThiG)  to  give  22. 
Tautomerisation followed by addition of thiocarboxylate to the C3 ketone of 26 gives 
23, this intermediate then undergoes an S/O acyl shift followed by loss of water to yield 
thioketone 29. Tautomerisation followed by the elimination of the ThiS 14, the sulfur 
carrier  protein,  gives  31.  Addition  of  the  glycine  imine  32,  formed  in  a  separate 
reaction, followed by transamination produces the thiazole tautomer 34. The enzyme 
TenI is responsible for the aromatisation of 34 to Thz-P 7. This mechanistic proposal 
has considerable experimental support40-43. 
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Scheme 1.8 Mechanistic proposal for the thiazole synthase (ThiG) catalysed formation of the 
thiazole moiety of Thz-P. Adapted from44. 
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Based on this mechanistic proposal combined with the structure of thiazole synthase 
complexed  to  ThiS,  Settembre  and  co-workers31  further  elucidated  the  catalytic 
mechanism of this complex by modelling the thiazole synthase active site (scheme 1.9). 
The residues likely to be involved in the catalysis are: Glu98 and Asp182. Glu98 has 
close proximity to Dxp, and Asp182 is close to the C3 and C4 of Dxp.  
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Scheme 1.9 Diagram representing Dxp bound to the thiazole synthase active site. The scheme 
shows a representation of Dxp and key amino acid side chains. Atoms shown in black were 
observed  experimentally,  and  atoms  shown  in  red  were  modelled  using  structural  and 
mechanistic information. Adapted from44. 
 
The  biosynthesis  of  Thz-P  biosynthesis  in  eukaryotes  has  been  shown  to  differ 
significantly.  The  proposed  mechanism  is  outlined  in  scheme  1.10.  The  reaction  is 
catalysed by the thiazole synthase (THI4), and whilst this reaction has not been yet 
fully reconstituted in vitro, THI4 was successfully isolated and revealed the presence of 
three tightly bound metabolites (42, 46, 47) and the structure of the complex  between 
the  enzyme  and  46  has  been  determined45-48.  These  studies  suggest  that  NAD  is  a 
precursor to the thiazole. The reaction is initiated by the cleavage of the N-glycosyl 
bond of NAD 35 followed by the opening of the ring and tautomerisation and loss of 
water to give 40, this is followed by two tautomerisations and sulfide addition to yield 
43. This intermediate then cyclises to give 44. The loss of two water molecules gives 46 
followed by the thiazole aromatisation completes the reaction with the formation of 47. 
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Scheme 1.10 Proposed mechanism for thiazole biosynthesis in S. cerevisiae. The sulfur source 
indicated by “S=” has not yet been identified. Adapted from49. 
 
The pathways of thiamine biosynthesis in prokaryotes and eukaryotes are summarised 
in scheme 1.11 and table 1.3 lists the enzymes of thiamine biosynthesis in E. coli, B. 
subtilis and S. cerevisiae. Comprehensive reviews of thiamine biosynthesis are those by 
White and Spenser6,15, and more recently by Webb and co-workers50. 
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Scheme 1.11 Thiamine biosynthesis in prokaryotes and eukaryotes. Adapted from50. 
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Table 1.3 Gene names corresponding to enzyme activities of thiamine biosynthesis in E. coli, 
B. subtilis and S. cerevisiae. Adapted from50. 
Enzyme activity  E. coli  B. subtilis  S. cerevisiae 
Thz-P biosynthesis 
S donor  IscS  NifS   
S activation  ThiS, ThiF  ThiS, ThiF   
Thz-P synthase  ThiG & ThiH  ThiG & ThiO   
Thz-P synthase      Thi4 
HMP-PP biosynthesis 
HMPP kinase  ThiD  ThiD  Thi20/21 
HMP synthase  ThiC  ThiA   
HMP synthase      Thi5/11/12/13 
TPP biosynthesis 
TP synthase  ThiE  ThiC  Thi6 
TP kinase  ThiL  ThiL   
TPK    ThiN  Thi80 
Salvage enzymes 
HMP kinase  PdxL/ThiJ  ThiD  Thi20/21 
Thiazole kinase  ThiM  ThiK  Thi6 
Thiamine kinase  ThiK     
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1.4 ‘Radical AdoMet’ superfamily and ThiH 
 
In prokaryotes, at least seven genes, thiFSGH, thiI, iscS, and dxs are required to convert 
Dxp, cysteine and tyrosine to Thz-P  24,29,30,51-54. In vitro studies, in particular, using B. 
subtilis and E. coli proteins have provided significant amount of information about the 
mechanism by which Thz-P is biosynthesised and were discussed in detail in section 
1.327,40,41,43,51,55.   
 
In E. coli, the imine intermediate (32, dehydroglycine) is proposed to be a product of 
tyrosine  cleavage  reaction  catalysed  by  the  enzyme  ThiH.  Genetic  and  biochemical 
studies  have  provided  evidence  of  the  presence  of  an  oxygen  sensitive  iron  sulfur 
cluster  in  ThiH24,56,57,  this  cluster  is  proposed  to  reduce  S-adenosyl  methionine 
(AdoMet) to form a highly reactive 5’-deoxyadenosyl radical (Ado●) that will generate 
a tyrosyl radical that will further produce the glycine imine51. However, the role of the 
iron sulfur cluster in Thz-P biosynthesis is still unclear as attempts to reconstitute in 
vitro enzymatic activity were unsuccessful58. 
 
‘Radical AdoMet’ superfamily 
 
ThiH is a 45 kDa protein that has been classified as a member of the ‘radical AdoMet’ 
superfamily  of  proteins52,59.  The  common  feature  of  radical  AdoMet  family  is  the 
presence of a highly conserved CXXXCXXC motif (table 1.4). Over 600 proteins have 
been identified as potential ‘radical AdoMet’ members.  
 
Lysine  2,3-aminomutase  (KAM)60,61,  pyruvate  formate  lyase  activase  (PFL-AE)62, 
anaerobic ribonucleotide reductase  (ARR-AE)63,  biotin synthase (BioB)64,65  and  lipoyl 
synthase (LipA)65,66 were the first enzymes to be classified as members of the ‘radical 
AdoMet’ superfamily (figure 1.3).  
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Table 1.4 Alignment E. coli ThiH with sequences from biotin synthase (BioB), lipoic acid 
synthase (LipA), anaerobic ribonucleotide reductase activating enzyme (ARR-AE), pyruvate 
formate lyase activating enzyme (PFL-AE) from E coli and lysine-2,3-aminomutase (LAM) 
from Bacillus halodurans. 
Protein  Residues  Sequence 
ThiH  83-94  N L C A N D C T Y C G F 
BioB  51-62  G A C P E D C K Y C P Q 
LipA  92-103  A I C T R R C P F C D V 
ARR-AE  24-35  S G C V H E C P G C Y N 
PFL-AE  28-39  Q G C L M R C L Y C H N 
KAM  131-71  N Q C S M Y C R Y C T R 
 
‘Radical  AdoMet’  enzymes  catalyse  a  single  electron  reduction  of  AdoMet  and 
subsequent homolysis to produce a highly reactive 5’-deoxyadenosyl radical (Ado●) 
and  methionine.  The  reduction  of  AdoMet  occurs  via  a  reduced  [4Fe-4S]1+  cluster, 
present  in  all  AdoMet  family  enzymes,  generating  Ado●  which  then  abstracts  an 
hydrogen from a substrate (scheme 1.12). This iron sulfur cluster is therefore essential 
for enzyme activity66-69.  
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Figure  1.3  Examples  of  reactions  catalysed  by  ‘radical  AdoMet’  enzymes.  (a)  lysine  2,3-
aminomutase (KAM); (b) general representation of the generation of glycyl radicals by pyruvate 
formate lyase activating enzyme (PFL-AE) and anaerobic ribonucleotide reductase activating 
enzyme (ARR-AE); (d) biotin synthase (BioB); lipoyl synthase (LipA). (*) marks the conserved 
hydrogen. Adapted from70. 
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Scheme 1.12 Mechanism of radical AdoMet enzymes. The reaction is initiated by the reduction 
of  [4Fe-4S]  cluster  that  transfers  an  electron  to  AdoMet,  forming  the  5’-Ado  radical  and 
methionine. Steps A and B are probably concerted, and it is unlikely that significant amount of 
Ado● accumulates in the active site. Ado is a highly reactive primary radical that is assumed to 
undergo  further  reactions  with  substrates,  usually  through  hydrogen  abstraction  to  form  a 
substrate radical. 
 
Step 1: Reduction of the [4Fe-4S]2+ cluster 
 
The first step of AdoMet mediated reactions is the reduction of the [4Fe-4S]2+ cluster to 
the +1 state. In vitro, dithionite66 and 5-deazaflavin71 can be used as reducing agents. 
The physiological reducing system [NADPH, flavodoxin (FldA), flavodoxin reductase 
(Fpr)]  (scheme  1.13)72-74  is  commonly  used  and  has  proved  to  be  more  efficient  for 
reducing PLF-AE, ARR-AE, BioB, LipA and MiaB. In other cases the reductant system 
is still unknown.  
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Scheme  1.13  Reduction  of  the  iron  sulfur  cluster  using  NADPH,  flavodoxin,  flavodoxin 
reductase system. The number of electrons transferred is indicated at each stage. 
 
Step 2: Formation of Ado● 
 
Due  to  the  strength  of  the  S-adenosyl  bond  (~60  kcal  mol-1),  AdoMet  cannot 
spontaneously cleave homolytically to produce Ado● and methionine. Therefore, one 
of the important features of radical AdoMet enzymes is the presence of an iron sulfur 
cluster,  allowing  them  to  initiate  radical  chemistry,  in  which  this  unusual  reaction 
takes  place.  The  radical  Ado  radical  has  never  been  experimentally  observed. 
However,  electron  paramagnetic  resonance  (EPR)  spectroscopic  studies  using  KAM 
and anhydroAdoMet, an AdoMet analogue, generate a stable, and therefore detectable, 
anhydroadenosyl radical75. Substrate carbon radicals have also been characterised by 
EPR with some enzymes: in KAM the substrate radical at C-3 has been detected using 
unsaturated analogues of lysine (trans-4, 5-dehydro-L-lysine) and 4-thia-L-lysine76; the 
glycyl radical of PLF77, ARR78, and benzylsuccinate synthase79 as well as the substrate 
benzylic radical in HemN80, have also been detected by EPR.   
 
The [4Fe-4S]+ clusters of KAM and PFL-AE have been shown to interact directly with 
AdoMet81,82, and in the case of PFL-AE, the interaction occurs through the binding of 
this cofactor at the non-cysteinyl-ligated unique Fe site81 (in these enzymes the cluster 
is  chelated  to  three  cysteines  of  the  CX3CX2C  triad)  (scheme  1.12).  This  direct 
interaction  may  provide  an  easier  route  to  the  reduction  and  homolytic  scission  of 
AdoMet. 
 
Step 3:  Hydrogen abstraction by Ado● 
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The Ado● formed upon AdoMet cleavage will abstract hydrogen atoms, either from 
substrate molecules to form radical intermediates, or from glycyl residues of enzymes 
to activate them for further radical chemistry83. The ‘radical AdoMet’ enzymes can be 
sub categorised into two main subfamilies.  
 
Subfamily 1 
Reactions via a glycyl radical intermediate 
 
These  enzymes  require  an  activase  to  bind  to  AdoMet.  Enzymes  that  have  been 
classified  as  members  of  this  subfamily  include:  PLF-AE,  ARR-AE,  Benzylsuccinate 
synthase  activase,  glycerol  dehydratase  activase  and  4-hydroxyphenylacetate 
decarboxylase  activase.  In  this  reaction,  AdoMet  acts  as  a  co-substrate  for  the 
production of a glycyl radical intermediate generated on a highly conserved glycine 
residue. The consumption of AdoMet is stoichiometric with respect to the enzyme. The 
glycyl  radical  is  transferred  to  the  cysteine  and  the  thiyl  radical  reacts  with  the 
substrate. This  step  is  catalytic, as  the  reaction leads  to  a weak  S-H bond that will 
donate a H● back to the product radical70. 
 
Subfamily 2 
Reactions via a direct hydrogen transfer from the substrate to Ado● 
 
Enzymes that have been classified as members of this subfamily include KAM and 
spore photoproduct lyase and the sulfur transfer enzymes BioB and LipA. 
 
Members of this subfamily do not require a protein derived radical intermediate. The 
hydrogen  is  transferred  directly  between  Ado●  and  the  substrate.  This  reaction  is 
reversible  and  the  deoxyadenosine  produced  in  the  C-H  bond  cleavage  returns  a 
hydrogen  to  the  rearranged  product  radical.  AdoMet  behaves  as  a  cofactor  in  this 
reaction. However, in most cases studied AdoMet is a co-substrate, with one molecule 
being consumed per cleavage of C-H bond. For recently discovered enzymes such as   25 
MoaA,  ThiH  and  formyl  glycine  synthase,  there  is  not  enough  experimental  data 
available to classify them as members of one of the two subfamilies70. 
 
Within this subfamily there is a subclass of enzymes that catalyses a specific reaction, 
the formation of C-S bonds at non-activated carbons. So far only BioB, LipA and MiaB 
have been identified to be part of this family. 
 
Biotin Synthase (BioB) 
 
Biotin synthase is responsible for the conversion of dethiobiotin 48 (DTB) into biotin 52 
via the insertion of a sulfur atom into an unreactive C-H bond of DTB. A mechanism 
has  been  proposed,  although  the  detailed  mechanistic  enzymology  by  which  this 
reaction occurs is still controversial (scheme 1.14)84,85.  
 
Jarrett and co-workers proposed that the active site of BioB contains two iron sulfur 
clusters. A [4Fe-4S]2+/1+, characteristic of all ‘radical AdoMet’ enzymes, responsible for 
the reduction of AdoMet,  and the second cluster, a [2Fe-2S]2+,  located at a different 
site86-89.  EPR,  Mossbauer  and  Raman  spectroscopic  studies  and  the  recently  solved 
crystal structure of BioB (figure 1.4), support this hypothesis90.  
 
The iron sulfur cluster present in BioB is oxygen sensitive, therefore isolated protein 
samples contain mainly [2Fe-2S], and addition of exogenous Fe2+ and S2- is required to 
reconstitute biotin synthase activity in vitro. When chemically reconstituted, protein 
samples  contain  a  1:1  mixture  of  the  two  clusters  ([4Fe-4S]2+/1+,  [2Fe-2S]2+),  as 
determined  by  Mossbauer  spectroscopy87.  It  was  also  verified  that  the  maximum 
turnover for this reaction was one. Figure 1.4 shows the 3D structure of the protein (a) 
and the section where AdoMet binds the iron sulfur cluster90. 
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Figure  1.4  (a)  Crystal  structure  of  biotin  synthase  monomer  (BioB)  from  E.  coli;  (b) 
amplification showing the AdoMet binding to the [4Fe-4S]+1 cluster to the unique Fe site of 
BioB. Dethiobition (DTB) and the [2Fe-2S]2+ cluster are also shown. Image created using POV-
Ray version 3.6 and Swiss-Pdb Viewer Deep View version 4.090.   27 
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Scheme 1.14 Biotin synthase mechanism. The number of electrons transferred is indicated at 
each stage. Adapted from42. 
 
Studies have suggested that the sulfur source is the [2Fe-2S] cluster present in BioB87-89. 
Mossbauer studies have shown that during the formation of biotin, the amount of [2Fe-
2S]2+ cluster decreases, whereas the amount of [4Fe-4S] cluster remained constant87,91. 
However,  studies  suggest  that  the  source  of  sulfur  in  this  reaction  derives  from 
cysteine of PLP, not from the [2Fe-2S] cluster92. 
 
The formation of radicals at C-6 and C-9 of DTB has been further clarified by Lotierzo 
and co-workers93. Isotopic labelling studies demonstrated that biotin synthase catalyses 
the direct transfer of H● between Ado● and the substrate. However, the reaction of Ado   28 
with  the  substrate  remains  to  be  clarified  as  isotopic  studies  proved  to  be 
unsuccessful93. 
 
Lysine 2, 3-aminomutase (KAM) 
 
Lysine  2,  3-aminomutase  (KAM)  is  the  most  thoroughly  studied  radical  AdoMet 
enzyme.  KAM  catalyses  the  interconversion  between  L-lysine  and  β-lysine,  by  an 
unusual reaction in which a hydrogen of C-3 exchanges position with the aminogroup 
on C-242. Figure 1.5 shows the 3D structure of the protein (a) and the section where 
AdoMet binds the iron sulfur cluster94. 
 
There  are  many  mechanistic  similarities  between  this  rearrangement  and  of  the 
reactions  catalysed  by  adesosylcobalamin(AdoCbl)-dependent  enzymes95,  which  is 
unsurprising as both AdoCbl and AdoMet act as sources of Ado radicals.   
 
In the interconversion of lysine and β-lysine, the 3-proR hydrogen migrates to the 2-
proR position of β-lysine with inversion of configuration, AdoMet is used as a cofactor 
given that the redox state of the substrate remains unchanged. Besides AdoMet this 
enzyme also requires pyridoxal phosphate (PLP) as a cofactor96,97. Studies using tritium 
labelled  AdoMet  showed  that  AdoMet  is  the  intermediate  carrier  of  hydrogen  in 
KAM98,99,  and  EPR  experiments  using  isotopically  labelled  substrates,  and  substrate 
analogs  of  lysine  have  allowed  various  radical  species  that  are  proposed  to  be 
intermediates in the mechanism to be identified100,101. 
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Figure 1.5 (a) Crystal structure of lysine 2,3-aminomutase (KAM) from C. subterminale; (b) 
amplification showing the AdoMet binding to the [4Fe-4S]+1 cluster to the unique Fe site of 
KAM  and  lysine  residue  binding  to  pyridoxal-5’-phosphate  (PLP).  Image  created  using 
POV-Ray version 3.6 and Swiss-Pdb Viewer Deep View version 4.094. 
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The mechanism of this reaction is outlined in scheme 1.16. Lysine binds to KAM as its 
external aldimine with PLP. The reversibly generated Ado●, from AdoMet in a reaction 
with the [4Fe-4S] cluster, abstracts a hydrogen atom from lysyl at C-3 to form AdoH 
and the lysyl radical 56. Cyclisation by radical addition to the π-bond of the imine 
group  produces  the  azacyclocarbinyl  radical  57,  a  quasisymmetric  intermediate. 
Forward ring opening of the azacyclopropylcarbinyl ring produces the β-lysyl radical 
58, which abstracts a hydrogen atom from methyl group of AdoH to regenerate Ado● 
and form the external aldimine between β-lysine and PLP 53. Release of β-lysine and 
binding of lysine in several steps recharges the enzyme for another cycle of catalysis102.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 1.16 Radical rearrangement catalysed by lysine 2, 3-aminomutase (KAM). Adapted 
from103. 
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In KAM, the mechanism by which AdoMet is cleaved by the iron sulfur cluster to 
generate Ado●, has been the subject of great interest. EPR spectroscopy studies have 
shown that KAM contains four forms of iron sulfur cluster: [3Fe-4S], [4Fe-4S]3+, [4Fe-
4S]2+ and [4Fe-4S]1+ 69,104. Two of these oxidation states are important for the reversible 
cleavage of AdoMet, [4Fe-4S]2+ and [4Fe-4S]1+.  
 
Several hypothetical mechanisms have been proposed for the generation of the radical 
that occurs upon the reaction of AdoMet with the iron sulfur centre  83. One of these 
mechanisms  involves  the  direct  interaction  between  the  unligated  iron  of  the  iron 
sulfur cluster and the sulfonium sulfur of AdoMet. This is associated with an inner 
sphere electron transfer that occurs simultaneously with the homolytic cleavage of C-S 
bond  of  AdoMet.  This  process  leads  to  direct  coordination  of  the  sulfur  of  the 
methionine with the iron, after generation of Ado● (scheme 1.17)83.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 1.17 Proposed mechanism for the reversible cleavage of AdoMet by the [4Fe-4S] cluster 
to generate Ado●. Adapted from83.   32 
An  electron  is  transferred  from  [4Fe-4S]+  to  AdoMet  and  the  C-S  bond  cleaves 
homolytically, leaving methionine and generating the 5’deoxyadenosyl radical (Ado●). 
This reactive radical will then abstract an hydrogen atom (3-pro-R) from the external 
aldimine  of  lysine  with  PLP.  This  mechanism  is  supported  by  X-ray  absorption 
spectroscopic studies (XAS) using Se-adenosyl-L-methionine (SeAdoMet)105.    
 
Comparison between the binding of AdoMet to the [4Fe-4S] cluster in KAM and BioB 
 
Electro paramagnetic resonance (EPR) experiments with KAM showed that the rates of 
formation of the organic substrate radical and the rate of decomposition of the [4Fe-
4S]1+ cluster signal were the same, as were the rates of formation of 5’-deoxyadenosine 
and methionine 76. The unligated iron is crucial for the interaction between the cluster 
and AdoMet, and EPR experiments demonstrated that addition of AdoMet (in absence 
of a substrate) to the protein changes the spectral properties of the cluster97,106-108. Recent 
spectroscopic studies resulted in two detailed proposals for the interaction of AdoMet 
and  the  Fe-S  cluster,  resulting  in  two  different  proposed  mechanisms  for  AdoMet 
cleavage (scheme 1.18). 
 
Studies  of  KAM  with  selenium  X-ray  absorption  spectroscopy  indicate  the  direct 
ligation of the sulfonium sulfur of AdoMet to the unligated iron  105. This study was 
complemented by experiments using electron double nuclear resonance that verified 
that the α-amino and α-carboxyl groups of AdoMet coordinate to the unligated iron of 
the cluster. Therefore, the proposed mechanism, for KAM, entails an electron transfer 
from the iron sulfur cluster to the sulfonium of AdoMet, consequent ligation of the iron 
to  the  sulfur  of  AdoMet  and  simultaneous  cleavage  of  the  S-C  bond  to  form  5’-
adenosyl radical (Ado●) resulting in a methionine coordinating the iron atom of the 
cluster97,109. 
 
Studies with BioB and PFL, using EPR and Mossbauer spectroscopy, suggest that the 
sulfonium of AdoMet is more closely associated with one of the sulfides rather then the 
unligated  iron  of  the  [4Fe-4S]1+    81,110-112.  The  proposed  mechanism  starts  with  an 
electron  being  transferred  from  the  [4Fe-4S]+1  cluster  to  AdoMet  via  a  sulfide-  33 
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sulfonium  interaction.  The  sulfonium-adenosyl  bond  from  AdoMet  cleaves 
homolytically  to  generate  Ado●.  In  this  proposed  mechanism,  methionine  can  only 
coordinate to the iron sulfur cluster through the amino and carboxyl groups112.  
 
These two different proposed mechanisms for AdoMet binding may suggest slightly 
different  functions  for  AdoMet  in  each  reaction.  Whilst  in  KAM,  AdoMet  is 
regenerated after each turnover, in BioB and PFL-AE AdoMet acts as a co-substrate 
and is consumed after each turnover. Coordination between the iron ion of the cluster 
and the sulfur of the methionine may have significant influence on the reactivity of the 
sulfur and therefore can alter reformation of AdoMet in the reaction109.  
 
(a) 
 
 
  
 
 
 
(b) 
 
 
 
 
 
 
 
Scheme 1.18 Binding of AdoMet to the [4Fe-4S]+1 cluster in: (a) KAM and (b) BioB. Adapted 
from95. 
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Thiamine biosynthetic protein ThiH 
 
As mentioned previously, ThiH is a member of the ‘radical AdoMet’ superfamily. As 
far as the classification of this protein within the radical AdoMet, ThiH is still part of an 
unknown subfamily because the mechanism by which the iron sulfur cluster (of ThiH) 
interacts with AdoMet to generate Ado and cleave tyrosine is still unknown. Thiazole 
synthase  catalyses  an  AdoMet  and  NADPH  dependent  radical  reaction,  being 
therefore  a  novel  example  of  the  diverse  chemistry  catalysed  by  ‘radical  AdoMet’ 
superfamily of enzymes. 
 
The proposed mechanism for Thz-P biosynthesis by Leonardi51, together with the new 
discoveries  achieved  by  Begley  and  co-workers  on  B.  subtilis,  leads  to  an  overall 
proposal for the biosynthesis of the thiazole moiety in E. coli (scheme 1.19).  
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Scheme 1.19 Proposed mechanism for Thz-P biosynthesis in E. coli. Adapted from43,58.   35 
The [4Fe-4S]1+ cluster of ThiH catalyses the reductive cleavage of AdoMet to generate 
Ado●. This highly reactive radical will then abstract an hydrogen atom from tyrosine 24 
and forms a tyrosyl radical 59 that will react cleaving the Cα-Cβ bond. Glycine 32 is 
released  together  with  the  quinone  methide  60.  Hydration  of  60  leads  to  p-
hydroxybenzyl alcohol 61, a known thiamine by-product113.  
 
1.6 Aims of this project 
 
The main aim of this project is to understand the mechanistic enzymology by 
which the thiazole moiety of thiamine is assembled by E. coli. This initially requires the 
expression, isolation and characterisation of the enzymes involved in these reactions 
and subsequent reconstitution of the in vitro activity. The properties of ThiH and ThiG 
have been reported; in particular of ThiGH complex. ThiH has been  classified as a 
member of the ‘radical AdoMet’ superfamily. All the members of this family have been 
shown  to  be  Fe-S  cluster  enzymes  requiring  S-adenosyl  methionine  (AdoMet)  for 
activity, and recent studies showed that the [4Fe-4S] cluster of ThiH is essential for the 
catalytic  activity.  However,  the  complex  isolated  has  a  deficiency  in  iron  content; 
therefore novel expression and purification techniques need to be explored with the 
purpose  of  producing  holo-ThiH,  and  consequently,  increase  the  activity  that  will 
facilitate the development of an in vitro assay to investigate thiazole biosynthesis and in 
particular, the mechanism of tyrosine cleavage. 
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CHAPTER 2 
Isolation and Reconstitution of Escherichia coli ThiH 
 
2.1 Introduction 
 
The investigation of the mechanism by which the thiamine precursor 4-methyl-5-(β-
hydroxyethyl)  thiazole  phosphate  (Thz-P)  is  assembled  required  the  isolation  of 
enzymes  involved  in  an  active,  stable  form.  Significant  progress  has  been  made  in 
elucidating  the  function  of  several  of  the  enzymes  involved  in  bacterial  thiazole 
biosynthesis as discussed in Chapter 1. However, limited progress had been made in 
understanding the function and mechanism of ThiH, a protein that shows considerable 
sequence  similarity  to  the  'radical  AdoMet'  family.   Initial  studies  by  R.  Leonardi58 
established methods for the expression, isolation and characterisation of ThiH. This 
enzyme was isolated in a complex with ThiG in an approximate 1:1 ratio. However the 
iron content of the purified protein complex was much less then expected containing 
around 1Fe (0.96 ± 0.03 Fe/ThiH) and 2S (1.87 ± 0.09 S2-/ThiH) atoms per ThiGH58, as 
opposed to 4 moles of Fe/protein expected in a [4Fe-4S] cluster protein. The isolation of 
iron sulfur cluster proteins containing less iron then expected is not uncommon114-116 as 
iron  may  be  lost, mainly  by  oxidative  degradation, either  during  the  expression  or 
purification procedure 114-116. For proteins of the ‘radical-AdoMet’ family, in which the 
cluster  rests  in  the  [4Fe-4S]2+  state,  oxidation  can  convert  it  to  a  metastable  form. 
Further exposure to oxidising conditions leads to additional degradation of the cluster 
which may result in a [2Fe-2S] or even an apo-form117.  The [4Fe-4S] cluster of ThiH is 
thought to be essential for its activity and therefore oxidative degradation results in 
inactivation  of  the  protein24.  To  avoid  this  problem,  R.  Leonardi58  developed  an 
anaerobic  purification  protocol  (method  12).  ThiGH  complex,  purified  using  this 
method, was tested for activity in an assay containing cell free lysates of de-repressed 
E.  coli  83-1,  tyrosine,  4-amino-5-hydroxymethyl-2-methylpyrimidine  (Hmp)  and   37 
adenosine triphosphate (ATP). The protein was shown to be active51. A hypothesis for 
this observation is that the cellular machinery required for cluster (re-) assembly may 
have been present in the cell-free lysates and facilitates reactivation of the ThiH in the 
holo- form. It was further observed that the addition of AdoMet, ferric chloride, sodium 
sulfide and NADPH doubled the relative thiamine forming activity in these assays. 
The effect of AdoMet on the activity is not perhaps very surprising, and is consistent 
with enzymes from ‘radical AdoMet’ family, but the effect of ferric chloride, sodium 
sulfide and NADPH may suggest that chemical reconstitution of ThiH to an active 
form is occurring in the assay.  
 
With  the  purpose  of  expressing  ThiGH,  several  plasmids  were  assembled  by  R. 
Leonardi (figure 2.1). These plasmids were derived from either a pBAD-HisA (araBAD 
promoter) or pET-24d(+) (T7 promoter) parental plasmid. Expression and purification 
studies showed that the nature of the expression system had significant influence not 
only on the production of soluble ThiGH complex but also on the iron and sulfide 
content  of  the  samples  (table  2.1)58.  It  was  observed  that  pET-derived  plasmids 
produced poor yield of cell paste compared to the plasmids derived from pBAD-HisA, 
possibly  due  to  the  fact that production  of protein  was  too  fast for  the  iron  sulfur 
cluster biosynthesis machinery to support; ultimately the protein becomes toxic to the 
cells, resulting in the formation of inclusion bodies58. Plasmids expressing ThiH with 
ThiG, ThiF and ThiS resulted in a higher level of soluble ThiGH and neither ThiF nor 
ThiS were detected in the purified samples. From the assembled plasmids, pRL1000 
and pRL1020 produced ThiGH samples containing higher content of iron and sulfide 
comparing to other expression plasmids (table 2.1)58. 
 
As previously mentioned the partial degradation or incomplete assembly of the iron 
sulfur cluster might explain the lower content in iron of the samples. With the purpose 
of investigating ways to assist in vivo formation of the iron sulfur cluster of ThiH, R. 
Leonardi assembled the pRL1021 plasmid (figure 2.1), encoding for iscSUA-hscAB-fdx 
downstream  from  the  thiFSGH  operon.  Proteins  encoded  by  the  iscSUA-hscAB-fdx 
operon  assist  Fe-S  cluster  assembly  in  vivo,  a  key  step  in  the  post-translational 
maturation of Fe-S cluster proteins118,119, therefore improving expression of enzymes in   38 
the holo- form120-122. Table 2.2 and figure 2.2 summarise the functions of each of these 
proteins. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.1 Artificial operons assembled in plasmids derived from either pBAD-HisA  (araBAD 
promoter) or pET-24d(+) (T7 promoter) used to study ThiH expression.  
 
 
Table 2.1 Sulfide and metal content of ThiGH-His samples isolated from different 
expression systems. The sulfide and iron values represent the mean of three independent 
measurements ± SD. Adapted from58. 
ThiGH-His from 
[vector/BL21(DE3)] 
Sulfide                                          Iron 
mol/mol ThiGH-His 
pRL800  0.69 ± 0.02  0.45 ± 0.05 
pRL820  2.31 ± 0.08  0.87 ± 0.02 
pRL1000  2.32 ± 0.06  0.91 ± 0.03 
pRL1020  1.87 ± 0.09  0.96 ± 0.03 
pRL1021  2.4 ± 0.1  1.36 ± 0.03 
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Table 2.2 Proteins of the Isc cluster and their functions. 
Gene  Orthologs  Potential Functions  References 
iscS  nifS, sufS 
Cysteine desulfurase 
Transfers the sulfur atom to IscU 
123-127 
iscU  nifU, sufU 
Scaffold protein 
Assembly of iron sulfur clusters 
128,129 
iscA  sufA 
Scaffold protein 
Assembly of iron sulfur clusters 
130 
iscR   
Iron sulfur cluster regulator 
Repressor for the Isc operon 
131 
hscA/hscB   
Molecular chaperones 
Facilitate [2Fe-2S] cluster transfer from IscU to 
apoferredoxin in ATP-dependent reactions 
132-134 
fdx   
Adrenodoxin-type ferredoxin 
Electron donor in cluster assembly 
135 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.2 Biosynthesis of iron sulfur clusters in bacteria. IscA, IscU and SufA are the central 
components. They function as molecular scaffolds mobilising the sulfur atoms from IscS or SufS 
and iron atoms from an iron donor to synthesise [4Fe-4S] or [2Fe-2S] clusters. Adapted from136.   40 
Initial in vitro experiments to test the activity of purified ThiH, carried out by Dr. M. 
Kriek in our laboratory, showed limited or no activity [as estimated by the turnover of 
14C-tyrosine (results not shown)], although the reasons for the lack of turnover were 
unclear. To solve this problem, a wide range of parameters that might have affected the 
activity were investigated: 
 
1.  Purification  methodology  -  several  modifications  were  applied  including: 
additions  to  the  chromatography  buffers  to  include  protective  reagents; 
modification of the chromatography media and methods used, including ion 
exchange  methods;  and  modification  of  the  affinity  tag  used  during  the 
purification.  
2.  In vivo assembly of holo-ThiH - modifications to the expression plasmid, effects 
of different E. coli strains and varying the growth conditions. 
3.  In vitro chemical reconstitution of purified ThiH into active holo-ThiH. 
 
The studies described in this chapter were carried out in parallel to the development of 
an in vitro assay (discussed in Chapter 3). 
 
2.2 Results and discussion 
 
2.2.1 Improving cell lysis 
 
The successful method for isolation of ThiGH, developed by Leonardi24, involved an 
aerobic cell lysis step using sonication. However, the release of ThiH protein from the 
cells into an aerobic buffer might result in a rapid degradation of the oxygen sensitive 
iron  sulfur  cluster.  Therefore,  before  attempting  any  other  approach  to  solve  the 
deficiency in iron content of ThiH, the effect of anaerobic cell lysis was investigated. 
This  might  produce  purified  protein  samples  with  higher  iron  content  and  in  turn 
result in a higher specific activity. Table 2.3 summarises the results obtained from both 
purification methods.  
   41 
Table 2.3 Comparison of two cell lysis methods during ThiGH-His purification. 
Cell Lysis 
Yield of protein 
(mg/g cell) 
Iron content 
mol/mol ThiGH 
Aerobic  2.2  0.97 ± 0.03 
Anaerobic  5.2  1 ± 0.05 
 
ThiGH-His was expressed using pRL1020, a plasmid containing the thiFSGH operon 
under the control of the arabinose promoter,  with a C-terminal His-tag attached to 
thiH.  Purification  of  ThiGH  was  carried  out  using  nickel  affinity  chromatography 
followed by a desalting gel filtration step, using aerobic cell lysis (method 12)  24. A 
second experiment was carried out using the same protocol described above but cell 
lysis was carried out anaerobically by using a sonicator placed inside the anaerobic 
glove  box  (method  12a).  The  iron  content  of  the  purified  protein  samples  was 
measured by the method of Fish (method 14)137. The new modified method (method 
12a), produced more efficient cell lysis (judged by the increase of the yield of protein) 
but also, on average, no increase of the iron content of ThiGH samples was observed. 
The elution of the ThiGH complex was identical in both methods (figure 2.3). 
 
 
 
 
 
 
 
 
 
 
Figure 2.3 Coomassie Blue stained 15% SDS-PAGE gel of ThiGH-His purification expressed 
from pRL1020/BL21(DE3) cells in 2YT medium. Lane 1: aerobic sonication; lane 2: anaerobic 
sonication. 
2.2.2  Improving in vivo assembly of holo-ThiH 
   1      2 
ThiH-His  
ThiG   42 
 
Two aspects were considered for the improvement of in vivo assembly of holo-ThiH: 
 
1.   E. coli  is  a facultative anaerobe  and  is able  to  grow under aerobic  or anaerobic 
conditions. In the absence of oxygen E. coli grows by anaerobic respiration with nitrate, 
nitrite, fumarate, dimethyl sulfoxide and trimethylamine N-oxide as electron acceptors 
or by fermentation138,139.  
 
ThiH production under anaerobic conditions is of interest as it may help to protect the 
Fe-S  cluster  from  oxidative  degradation.  The  [4Fe-4S]  cluster  of  ‘radical-AdoMet’ 
proteins is known to be particularly oxygen sensitive because, in the resting state, it is 
bound only by three cysteine ligands (CXXXCXXC motif): the fourth coordinating site 
is thought to be occupied by a labile water molecule which may provide a particularly 
effective route for attack by dioxygen (scheme 2.1). However, anaerobic metabolism is 
rather inefficient; therefore growth and protein production under these conditions can 
be  inefficient.  The  use  of  nitrate  as  the  terminal  electron  acceptor,  a  process  called 
denitrification, enhances growth whilst permitting the exclusion of dioxygen. 
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Scheme 2.1 Structure of the [4Fe-4S] cluster in the resting state. This cluster can either bind 
AdoMet or undergo oxidative degradation by dioxygen.  
 
2. The addition of supplements to the growth medium may favour efficient assembly 
and/or  protection  of  the  essential  iron  sulfur  cluster  of  ThiH.  This  included 
supplementing iron and other substrates to ensure efficient Fe-S cluster assembly.  
 
Studies using purified E. coli dihydroxy-acid dehydratase, fumarase A, fumarase B and 
mammalian aconitase, all belonging to the hydrolyase class that contain a catalytically 
active  [4Fe-4S]  cluster,  demonstrated  that  these  enzymes  are  inactivated  by  the 
presence  of  dioxygen.  In  this  work,  Flint  hypothesised  that  the  presence  of  O2, 
inactivates these enzymes by oxidizing their clusters to an unstable oxidation state, 
resulting in cluster degradation (scheme 2.1)140. This hypothesis was supported by the 
following findings: 1) a substrate protects against inactivation of the iron sulfur cluster 
enzyme,  2)  iron  is  lost  on  inactivation  as  would  be  expected  if  the  clusters  were   44 
oxidized, 3) enzymatic activity is recovered under conditions which lead to cluster re-
synthesis140.  Thus,  the  presence  of  a  substrate  in  the  growth  medium  or 
chromatography  buffers  might  prevent  the  oxidation  of  ThiH  [4Fe-4S]  cluster. 
Potentially, the addition of tyrosine, AdoMet or iron, which might all bind to the active 
site  of  ThiGH,  could  protect  the  cluster  during  cell  growth,  or  during  purification, 
leading to an increase in the yield of holo-ThiGH.  
 
With  the  aim  of  improving  in  vivo  assembly  of  holo-ThiH,  and  two  alternative 
expression systems available (pRL1020 encoding for thiFSGH and pRL1021 containing 
the additional isc operon); a number of experiments were carried out using modified 
growth conditions.  The purification methods used were  all  derived from  the  initial 
purification procedure developed by Leonardi (method 12)24. All anaerobic growths 
were  carried  out  at  low  temperatures  in  an  attempt  to  prevent  protein  misfolding 
(overnight at 4 ºC).  
 
Expression and purification experiments with pRL1020/BL21(DE3) 
 
When modifying the cell culture and purification methods, the results are compared at 
each  stage  to  the  yield  and  iron  content  of  ThiGH  anaerobically  isolated  from 
aerobically cultured pRL1020/BL21(DE3). 
 
Expression  experiments  using  pRL1020/BL21(DE3)  were  carried  out  aerobic  and 
anaerobically  (table  2.4).  Several  parameters  were  considered  when  optimising  the 
expression  of  ThiH,  including  the  yield  of  cell  paste  from  the  growth,  the  yield  of 
protein upon cell lysis and, after purification of ThiH, the iron content of the resultant 
protein.  Anaerobic  cell  growths  were  carried  out  using  glycerol  minimal  medium 
(GMM) and 2YT medium (with or without nitrate addition). A significant decrease of 
the yield of cells and protein content was observed (table 2.4, entries 1-4). In addition, 
no improvement was observed in the iron content of purified ThiGH. These results 
suggest that either anaerobic growth is not facilitating the assembly of holo-ThiH, or the 
holo-ThiH is being degraded during a subsequent step.   45 
SDS-PAGE  gel  analysis  of  ThiGH-His  purification  using  pRL1020/BL21(DE)3 
expression system under aerobic conditions is shown as an example (figure 2.4). The 
numbers on the left refer to the molecular weight marker in kDa; ThiH-His (44 kDa), 
ThiG (27 kDa). This notation will be used throughout this thesis. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure  2.4  Coomassie  Blue  stained  15%  SDS-PAGE  gel  of  ThiGH-His  purification  from 
pRL1020/BL21(DE3)  cells  in  2YT  medium.  M=  molecular  weight  marker  (kDa).  1: 
supernatant;  2:  re-suspended  cell  pellet;  FT:  flow  through.  The  numbers  correspond  to  the 
fractions  eluted  from  each  column;  11-19:  nickel-chelating  column,  1-7:  S-75  gel  filtration 
column  (obtained  by  pooling  fractions  11-16  from  the  nickel  column  and  loading  onto  gel 
filtration column).   
 
With the purpose of investigating the effect of nitrate addition in the production of 
holo-ThiH, investigations were initiated to determine the most suitable growth medium 
to  use  in  pRL1020/BL21(DE3)  expression  under  anaerobic  conditions.  Flint  and  co-
workers reported that minimal medium was a good choice for E. coli growth under 
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anaerobic conditions140. A comparison of the total cell biomass produced using glycerol 
minimal medium (GMM) or 2YT growth using the same conditions was carried out.  
 
A set of experiments were carried out in parallel (table 2.4). Sodium nitrate (40 mM, 
NaNO3) and sodium nitrite (5 mM, NaNO2) were added to 2YT and GMM medium. 
The yield of cells produced with 2YT growth was much larger than with GMM, but the 
yield of protein produced from GMM was higher then that from 2YT.  The purified 
ThiGH-His samples from these growths were then analysed by the method of Fish to 
determine  the  iron  content  (method  14)137.  Results  show  no  improvement  on  the 
production of holo-ThiH using this method, indicating that the addition of nitrates was 
not assisting in the in vivo production of ThiH, therefore, this line of investigation was 
terminated. 
 
Expression and purification experiments with pRL1021/BL21(DE3) 
 
Studies  on the effect  of substrate  addition were  initiated using pRL1021/BL21(DE)3 
expression system. Trial growths, under aerobic conditions, were carried out to assess 
the expression level of the proteins using GMM and 2YT medium (results not shown). 
Growths  using  2YT  medium  resulted  in  a  higher  yield  of  protein,  therefore  all 
experiments were carried out using this growth medium. 
 
Aerobic and anaerobic growth conditions were compared (table 2.4). Cells were grown 
initially aerobically in 3 L of 2YT supplemented with tyrosine (0.2 mM), ferrous sulfate 
(FeSO4,  0.3  mM)  and  ampicillin  (100   g/mL),  upon  reaching  an  OD600~0.6,  protein 
expression was induced. After induction, the cells were transferred to gas tight bottles, 
grown  anaerobically  overnight  and  harvested  anaerobically  in  gas  tight  centrifuge 
bottles. ThiGH-His was anaerobically purified by the optimised purification protocol 
(method 12a). During the elution of ThiH-His from the nickel-chelating column, two 
sets of equally concentrated fractions, named A and B and different in colour, were 
observed; these fractions were separately pooled and pool from batch B was desalted 
and concentrated. Batch A was intensely coloured and darker then batch B. SDS-PAGE   47 
analysis revealed the presence of YqjI (23 kDa) protein in both batches, but slightly 
more abundant in batch A (figure 2.5).  
 
                  A 
 
      
 
 
 
 
 
 
 
 
B 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.5 Purification of ThiGH-His from pRL1021/BL21(DE3) cells in anaerobic 2YT 
medium supplemented with iron and tyrosine. Coomassie Blue stained 15 % SDS-PAGE gels of 
proteins eluted from A: nickel-chelating column and B: gel filtration column (fractions 17-21, 
batch B); FT = flow through; W = washing; P = re-suspended pellet; M = molecular weight 
marker (kDa). The numbers correspond to fraction numbers.  
 
 
 
 
Batch A  Batch B 
17 
12 
 
42 
66 
76 
30 
ThiH-His  
ThiG 
M  11  12  13  14  15  16  17  18  19  20  *  21   
YqjI 
ThiH-His  
ThiG 
YqjI 
17 
12 
 
42 
66 
76 
30 
M      3    4     5     6     *    FT   P    W1  W2     48 
R. Leonardi also reported the co-elution of this protein with ThiGH when isolated from 
pRL1021/BL21(DE3) expression system58. In these experiments however, no exogenous 
iron  had  been  added  to  the  growth  medium,  also,  the  growth  was  carried  out 
aerobically. Leonardi further investigated this protein. N-terminal sequencing of the 
protein  and  a  database  search  based  on  the  knowledge  of  the  first  seven  residues 
(SHHHEGL) identified a protein, YqjI containing eleven histidines in a sequence of 
forty  residues,  thus  rationalising  the  high  affinity  for  the  nickel-chelating  column.  
Although not characterised in detail, this protein shows a broad absorption maximum 
at 420 nm and may contain an iron cofactor resulting in the dark colour of the batch58.  
Therefore the additional iron may be associated with the presence of YqJI. The nature 
of  this  correlation  is  presently  unclear  as  the  function  of  the  protein  is  thus  far 
unknown.  The  iron  content  of  isolated  ThiGH  was  2.6  Fe/ThiH  from  anaerobically 
cultured cells, supplemented with additional iron and tyrosine. Table 2.4 summarises 
the list of methods used as well as the results obtained from each experiment.   
 
Studies on YqJI mutants have been continued by Mr. M. Challand. These experiments 
were designed to test whether E. coli cells with the genomic copy of YqJI deleted would 
provide a valuable system for production of holo-ThiH. However, the deletion of YqJI 
seems to adversely effect cell growth, as a typical 5L cell growth, using a –YqJI strain, 
produced  only  13.3  g  cell  paste,  and  SDS  PAGE  analysis  of  protein  expression 
suggested no improvement to the yield of ThiGH. 
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Table 2.4 Expression  of ThiGH-His using a range of growth conditions and two expression 
systems. 
pRL1020/BL21(DE3) 
Cellular 
respiration 
Growth 
medium 
Additives 
Yield 
Cells 
(g/L) 
Yield Protein 
(mg/g cell) 
Iron 
Content◊ 
(ThiH:Fe) 
Methods* 
aerobic  2YT  -  7.6  5.2  1:1  11, 13 
GMM  -  1.4  n/m  1:1 
-  2.5  0.2  1:1 
anaerobic 
2YT  NaNO3 
NaNO2 
1.4  0.3  1:1 
6.4.1, 6.4.4 
pRL1021/BL21(DE3) 
Cellular 
respiration 
Growth 
medium 
Additives 
Yield 
Cells 
(g/L) 
Yield Protein 
(mg/g cell) 
Iron 
Content◊ 
(ThiH:Fe) 
Methods* 
aerobic  2YT  -  7  3.5  1:2  11, 13 
-  1  ?  - 
-  1.8  n/m  1:2 
iron  1  0.72  1:1.2 
tyrosine  1  n/m  - 
1  1.1  1:2.2 
6.4.2, 6.4.4 
anaerobic  2YT 
tyrosine, 
iron  2.7  3.7  1:2.6  6.4.3, 13 
◊ Iron content determined by the method of Fish (method 14)137; * Methods used for 
expression  and  purification;  the  numbers  correspond  to  the  experimental  methods 
(general methods: 11, 13; experimental for chapter 2: 6.4.1, 6.4.2, 6.4.3, 6.4.4); n/m: not 
measured. 
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2.2.3 Improving purification methodology 
 
2.2.3.1 Chromatography 
 
i) Affinity chromatography: hexahistidine tag 
 
ThiH  from  E.  coli  was  successfully  purified  in  a  complex  with  ThiG  using  several 
expression plasmids (described above) that make use of a C-terminal hexahistidine-
tagged ThiH (ThiH-His)58. This strategy has been employed for the isolation of many 
proteins  containing  an  oxygen  sensitive  iron  sulfur  cluster64,66,115,141.  Nevertheless, 
because the iron content of the purified protein was consistently lower then expected, 
an  explanation  for  this  result  might  be  that  the  imidazole,  used  to  elute  proteins 
containing a His-tag, participates in the removal of the iron from the protein. Therefore 
other affinity chromatography methods, which do not involve elution with imidazole, 
were investigated. 
 
ii) Strep-tag purification 
 
The Strep-tag system was considered to be potentially valuable for metallo-enzymes 
such as ThiH, as an alternative to the His-tag method because it involves elution from 
an affinity column using dethiobiotin (DTB). This purification system is based on the 
interaction between the Strep-tag II affinity peptide (NH2-WSHPQFEK-COOH)142 and 
StrepTactin, a specifically engineered streptavidin143 (figure 2.6, step 1). The elution is 
based on the displacement of the Strep-tag II protein by dethiobiotin (DTB, 2 mM), 
which  is  a  specific  competitor  (figure  2.6,  step  2).  Dethiobiotin  binds  reversibly  to 
streptavidin with an association constant (Ka) of 5 × 1013 M-1, with a less tight binding 
constant then the natural ligand, biotin (1 × 1015 M-1); this competitive elution is based 
on specificity, which allows the one-step purification providing a simple and efficient 
method142,144.   
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 Figure 2.6 Step-tag purification system. 
 
In  order  to  use  this  method  for  ThiH  purification,  two  plasmids  were  assembled: 
pFM700, encoding for thiFSG and a C-terminal Strep tagged thiH (ThiH-StagII) (figure 
2.7) and pFM707, encoding for thiFSGH-StagII and the isc operon (figure 2.8) (method 
6.4.5). Purified expression plasmids, pFM700 and pFM707, were used to transform E. 
coli BL21(DE3) cells (method 2) for cell culture and expression. 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.7 Map of pFM700. The restriction sites used to insert ThiH-StagII are indicated in 
blue (XhoI/NcoI). MCS = multiple cloning site. araBAD = operon promoter. Image created 
using pDraw32 DNA analysis software v1.0145. 
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Figure 2.8 Map of pFM707. The restriction sites used to insert ThiH-StagII are indicated in 
blue (XhoI/NcoI).  MCS = multiple cloning site. araBAD = operon promoter. Image created 
using pDraw32 DNA analysis software v1.0145. 
 
The cell paste obtained from the plasmid pFM707/BL21 (DE3) was dark brown (table 
2.5), similar to that obtained with pRL1021 (both plasmids encoding Isc proteins). This 
dark brown colour is thought to be associated with the presence of [4Fe-4S] clusters. 
ThiGH-Stag  obtained  from  these  growths  was  purified  with  a  Strep-tag  II  affinity 
column and the eluted fractions were analysed by SDS-PAGE gel (method 8). 
 
Similar results were obtained from all the purifications using Strep-tagged proteins. As 
an example figure 2.9 shows the analysis of the fractions obtained from purification of 
pFM700/BL21(DE)3 grown aerobically. 
 
Table 2.5 Expression of pFM700/BL21(DE3) and pFM707/BL21(DE3). 
Aerobic  Anaerobic 
Expression 
plasmid 
Yield of cells 
g/L 
Colour of cells  Yield of cells 
g/L 
Colour of cells 
pFM700  6.8  Light brown  3.6  Brown 
pFM707  5.4  Dark brown  -  - 
pRL1020  7.6  Light brown  2.5  Light brown 
pRL1021  7.0  Dark brown  2.7  Dark brown 
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B 
 
 
 
 
 
 
 
Figure 2.9 Coomassie Blue stained 15% SDS-PAGE gel of ThiGH-Stag purification expressed 
from pFM700/BL21(DE3) cells. M= molecular weight marker (kDa). P: re-suspended cell pellet; 
gel A: fractions 6-11 eluted during the wash with buffer A; gel B: fractions 13-19 eluted with 
buffer B (2.5 mM DTB); M2: purified ThiGH-His from pRL1020/BL21 (DE3). The numbers 
correspond to the fractions eluted from the column. 
 
In all purification experiments it was observed that most of the ThiGH complex eluted 
directly through the column during the wash step (lanes 9, 10 and 11, figure 2.9), and 
only  monomeric  ThiH  was  eluted  by  dethiobiotin  with  very  little  ThiG  associated. 
These observations may be explained if, due to the size of the ThiGH complex, the 
Strep-tag peptide attached to ThiH cannot efficiently bind to the resin; the quaternary 
structure of the ThiGH complex may cause the Strep-tag to be sequestered within the 
large complex and therefore is not able to reach into the rather deep biotin binding 
pocket of streptavidin (figure 2.10). Monomeric ThiH, however, binds more efficiently 
to the column, as observed by SDS Page gel analysis (figure 2.9). Figure 2.11 shows the 
hypothesised interaction of (ThiGH)6 complex and monomeric ThiH to the StrepTactin 
resin. 
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Figure 2.10 Crystal structure of avidin (1) and surface presentation of the biotin-binding region 
of avidin (2). Image created using POV-Ray version 3.6 and Swiss-Pdb Viewer Deep View 
version 4.0146. 
 
Iron analysis (method 14) of the purified sample shows that 1 mol of purified ThiH-
StagII contains only 0.08 moles of Fe. This is a disappointing result, but it is consistent 
with hypothesis that holo-ThiH protein is stabilised by the formation of the complex 
with ThiG58. 
 
(ThiGThiH)6 Complex
C-terminal affinity tags
monomeric ThiH
StrepTactin Resin
ThiH
ThiH
ThiH
ThiG
ThiG
ThiG
ThiH
ThiH
 
 
Figure  2.11  Schematic  view  of  ThiGH  complex  and  monomeric  ThiH  interacting  with 
StrepTactin resin. For clarity only partial view of the structure is shown is the scheme. 
One approach to solve this problem and improve the use of the Strep-tag system for 
ThiH purification would be the insertion of a flexible linker between the main ThiH   55 
sequence  and  the  strep-tag  sequence,  thus  permitting  more  efficient  binding, 
particularly of the ThiGH complex. Another alternative would be to add the Strep-tag 
to the N-terminus of ThiH, or to either terminus of ThiG. However, success in chemical 
reconstitution  of  ThiGH,  isolated  from  pRL1020  and  His-tag  (described  in  section 
2.2.4), made further developments of this method redundant and this approach was 
not continued. 
 
iii) Ion exchange chromatography 
 
The  first  attempts  to  purify  ThiH  were  carried  out  aerobically  using  ion  exchange 
chromatography58. This method was originally abandoned due to the presence of a 28 
kDa protein, subsequently identified as ThiG.  
 
Ion  exchange  chromatography  was  thought  to  be  an  alternative  to  the  affinity 
chromatography since elution is based on a salt gradient, rather then imidazole, and 
therefore worthy of re-investigation. In this technique, separation is dependent upon 
the  interaction  between  the  charged  solute  molecules  and  the  opposite  charge 
immobilised  ion  exchange  groups.  These  interactions  can  be  controlled  by  varying 
conditions such as ionic strength and pH.    
 
Q and S sepharose are commonly used resins in ion exchange chromatography. Q-
Sepharose Fast Flow is a strong anion exchanger where the ion exchange group is a 
quartenary amine group (–O–CH2CHOHCH2OCH2CHOHCH2N+(CH3)3).  S-Sepharose 
Fast Flow is a strong cation exchanger. The ion exchange group is a methyl sulfonate (-
CH2SO3-).  The  elution  of  proteins  bound  to  an  ion  exchange  resin  is  typically 
accomplished by varying the concentration of salt in the elution buffer; also the ionic 
interaction between the protein and the resin can be manipulated as the charge of the 
protein is determined by its pI and the buffer pH.  
 
 
The isoelectric point (pI) of ThiGH complex was estimated in order to assist on the 
choice of purification conditions, i.e. type of resin, pH. The pI of ThiG and ThiH was   56 
calculated separately using Expert Protein Analysis System (ExPASy)147; pI(ThiH)= 6.57 
and pI(ThiG)=5.36, as a result the average pI for the ThiGH complex is estimated to be 6.   
 
ThiGH was expressed from pRL1021/BL21(DE3), aerobically in 2YT medium without 
the addition of supplements (method 7) and purified using Q-Sepharose at pH 8.0. The 
protein was eluted from the column using a gradient of salt (0-500 mM NaCl) (method 
6.4.7). During the elution gradient three different coloured fractions were observed; 
lower  concentration  of  salt  eluted  protein  with  light  yellow  colour,  turning  into 
greenish  and  after  pinkish  colour  towards  the  end  of  the  elution.  ThiGH  complex 
eluted in fractions 46-54, as shown by SDS-PAGE gel analysis (figure 2.12), together 
with a band tentatively identified as IscU (13.8 kDa), an iron sulfur cluster scaffold 
protein.  
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Figure 2.12 Coomassie blue stained 15% SDS-PAGE gel of ThiGH purification expressed from 
pRL1021/BL21(DE3)  cells  with  Q-Sepharose.  M=  molecular  weight  marker  (kDa);  P=  re-
suspended pellet; S= supernatant; gel A: fractions 1-29 eluted during the wash using salt free 
buffer A; gel B: fractions 36-56 eluted using 500 mM NaCl buffer; M2= purified ThiGH-His 
from pRL1020/BL21(DE3) using nickel affinity chromatography. The numbers correspond to 
the fractions eluted from the column. 
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The UV-visible spectra of the different colour fractions (28, 48 and 54) were recorded 
(figure 2.13, 2.14 and 2.15). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.13 UV-visible spectra of fraction 28 (light yellow colour).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.14 UV-visible spectra of fraction 48 (yellow-greenish colour). 
 
 
 
 
 
 
 
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
1.6
1.8
2.0
2.2
2.4
300 400 500 600
Absorbance
Wavelength (nm)
Purification of ThiFSGH Isc Hsc (aerobic growth) with Q Sephrose 07 03 05; Fraction 48
ThiH 
ThiG 
IscU 
YqjI 
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
1.6
1.8
2.0
2.2
2.4
300 400 500 600
Absorbance
Wavelength (nm)
Purification of ThiFSGH Isc Hsc (aerobic growth) with Q Sephrose 07 03 05; Fraction 28
40 kDa   59 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.15 UV-visible spectra of fraction 54 (pinkish colour). 
 
Fe-S cluster proteins are normally coloured because of their characteristic absorbance 
between 400 and 500 nm; more specifically they tend to be dark brown-reddish colour 
if containing [4Fe-4S] or [3Fe-4S] clusters114,115,148,149. UV-visible spectra analysis revealed 
that the shoulder at around 400 nm is probably associated with Isc proteins present in 
the samples. The spectra of fraction 28 has a shoulder at 410 nm which, initially was 
thought to be associated with an intact Fe-S cluster of ThiH but SDS-PAGE gel analysis 
revealed the presence of an unidentified 40 kDa protein, which might be IscS (~ 45 
kDa).  Studies  by  Mihara  and  co-workers150  have  shown  that  IscS  has  a  maximum 
absorbance at 420 nm, but when reduced it loses the pyridoxal phosphate co-factor 
producing a peak at 335 nm; this is consistent with the observed spectra of fraction 28, 
the yellow colour of this fraction also indicates that it could be IscS. Fraction 48 shows a 
peak at ~400 nm, which could be attributed to a Fe-S cluster, but the presence of the 
23kDa protein YqJI, together with the fact that fraction 54 has a lower absorbance at 
this wavelength (when YqJI is not present), leads to the conclusion that in fact this 
feature is due to the presence of this protein and not ThiH related.  
 
Fraction  48  was  further  purified  using  S-sepharose  resin  at  pH  6.7.  The  pH  of  the 
protein sample was adjusted before purification to 6.7. The protein was eluted from the 
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column using a gradient of salt (0-500 NaCl) (method 6.4.8). Figure 2.16 shows a SDS-
Page gel analysis of the fractions obtained from this purification. 
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Figure 2.16 Coomassie Blue stained 15% SDS-PAGE gel of ThiGH purification from fraction 
48 eluted from Q-Sepharose using S-Sepharose at pH 6.7. M= molecular weight marker (kDa); 
gel A: fractions 1-10 eluted during the wash with salt free buffer A; gel B: fractions 11-17 eluted 
with 500mM NaCl buffer; M2: purified ThiGH-His from pRL1020/BL21(DE3) using nickel 
affinity chromatography. The numbers correspond to the fractions eluted from the column. 
 
During  the  beginning  of  the  salt  gradient,  a  small  amount  of  ThiGH  complex  was 
eluted from the column (fractions 11 and 12), together with other proteins. Towards the 
end  of  the  gradient,  mainly  monomeric  ThiH  (44  kDa)  eluted  together  with  the 
proteins  IscU  (13.8  kDa)  and  IscS  (45  kDa)  (fractions  14-17).  This  chromatographic 
method proved to be ideal for the isolation of monomeric ThiH, but due to previous 
observations of monomeric ThiH behaviour, i.e. high tendency to precipitate when not 
in  a  complex  with  ThiG,  this  purification  method  was  not  used  for  large  scale 
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purifications.  However,  after  a  successful  chemical  reconstitution  and  isolation  of 
stable  holo-ThiH,  using  His-tag  affinity  chromatography  (described  in  sections  2.2.4 
and 2.2.5), this method could now be re-considered for isolation of holo-ThiH. 
 
2.2.3.2 Modified purification buffers 
 
Throughout  this  project,  many  variations  to  the  cell  growth  medium  and 
chromatography  were  attempted.  Using  nickel  affinity  chromatography,  and 
expression from pRL1020/BL21(DE3), which proved to be so far the best expression 
system  for  ThiGH,  a  range  of  purification  buffers  were  tested  (method  6.4.9).  The 
changes in purification buffers are discussed in the next paragraphs and listed in table 
2.6. All the purified protein samples were analysed for iron content using the method 
of Fish (method 14).  
 
(a)  Tris  buffer,  pH  8.0:  this  buffer  was  used  in  the  initial  purification  procedure 
developed by R. Leonardi (method 12)58. ThiGH complex was purified in a 1:1 ratio 
eluting  consistently  in  fractions  9  to  23.  The  earlier  eluted  fractions  contain  higher 
concentration  of  ThiGH  complex  (9  –  17)  and  later  fractions  mainly  contained 
monomeric ThiH (18 – 23). Only fractions containing high ratio of ThiH:ThiG complex 
were  desalted  and  used  for  further  studies.  Even  if  this  method  was  highly 
reproducible, purified samples of ThiGH not only contain low iron content but showed 
a high tendency to precipitate. To overcome this problem glycerol was added routinely 
to  the  samples  to  a  final  concentration  of  25%  (w/v).  ThiGH  complex  could  be 
concentrated to a maximum of 5-6 mg/mL. The iron content of the purified samples 
was 1:1 (mol Fe/mol ThiH). 
 
(b)  MOPS  buffer,  pH  7.7:  since  Tris  buffer  interferes  with  amino  acid  analysis,  the 
purification buffer was replaced by MOPS buffer (method 13). The use of this buffer 
did not alter the behaviour of the protein during purification. ThiGH complex was still 
routinely  obtained  around  the  same  fractions,  and  the  ratio  of  ThiGH  complex  to 
monomeric  ThiH  was  similar  to  that  obtained  whilst  using  Tris.  However  protein 
purified using this buffer, possibly assisted by the addition of an anaerobic cell lysis   62 
step, was far more stable. In addition, the yield of protein was much higher then that of 
previous experiments. For this reason, the addition of extra glycerol to the final protein 
samples was not required; and also less glycerol was added to the purification buffers 
[10% (w/v) rather than 12.5% (w/v)]. The iron content of the purified samples using this 
buffer  increased  compared  to  the  previous  method,  and  was  in  average  1.4:1  (mol 
Fe/mol ThiH). 
 
(c) MOPS buffer, pH 7.7 supplemented with dithionite: to improve anaerobicity, dithionite 
(final concentration 1 mM) was added to the purification buffers. ThiGH complex was 
isolated successfully and in a stable form. However, the iron content of the purified 
ThiGH samples was low, containing only 0.6 mol of Fe per mol of ThiH. 
 
(d)  MOPS  buffer,  pH  7.7supplemented  with  AdoMet:  AdoMet  might  prevent  oxidative 
degradation of the iron sulfur cluster of ThiH during purification, by competing with 
oxygen to bind the unligated iron of the cluster (section 2.2.2, scheme 2.1). Due to the 
significant amounts of AdoMet required, a low-cost source of AdoMet was identified. 
SAM-e® tablets are commercially available pills that contain AdoMet (also abbreviated 
as  SAM).  An  extraction  procedure  was  developed,  followed  by  quantification  of 
AdoMet present in the tablets by RP-HPLC (method 6.4.10). On average, each tablet 
contained approximately 35% (w/w) of pure AdoMet. Bearing this in mind, AdoMet 
was added accordingly to the purification buffers to final concentration of 0.5 mM. 
ThiGH  complex  was  purified  with  high  stability.  The  highest  yield  of  protein  was 
obtained using this method (8.5 mg protein/g cell) but unfortunately no improvement 
was observed on the iron content of the samples. 
 
(e) MOPS buffer, pH 7.7 supplemented with AdoMet and tyrosine: the addition of substrates 
might also prevent oxidative degradation of the iron sulfur cluster140. AdoMet (final 
concentration  0.5  mM)  and  tyrosine  (final  concentration  1  mM)  were  added  to  the 
purification buffers. The protein obtained was highly stable and contained higher iron 
content, 1.5 mol of Fe per mol of ThiH. 
   63 
(f) MOPS buffer supplemented with tyrosine: due to the successful isolation of ThiGH with 
increase of iron content and stability (e), tyrosine was added to the purification buffers; 
1) pH 7.7; final concentration of tyrosine 1 mM: ThiGH eluted using these purification 
buffers eluted normally, and a significant increase in iron content was observed (2.5 
mol of iron per mol of ThiH). However, after storage at - 80 ºC, freeze and thawed, 
samples showed low stability resulting in slight protein precipitation. 2) pH 7.4, final 
concentration of tyrosine  2 mM:  ThiGH  eluted  using  these  purification  buffers  eluted 
normally,  and  as  in  previous  experiments  significant  increase  in  iron  content  was 
observed (2.0 mol of iron per mol of ThiH). After storage at -80 ºC, freeze and thawed, 
samples showed low stability resulting in slight protein precipitation. 
 
(g) MOPS buffer, variation to pH 7.0 and 6.5: variations on the pH of the purification 
buffers were carried out. ThiGH was purified using the novel method (method 13), and 
eluted as expected. However after storage at -80 ºC, freeze and thawed the purified 
protein  samples  showed  very  low  stability  and  high  tendency  to  precipitate. 
Nevertheless, the iron content of ThiGH was higher then when purified at pH 7.7 (pH 
7.0: 1.8 mol of iron per mol of ThiH; pH 6.5: 1.7 mol of iron per mol of ThiH). 
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Table 2.6 Buffers used for purification of ThiGH-His from pRL1020/BL21(DE3). 
Buffer  pH  Additives 
Yield of 
protein 
(mg/g cell) 
Iron 
content 
(ThiH/Fe) 
Protein 
stability* 
Method* 
-  2.2  1:0.9  Medium  12 
Tris*  8.0 
-  2.8  1:1  Medium  12a 
-  5.2  1:1.2  High  13 
dithionite,  1 mM  4.1  1:0.6  Low 
AdoMet, 0.5 mM  8.5  1:1  High 
AdoMet, o.5 mM 
Tyrosine, 1 mM 
5.7  1:1.5  Medium 
7.7 
Tyrosine, 1 mM  5.1  1:2.4  Medium 
7.4  Tyrosine, 2 mM  4.0  1:2  Low 
7.0  -  4.3  1:1.8  Very low 
MOPS** 
6.5  -  3.6  1:1.7  Very low 
6.4.9 
* 12.5% (w/v) glycerol; ** 10% (w/v) glycerol 
 
As an example, figure 2.17 shows the SDS-PAGE gel analysis of ThiGH purification 
using MOPS buffer (pH7.7, 2 mM tyrosine). 
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Figure  2.17  Example  of  a  purification  of  ThiGH-His  using  modified  purification  buffers. 
Coomassie Blue stained 15% SDS-PAGE gel of ThiGH purification using MOPS buffer, pH 
7.4,  containing  2mM  tyrosine.  M:  molecular  weight  marker  (kDa);  S:  supernatant;  P:  re-
suspended pellet; FT: flow through from nickel affinity column; gel A: fraction 16-28 eluted 
from nickel affinity column; gel B: fractions 2-6 eluted from gel filtration column. The numbers 
correspond to the fractions eluted from the column.  
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2.2.4  In vitro chemical reconstitutions of ThiH 
 
In  parallel  with  these  purification  studies,  Dr.  M.  Kriek  of  our  laboratory  was 
investigating the chemical reconstitution of ThiGH. These experiments were critical to 
achieving active holo-ThiGH and are discussed in the following section. 
Fe-S  clusters  can  easily  interconvert  (figure  2.18),  depending  on  the  oxidising  or 
reducing  conditions65,148,151,152.  They  can  undergo  conversion  from  the  free  to  the 
protein-bound form and also oxidative degradation140. 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.18 Interconversion between Fe-S clusters. Adapted from58. 
 
As discussed in section 2.2.2, the biogenesis of iron sulfur clusters requires a group of 
specific proteins (Isc proteins). However, protein-bound [2Fe-2S] and [4Fe-4S] clusters 
can be obtained in vitro by chemical reconstitution. Studies with BioB and LipA show 
that by incubating apo-protein with an excess of iron and sulfide (5-10 molar excess) 
under  anaerobic  conditions62,153,154  it  is  possible  to  obtain  fully  reconstituted  protein 
containing  about  4Fe/polypeptide  chain65,151.  Chemically  reconstituted  ArrAE  and 
MiaB,  however,  contain  only  2-3  Fe/polypeptide  chain68,115.  Anaerobically  purified 
ThiGH complex, from pRL1020/BL21(DE3), typically contains 1.0 ± 0.4 mol equivalent 
of Fe per mol of ThiH, but was occasionally higher (up to 2 equivalents of Fe).  
 
S
S Fe
Fe
OH2
Cys
Cys
Cys
Fe
S
S
S
Fe
Fe
S
Cys
Cys
Cys
[3Fe-4S] 
0/1+ [2Fe-2S] 
1+/2+
Fe
S
S
S
Fe
Fe
Fe
S
Cys
OH2
Cys
Cys
[4Fe-4S] 
1+/2+
+ Fe
2++ S
2- + Fe
2++ S
2-
- Fe
2+- S
2- - Fe
2+- S
2-
+ Fe
2++ S
2-
- Fe
2+- S
2-
Apo-
protein
Reducing conditions 
Oxidising conditions   67 
An optimised protocol for chemical reconstitution of ThiH was developed by Dr. M. 
Kriek  over  many  purifications  and  months.  This  optimisation  involved  the 
collaboration of the author who provided protein samples used for these experiments 
and final stages of optimisation. The optimised method can be summarised as follows: 
purified ThiGH complex was gently mixed with DTT solution (1 mL of 200 mM stock 
solution prepared in buffer D: 50 mM MOPS, 100 mM NaCl, 10% (w/v) glycerol) to a 
final concentration of 83  M. After 15 minutes, 5 mol eq of FeCl3 in water (40  L, 10 
mM) was added very carefully in small aliquots (5  L), and after a further 10 minutes, 
5 mol eq of Na2S in water was added likewise (total added 40  L, 10 mM). The protein 
solution was then incubated for another 2 hours, and the precipitated iron sulfide was 
removed by centrifugation. Because iron particles are very fine, further removal was 
carried out by applying the solution to a NAP-10 gel filtration column pre-equilibrated 
and eluted with buffer D (method 6.4.11).   
 
The  iron  content  was  analysed  by  the  method  of  Fish  (method  14).  Reconstituted 
ThiGH  could  be  concentrated  to  a  maximum  concentration  of  40  mg/mL  using  a 
Biomax  5000  molecular  weight  cut-off  Ultrafree  0.5-mL  centrifugal  filter  (method 
6.4.11).  
 
Whilst this method was being developed, several factors were identified as important: 
 
-  The incubation period with fresh DTT solution, should be around 15 minutes, 
as  samples  incubated  for  longer  period  show  more  tendency  to  precipitate 
upon the addition of FeCl3. 
-  The  FeCl3 solution proved to  be more  effective  when  freshly prepared  from 
black anhydrous FeCl3, whereas the use of brown (wet) FeCl3 did not result in a 
successful reconstitution, i.e. ThiGH precipitation. 
-  The addition of the FeCl3 and Na2S solutions have to be carried out very slowly, 
small aliquots added with intervals and gentle mixing, otherwise resulting in 
protein precipitation.   68 
-  The  concentration  process  has  to  be  carried  out  very  carefully  to  avoid 
precipitation,  allowing  small  intervals  of  mixing  the  solution  whilst 
concentration is taking place.   
 
After chemical reconstitution and gel filtration, the iron content was measured as 5.2 ± 
1.3 mol equivalents of Fe per mol of ThiH, suggesting some residual non specifically 
bound iron may remain in these samples (method 14).  
 
Reconstituted protein could be stored at -80 ºC without any effect on the stability of the 
protein. However, reconstituted and concentrated samples showed a slight tendency to 
precipitate when frozen and thawed. Therefore, concentration of the protein was only 
carried out when protein needed to be used for other experiments.  
 
Comparative UV-visible spectra of purified ThiGH and purified/reconstituted ThiGH 
were  recorded.  This  experiment  was  carried  out  using  an  Ocean  Optics 
spectrophotometer attached to a cuvette holder placed inside the glove box (method 
6.4.12). 
 
Samples were thawed inside the glove box, diluted with anaerobic buffer D [50 mM 
MOPS, 100 mM NaCl, 10% (w/v) glycerol] to a final concentration of 1 mg/mL and 
spectra recorded at the range 250-700 nm, against buffer D. For reconstituted protein, 
the iron excess removed from samples by centrifugation (2 minutes, 12,000 rpm) and 
protein UV-vis spectra recorded. Figure 2.19 shows the UV spectra obtained. 
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Figure 2.19 UV-visible spectra of purified ThiGH before and after chemical reconstitution. 
 
The  spectra  exhibits  a  maximum  absorption  at  410  nm  which  is  characteristic  for 
sulfide-to-iron charge transfers within Fe-S centres65,151, clearly more accentuated for 
reconstituted  samples  of ThiGH,  indicating the successful reconstitution of  the  iron 
sulfur cluster. UV-vis spectra of ThiGH obtained are in agreement with those reported 
by R. Leonardi24, however with a stronger absorbance between 300 and 450 nm. The 
extinction coefficient for reconstituted ThiGH at 390 nm was 4678 cm-1 M-1/iron atom 
(assuming a 4Fe-4S cluster).  
 
2.2.5 Analytical gel filtration chromatography 
 
With  the  ultimate  objective  of  solving  the  crystal  structure  of  the  ThiH  or  ThiGH 
complex, the separation of monomeric ThiH from ThiGH complex was investigated. 
Analytical  gel  filtration  chromatography  was  carried  out  under  strictly  anaerobic 
conditions  (method  6.4.13).  ThiGH-His  was  expressed  from  pRL1020/BL21(DE3), 
purified (method 13), reconstituted, concentrated to 40 mg/mL and loaded onto a S-200 
column pre-equilibrated with buffer D [50 mM MOPS pH 7.7, 200 mM NaCl, 5 mM   70 
DTT, 10% (w/v) glycerol]. Protein elution was monitored at 280 nm. Fractions were 
collected and analysed by SDS-PAGE (method 8). Figure 2.20 shows the chromatogram 
(a) and the corresponding SDS-PAGE gels (b) obtained from the gel filtration. ThiGH 
complex eluted at t~120 min and monomeric ThiH eluted at t~160min. 
 
The iron content of the eluted samples was measured (method 14). Interestingly, both 
ThiGH  complex  and  monomeric  ThiH  samples  had  high  iron  content  after  the  gel 
filtration step (table 2.7). This demonstrates the high stability of not only the ThiGH 
complex but also of ThiH, since hardly any protein precipitated on during the elution. 
In  fact, monomeric  ThiH  was  further  concentrated  to  60  mg/mL,  which proves the 
efficiency and significant improvement of expression, purification, reconstitution and 
concentration methods, since the maximum previously obtained by R. Leonardi was 6 
mg/mL, when in a complex58. 
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Figure 2.20 Analytical gel filtration analysis of ThiGH-His isolated from pRL1020/BL21(DE3). 
(a) chromatogram recorded at 280 nm; (b) Coomassie Blue  stained 15% SDS-PAGE gel of 
fractions eluted from S-200 column. M: molecular weight marker (kDa); BGF: ThiGH initial 
sample before analytical gel filtration. The numbers correspond to the fractions eluted from the 
column. 
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Table 2.7 Iron content of the eluted samples from analytical S-200 column.  
Protein present  Fraction number  mg/mL protein 
Iron content  
mol Fe/mol ThiH 
ThiGH  24  0.438  4.5 
ThiGH  25  0.880  2.8 
ThiGH  26  0.689  2.4 
ThiH  34  0.443  3.8 
ThiH  35  0.469  3.6 
ThiH  36  0.396  3.5 
 
2.2.6 Initial studies on the crystallisation of ThiH 
 
After the successful optimisation of the chemical reconstitution and concentration of 
ThiGH  and  monomeric  ThiH,  studies  were  initiated  on  the  crystallisation  of  both 
ThiGH complex and monomeric ThiH. 
 
To  achieve  good  diffraction  data,  it  is  necessary  to  obtain  well  ordered  crystals. 
Locating and optimising the conditions required to produce diffraction quality crystals 
can be difficult due to the number of factors that can affect protein stability and crystal 
growth:,  i.e.,  purity  of  protein,  pH,  ionic  strength,  counter  ions,  and  temperature, 
nature of the precipitant.  
 
Because  there  is  not  an  unique  method  to  crystallise  proteins,  a  large  number  of 
screening  experiments  are  prepared  in  a  microplate  using  a  finite  number  of 
crystallization conditions with varying salt, buffer, pH, precipitants and other chemical 
components155,156. 
 
The sitting drop vapour diffusion method has been successfully used for producing 
good  quality  crystals  of  a  wide  range  of  proteins  and  was  chosen  to  initiate  the 
crystallisation studies of ThiGH. In this method, a drop of protein is mixed with a 
precipitant and is slowly dehydrated in a sealed well, by equilibration with a reservoir   73 
containing  higher  precipitant  solution.  Due  to  the  vast  number  of  parameters,  the 
formulation of trial screens often derives from past successful crystallisation trials. For 
the  ThiGH  initial  crystallisation  studies,  a  trial  screen  for  containing  a  range  of 
precipitants and buffers was used157.  
 
ThiGH-His  was  expressed  from  pRL1020/BL21(DE3),  purified  (method  13), 
reconstituted, concentrated to 40 mg/mL. An analytical gel filtration chromatography 
was carried out under strictly anaerobic conditions (method 6.4.13) to separate ThiGH 
complex from monomeric ThiH. The iron content of the protein samples was measured 
(table 2.7). Fractions 24-26 of ThiGH complex were pooled and concentrated to 28.3 
mg/mL. Fraction 34 of monomeric ThiH was concentrated to 60 mg/mL. These protein 
samples  were  then  used  to  set  up  the  crystallisation  trial  experiments.  All 
crystallisation experiments were carried out under strict anaerobic environment, inside 
a glove box, in a controlled temperature room. 
  
Screening for optimal crystal growth conditions of ThiGH and monomeric ThiH were 
prepared in 24 well plates. Precipitant solutions were prepared and dispensed onto the 
plate  (1000   L  each).  Protein  solutions  were  completed  by  the  addition  of  further 
reagents  (for  example  AdoMet,  tyrosine  or  Dxp).  Drops  were  prepared  by  placing 
drops of protein solution (1.5  L) onto cover slips (22 mm diameter) and then adding 
precipitant solution from the well (1.5  L). The cover slip was then carefully inverted 
to cover the rim of  each well of  the  plate.  Table 2.8  shows  the  protein, buffer  and 
additives on each tray. 
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Table 2.8 Protein, additives and buffers used for crystallisation 
Tray nº 
Protein/ 
volume added 
Additives*/ 
volume added 
Buffer 
1  ThiGH/30  L 
AdoMet/3.5  L 
Dxp/1.75  L 
Tyrosine/1.75  L 
MOPS pH 7.7 
2  ThiGH/90  L 
AdoMet/9.0  L 
Dxp/4.5  L 
Tyrosine/4.5  L 
Tris pH 8.8 
3  ThiH/45  L 
AdoMet/4.5  L 
Dxp/2.25  L 
Tyrosine/2.25  L 
MOPS pH 7.7 
* Stock solutions of 10 mM. 
 
The trays were checked at weekly intervals for 3 months. Precipitates were commonly 
observed, but no reproducible crystallisation conditions were observed.  
 
2.3 Summary and conclusions 
 
Studies on improving the in vivo production of ThiH were carried out using a range of 
expression conditions and chromatography techniques.  
 
Studies  were  carried  out  using  two  different  expression  plasmids  (pRL1020  and 
pRL1021). Expression of ThiGH using pRL1021, showed the consistent co-expression of 
YqJI  protein,  and  no  significant  improvement  on  the  stability  and  iron  content  of 
ThiGH. Expression of pRL1021 with E. coli knock out (-YqJI) cells carried out by Mr. M. 
Challand showed no significant improvement on the production of monomeric ThiH. 
pRL1020 expression plasmid is currently used for production of ThiGH.  
 
Addition  of  supplements  to  the  growth  medium  showed  no  improvement  on  the 
production  and  iron  content  of  ThiGH.  Strep-tag purification method  proved  to be 
ineffective, but ion exchange chromatography, in particular using S-sepharose, proved   75 
to  be  a  good  candidate  for  isolating  holo-ThiH.  Unfortunately  at  the  time  these 
experiments  were  carried  out,  due  to  previous  observations  of  monomeric  ThiH 
behaviour, i.e. high tendency to precipitate when not in a  complex with ThiG, this 
purification  method  was  discarded.  ThiGH  is  routinely  obtained  from 
pRL1020/BL21(DE3) and isolated using His-tag affinity chromatography.  
 
Variation of the purification buffer showed significant improvement on the yield of 
protein;  from 2.2 mg/g cell obtained using tris buffer  to 5.2 mg/g cell using  MOPS 
buffer. The use of MOPS buffer and, possibly also the addition of anaerobic cell lysis 
step to the purification protocol, produced very stable ThiGH complex. Addition of 
supplements, in particular tyrosine, to the purification buffers produced protein with 
higher iron content, however the stability was low, resulting in protein precipitation 
after freezing and thawing.  
 
For the first time, successful in vitro chemical reconstitution of ThiH was achieved (5.2 
±  1.3  mol  equivalents  of  Fe  per  mol  of  ThiH).  This  allowed  for  the  ThiGH  to  be 
concentrated  to  ~40  mg/mL,  and  further  separation  of  ThiGH  complex/monomeric 
ThiH showed that ThiH could be concentrated up to 60 mg/mL.  
 
Initial  studies  on  crystallisation  of  ThiGH  complex  and  monomeric  ThiH  were 
unsuccessful.  
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CHAPTER 3 
Investigating Thiazole Biosynthesis in Escherichia coli 
 
3.1 Introduction 
 
The study of the mechanism by which Thz-P is assembled in E. coli is one of the main 
focuses of this project. As introduced in chapter 1, the biosynthesis of this thiamine 
precursor has now been well characterised in the aerobe B. subtilis and a mechanism 
has been proposed43,44,158; the C2-N3 fragment of Thz-P derives from the oxidation of 
glycine  to  dehydroglycine,  in  a  reaction  catalysed  by  the  flavoenzyme  ThiO.  This 
hydrolytically unstable intermediate is incorporated into the thiazole in a multistep 
reaction  requiring  the  thiazole  synthase  (ThiG)45,159  the  sulfur  donor  ThiFS 
thiocarboxylate27,40 and 1-deoxyxylulose 5-phosphate (Dxp). However, in aerobes such 
as E. coli, the steps leading to the formation of the thiazole moiety are still unclear. 
Dehydroglycine 32 (scheme 3.1) has been proposed as the first common intermediate 
for  bacterial  thiazole  biosynthesis160,  this  precursor  is  formed  from  tyrosine  24  in  a 
ThiH dependent reaction161,162. This biosynthetic step therefore requires the cleavage of 
the Cα to Cβ bond of tyrosine and release of the aromatic side chain (scheme 3.1). ThiH 
shows sequence similarity to the ‘radical- S-adenosylmethionine (AdoMet)’ family of 
proteins59, including conserved ligands to an essential [4Fe-4S] cluster (section 1.4)52 
and  has  been  shown  to  form  a  complex  with  ThiG  (section  2.2)24.  The  proposed 
mechanism for Thz-P biosynthesis in E. coli is outlined in scheme 3.1. 
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Scheme 3.1 Original proposed mechanism for the formation of Thz-P in E. coli58. 
 
The [4Fe-4S]1+ cluster of ThiH catalyses the reductive cleavage of AdoMet to generate 
Ado●. This highly reactive radical will then abstract a hydrogen atom from tyrosine 24 
and  form  a  tyrosyl  radical  59  that  will  react  further  cleaving  the  Cα-Cβ  bond. 
Dehydroglycine 32 is released together with the quinone methide 60. Hydration of 60 
leads to p-hydroxybenzyl alcohol 61, a known in vivo thiamine by-product113.  
 
Initial studies on the development of an in vitro assay to measure ThiH activity, were 
carried out, attempting to monitor the formation of p-hydroxybenzyl alcohol (p-HBA) 
by HPLC. Despite extensive efforts, the formation of p-hydroxybenzyl alcohol could 
not be confirmed, but, interestingly, the presence of a reaction product with higher 
retention time than p-HBA was observed (results not shown). This work was carried 
out  by  the  author.  At  this  stage,  the  project  was  divided  into  two  main  routes  of 
investigation:  the  production  of  holo-ThiH  (described  in  chapter  2),  and  the 
development  of  a  functional  in  vitro  assay.  These  two  lines  of  investigation  were 
carried out in parallel, the first one by Dr. M. Kriek in the development of the in vitro 
assay; and a second route by the author in the production of holo-ThiH. During these 
investigations,  the  author  and  Dr.  M.  Kriek  collaborated  and  a  number  of  purified   78 
samples of ThiGH were provided by the author for the development of the in vitro 
assays. In addition, extensive studies were carried out by the author to develop and 
optimise  a  reliable  analysis  method  to  detect  the  in  vitro  reaction  products,  which 
included:  capillary  electrophoresis,  LC-MS  (results  not  shown)  and  HPLC  analysis. 
HPLC experiments were successfully applied and are described in detail in the next 
section. 
 
The optimisation of the purification methodology and in vitro chemical reconstitution 
made  possible  the  isolation  of  holo-ThiGH  (section  2.2).  This  allowed  for  the 
development of an in vitro assay that not only allowed the measurement of the activity 
of  the  isolated  protein,  but  ultimately  facilitates  the  study  of  the  mechanistic 
enzymology by which Thz-P is biosynthesised in E. coli.  
 
The development of a functional in vitro assay was carried out by Dr. M. Kriek from 
our  laboratory.  After  achieving  the  successful  chemical  reconstitution  of  ThiGH, 
electron paramagnetic resonance (EPR) studies were carried out to test the effect of the 
addition of substrates to the reconstituted holo-ThiGH samples (figure 3.1)160.  
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Figure 3.1 X-band EPR spectra of ThiGH. Adapted from160. 
 
The addition of tyrosine did not produce a marked change in the EPR spectrum (figure 
3.1,  B),  whereas  the  addition  of  AdoMet  had  a  major  effect  (figure  3.1,  C).  This 
observation can be explained by the reduction of the iron sulfur cluster of ThiH when 
binding  to  AdoMet.  Changes  of  reduction  potentials  for  [4Fe-4S]2+/1+  have  been 
observed  for  other  members  of  the  ‘radical  AdoMet’  family  such  as  anaerobic 
ribonucleotide reductase activating enzyme163 and lysine aminomutase69,164 (discussed 
in chapter 1). In comparison, a ThiGH sample which had both AdoMet and tyrosine 
added showed a much weaker EPR signal (figure 3.1, D). The rapid disappearance of 
the [4Fe-4S]1+ cluster signal upon addition of tyrosine in the EPR experiments shows 
that, at least under these conditions, the reaction with tyrosine is faster than the rate at 
which the cluster can convert back to the reduced state160.  These studies are consistent 
with the proposed mechanism for tyrosine cleavage (scheme 3.1), and previous studies 
by R. Leonardi using purified E. coli proteins have shown that ThiGH requires AdoMet 
and a reductant for activity51. 
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With  the  objective  of reconstituting  thiazole synthase activity  an in vitro assay was 
developed160.  This  assay  consisted  of  reconstituted  and  concentrated  ThiGH, 
anaerobically purified complex of ThiFS and a reducing system, [flavodoxin (FldA), 
flavodoxin  reductase  (Fpr)  and  NADPH].  Also,  three  substrates  were  shown  to  be 
essential: tyrosine, AdoMet and Dxp. Thz-P is highly polar and therefore difficult to 
detect by HPLC. An enzyme coupled reaction assay was carried out using 4-amino-5-
hydroxymethyl-2-methylpyrimidine (8, Hmp), ATP and the enzymes ThiD and ThiE. 
The  TP  formed  in  the  assays  was  converted  to  the  thiochrome  63  165,  separated  by 
HPLC and quantified using a fluorescence detector (scheme 3.2). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 3.2 In vitro assay for detection of TP formation165. 
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Figure 3.2 In vitro time course of thiamine phosphate formation: the TP formed in the assays 
was  converted  to  the  thiochrome,  separated  by  HPLC  and  quantified  using  a  fluorescence 
detector. Adapted from160. 
 
HPLC analysis of the fluorescent derivatives clearly shows that the purified ThiGH is 
active,  since  the  control  experiments,  lacking  one  of  the  substrates,  results  in  no 
formation of TP (figure 3.2). 
 
Radiochemical studies of in vitro assays using 14C labelled tyrosine were the first steps 
to elucidate the structure of the aromatic side-chain released from tyrosine cleavage. By 
using two TLC systems, two radiolabelled products with very different polarities were 
observed (figure 3.3). The highly polar component co-eluted with glyoxylate 62 and 
comparison of the less polar product with several aromatic standards showed that it 
co-eluted  with  p-cresol  63.  This  experiment  also  demonstrated  the  absolute 
requirement for AdoMet as the negative control showed no activity. 
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Figure 3.3 Autoradiograms of a ThiH assay. Two TLC systems (plates A and B) were used to 
resolve the products. The complete assay (lane 1 on each plate) contained L-[U-14C]-tyrosine, 
reconstituted ThiGH, AdoMet and a reductant. The negative control (lane 2) lacks AdoMet. 
Plate  A:  tyrosine  24,  glyoxylate  62;  plate  B:  p-cresol  63,  p-hydroxybenzyl  alcohol  61,  p-
hydroxybenzaldehyde 64. Adapted from160. 
 
Further  studies  with  these  assays  using  nuclear  magnetic  resonance  (NMR) 
spectroscopy and mass spectrometry (GC-MS), confirmed that the products derived 
from tyrosine cleavage are p-cresol and glyoxylate166.  
 
3.2 Results and discussion 
 
3.2.1 ThiH in vitro assay 
 
The optimised in vitro assay protocol was developed by Dr. M. Kriek160. The following 
proteins and reagents were added, anaerobically, to a reaction mixture in the following 
order  (with  final  concentrations):  reconstituted  and  concentrated  ThiGH  (255   M), 
tyrosine (0.51 mM), AdoMet (0.74 mM), NADPH (0.67 mM), FldA (62  M), Fpr (10 
 M). Negative control experiments were prepared using the same reagents but lacking   83 
tyrosine. FldA, Fpr and NADPH were mixed and left for 15 min until the solution 
turned blue (resulting from the semiquinone radical form of Fpr). ThiGH, AdoMet and 
tyrosine  solutions  were  mixed  and  after  the  reductant  mixture  was  added.  The 
reactions (200  L aliquots each) were incubated at 37 ºC and stored at -80 ºC. For time 
course experiments reactions were incubated at 37 ºC for 5, 15, 30, 45, 60, and 120 min 
and subsequently stored at -80 ºC.  
 
A standard method was developed for the analysis of these supernatants as follows. 
Samples were thawed and proteins were immediately precipitated with 20% perchloric 
acid  (12   L)  and  then  cleared  by  centrifugation  (14,000  rpm,  15  min),  and  the 
supernatants analysed by HPLC. This method was used throughout the experiments 
described in this chapter. 
 
3.2.2  Identification  of  the  intermediate  and  by-product  derived  from 
tyrosine 
 
The formation of the two products, glyoxylate and p-cresol, observed by Dr. M Kriek 
on  the  autoradiography  studies,  was  further  confirmed  by  13C  NMR  spectra  of 
reactions  containing  U-13C-tyrosine,  ThiGH,  AdoMet  and  a  reducing  system 
(NADPH/FldA/Fpr) which were incubated at 37 ºC for two hours. Negative control 
assays were also carried out using the same reagents but lacking the reducing system. 
Protein was precipitated by addition of perchloric acid and removed by centrifugation. 
NMR analysis of the aqueous supernatant showed signals typical of glyoxylate [figure 
3.4, (a)] signals at 173 and 86 ppm under these conditions, observed as doublets as a 
result of 13C-13C coupling.  
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Figure 3.4 NMR spectra of a ThiH assay complete assay containing 13C-tyrosine. (a) analysis of 
the assay  supernatant  after  protein removal;  (b) analysis  of the  supernatant  extracted  with 
CDCl3.  
 
An organic extract of the supernatant was prepared using CDCl3 and analysed by 13C 
NMR. The spectrum of the organic extract prepared from the supernatant is consistent 
with  13C-labeled p-cresol [13C NMR (100 MHz; CDCl3) δ = 153.2 (t, J = 66 Hz, COH), 
130.1 (m, 2CH, CCH3), 115 (m, 2CH), 20.4 ppm (m, CH3)] (figure 3.4, (b)).    85 
The  spectrum  of  the  supernatant  derived  from  the  negative  control  confirms  the 
presence of unreacted tyrosine (figure 3.5).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.5 NMR spectra of a negative control ThiH assay containing 13C-tyrosine. 
 
The organic extract, containing the aromatic by product derived from the tyrosine side 
chain, was analysed by GC-MS (figure 3.6). A peak was observed with a retention time 
of 13.38 min, identical to that observed for a p-cresol standard. The expected mass for 
the p-cresol (calculated) was 108.2, and the observed mass was 108.2. As for the p-cresol 
derived from 13C-tyrosine, the expected mass (calculated) was 115.14, and the observed 
mass was 115.2.  
 
In conclusion, both NMR and GC-MS analysis clearly demonstrate that p-cresol and 
glyoxylate were produced from tyrosine during in vitro reactions.  
 
 
 
 
 
δ δ δ δ/ppm 
H2N
O
O
HO
174.2
56.3  86 
HO
C
CH
H
C
C
HC
C
H
CH3
HO
C= 
13C
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.6 GC-MS analysis of a ThiH assay complete assay containing  13C-tyrosine. (a) p-
cresol, m/z = 108.2 (calculated mass 108.14); (b) U-13C-p-cresol, m/z = 115.2 (calculated mass 
115.14). 
 
 
 
   87 
3.2.3 Detection and quantification of p-cresol, AdoH and tyrosine by HPLC 
 
The development of an HPLC method, to investigate the reaction products of tyrosine 
cleavage, was initiated with an optimisation of the HPLC gradient conditions using 
standard  solutions  of:  5’-deoxyadenosine  (AdoH),  which  is  formed  upon  AdoMet 
reaction with  the  Fe-S  cluster  of  ThiH;  tyrosine; and  p-cresol, the  aromatic product 
released upon tyrosine cleavage. 
 
A range of HPLC conditions were investigated to achieve optimal separation of the in 
vitro assay components and reaction products. Table 3.1 shows a brief summary of the 
principle  methods  investigated.  These  are  described  in  more  detail  in  experimental 
section (section 6.5.2). 
 
Table 3.1 HPLC methods 
Method nº  Column  Aqueous phase    Organic phase  Separates 
1 
Hypersil 
BDS C18 
0.1% CH3CO2H 
CH3OH/ 
0.1% CH3CO2H 
HBA,  
p-cresol 
2 
Phenomenex 
C18 RP 
0.1% TFA 
CH3CN/ 
0.1%TFA 
AdoMet, 
p-cresol 
3 
Synergy polar 
RP 
0.1% HCO2H 
CH3CN/ 
0.1% HCO2H 
AdoH 
4 
Phenomenex 
ODS (3) 
0.1% TFA 
CH3CN/ 
0.1%TFA 
AdoH, 
tyrosine 
5 
Phenomenex 
C18 RP 
25 mM CH3CO2H/ 
8 mM C8H18O3S 
50% CH3CN/ 
50% Aq. phase 
AdoMet 
6 
Phenomenex 
C18 RP 
0.1% CH3CO2H 
CH3OH/ 
0.1% CH3CO2H 
Tyrosine, 
AdoH, 
 p-cresol 
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Separation of the main in vitro assay products was achieved by using method 6 which 
was used throughout the project to analyse all assay mixtures. Aliquots of standard 
solutions (40 μL) of AdoH, tyrosine and p-cresol were analysed by HPLC using UV-
visible detection (λex 223 nm, λem 280 nm). A range of concentrations of standards were 
used to construct calibration curves (section 6.5.2) for estimating the concentrations of 
tyrosine,  AdoH  and  p-cresol.  Concentrations  were  determined  from  experiments 
carried out in duplicate. The following retention times were observed for standards: 
tyrosine, Rt = 8 ± 0.3 min; AdoH, Rt = 11.8 ± 0.3 min; p-cresol, Rt = 16.7 ± 0.3 min. Unless 
otherwise  stated  all  the  data  from  the  experiment  described  in  this  chapter  were 
plotted using SigmaPlot v 10.0. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.7 HPLC analysis with UV detection (280 nm) of standard solutions of tyrosine, AdoH 
and p-cresol. The chromatogram corresponds to 10 nmoles injected of each standard solution. 
 
Assay mixtures containing purified and reconstituted ThiGH, AdoMet, tyrosine and 
FldA/Fpr/NADPH, were incubated at 37 ºC for one hour. ThiGH and other protein 
components were removed by acid precipitation and centrifugation. Aliquots of the 
resultant  supernatants  (40  μL)  were  analysed  by  reverse  phase  HPLC  (RP-HPLC) 
(figure 3.7). A negative control experiment was carried out under the same conditions 
but without the addition of AdoMet.  
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Figure 3.8 HPLC analysis with UV-vis detection of an in vitro assay: full assay (―); negative 
control (―). 
 
Time course experiments were carried out. Assay mixtures were incubated at 37 ºC for 
0, 15, 30, 60 and 120 minutes. After the removal of protein components, supernatants 
were analysed by RP-HPLC. Because the reactions were prepared inside an anaerobic 
glove box, it would be practically difficult to stop the assay immediately, i.e. to prepare 
a really  reliable time  zero as  the first point;  therefore,  the  time =  0  data  point was 
calculated from a full assay to which no reducing system was added. 
 
RP-HPLC analysis at 280 nm (figure 3.8) allowed the simultaneous measurement of 
AdoH  and  p-cresol  formation  in  the  in  vitro  assay.  Tyrosine  consumption  was  also 
measured. This HPLC method was optimised to allow for the products and substrates 
of interest to separate from other components present in the assay. The retention times 
for tyrosine (Rt = 8 ± 0.4 min), AdoH (Rt = 11.8 ± 0.4 min) and p-cresol (Rt = 16.7 ± 0.5 
min) were consistent with those obtained from the standard solutions.  
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Figure 3.9 HPLC analysis with UV-vis detection of an in vitro assay time course. For clarity 
traces corresponding to incubation at 15, 30, 60 120 minutes are offset by 200, 400, 600 and 
800 mV respectively. 
 
The  consumption  of  tyrosine,  and  AdoH  and  p-cresol  formation  was  quantified  by 
HPLC data by comparison of the peak areas with the calibration curves from standard 
solutions of each component. The preparation of the standard solutions and calibration 
curve  plotted  by  HPLC  analysis  are  described  in  detail  in  section  6.5.2.    The 
concentrations measured for each time point are listed in tables 3.2, 3.3 and 3.4. 
 
 
 
 
 
 
 
time/min
10 12 14 16 18 20
D
e
t
e
c
t
o
r
 
s
i
g
n
a
l
/
m
V
0
200
400
600
800
1000
1200
p-cresol 
AdoH 
5 min 
15 min 
30 min 
60 min 
120 min   91 
 
Table 3.2 Time course of tyrosine consumption. SD is standard deviation. 
[tyrosine]/ M 
Time/min 
sample 1  sample 2  average  SD 
0  154.8  128.1  137.9  14.7 
15  72.7  76.5  62.6  20.8 
30  0.0  30.3  26.1  24.3 
60  0.0  0.0  0.0  0.0 
120  0.0  0.0  0.0  0.0 
 
Table 3.3 Time course of AdoH formation. SD is standard deviation. 
[AdoH]/ M 
Time/min 
sample 1  sample 2  average  SD 
0  0  0  0  0 
15  134.7  126.0  130.3  6.1 
30  155.1  161.6  158.3  4.6 
60  182.7  189.2  185.9  4.6 
120  165.0  162.1  163.5  2.1 
 
Table 3.4 Time course of p-cresol formation. SD is standard deviation. 
[p-cresol]/ M 
Time/min 
sample 1  sample 2  average  SD 
0  0  0  0  0 
15  18.4  33.4  25.9  10.6 
30  86.5  113.5  100.0  19.0 
60  130.0  136.2  133.1  4.4 
120  85.0  143.9  114.5  41.7 
 
In order to investigate the kinetics and stoichiometry of substrate consumption and 
product formation, the p-cresol, AdoH and tyrosine (table 3.5) formed in this assay 
were quantified by HPLC and plotted together (figure 3.10).   92 
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Figure  3.10  Time  course  of  AdoH  and  p-cresol  formation,  and  tyrosine  consumption  in  a 
ThiGH  assay.  AdoH  (―●)  tyrosine  (―■)  and  p-cresol  (―▲).Error  bars  are  derived  from 
standard deviation of two data sets (tables 3.1, 3.2 and 3.3). The curves are fit to a first order 
exponential function. 
 
The  apparent  first  order  rate  constants  of  p-cresol  and  AdoH  formation,  and  for 
tyrosine consumption, were calculated. Data from figure 3.10 were fitted, using Origin 
v  6.0  analysis  software,  to  a  first-order  process  to  determine  and  calculate  the  final 
concentrations of products and substrate and the rate constant  (equation 6.1).  
 
y = A [1 – exp (-Bt)]     equation 6.1 
 
[y = final concentration of product or substrate; t = time, A = calculated final concentration, B = 
apparent first order rate constant (min-1)] 
 
By comparison with standards of known concentrations, HPLC was used to measure 
the quantity of tyrosine and AdoMet utilized and the amount of AdoH and p-cresol 
produced  during  a  time  course  experiment.  The  rate  of  formation  of  AdoH  is   93 
approximately two times faster then the rate of formation of p-cresol and the rate of 
consumption of tyrosine (table 3.5) and the reaction is shown to approach completion 
after 1 hour. The maximal expected concentration of AdoH was 160  M, assuming one 
mole equivalent was generated per mole of tyrosine. However, the amount of AdoH 
was higher and reached a maximum of 186  M. This result suggests that there may be 
some cleavage of AdoMet which does not lead to hydrogen abstraction from tyrosine. 
Similar results have been reported with in vitro assays of BioB and LipA, where for 
each mole of biotin generated approximately 2.9 moles of AdoH167; and in LipA assays 
where up to 2.4 mol equivalents of AdoH are formed with respect to the substrate168. 
Data from this set of assays indicated that the maximum production of p-cresol occurs 
at 60 min, with 133  M being produced.  
 
Table 3.5 Kinetic parameters for substrate utilisation and product formation. 
Product  Rate constant/min  Final concentration/ M 
Tyrosine  0.052 ± 0.003  0.0 ± 0.0 
AdoH  0.102 ± 0.033  167.2 ± 6.0 
p-cresol  0.032 ± 0.003  147.7 ± 1.9 
 
3.2.4 Detection and quantification of glyoxylate by HPLC 
 
In the absence of other components required for thiazole formation. dehydroglycine 32, 
formed upon tyrosine cleavage by AdoMet, is hydrolysed to yield glyoxylate 62 and 
ammonia. The direct detection of glyoxylate by HPLC is difficult because such polar 
molecules  are  usually  eluted  with  very  short  retention  times.  McNeill  and  co-
workers169 developed a very effective method to detect 2-oxoacids. The derivatisation 
of  glyoxylate  with  ortho-phenylene  diamine  64  (OPD),  produces  2-quinoxalinol  65 
which can be detected by fluorescence (λex 340 nm, λem 420 nm) (scheme 3.3). 
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Scheme 3.3 Derivatisation of glyoxylate 62 as fluorescent 2-quinoxalinol 65 with o-phenylene 
diamine 64. 
 
The optimisation of the HPLC method was carried out using standard solutions of 2-
quinoxalinol  and  derivatised  glyoxylate.  For  clarity  synthetic  standards  of  2-
quinoxalinol  are  referred  as  2-quinoxalinol  and  derivatised  samples  of  glyoxylate, 
which  also  contain  2-quinoxalinol,  are  referred  to  as  glyoxylate  or  derivatised 
glyoxylate. Aliquots of standard solutions (100 μL) of derivatised glyoxylate and 2-
quinoxalinol were analysed by HPLC using fluorescent detection (λex 340 nm, λem 420 
nm). A range of concentrations of standards were used to construct calibration curves 
(section  6.5.3)  for  estimating  the  concentrations  of  2-quinoxalinol  and  derivatised 
glyoxylate. Concentrations were determined from experiments carried out in duplicate. 
The following retention times were observed for standards: derivatised glyoxylate, Rt = 
11.6 ± 0.5 min; 2-quinoxalinol, Rt = 11.6 ± 0.05 min (figure 3.11). 
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Figure  3.11  HPLC  analysis  with  fluorescent  detection  of  standard  solutions  of:  derivatised 
glyoxylate (―), indicated as glyoxylate and 2-quinoxalinol (―).The chromatogram corresponds 
to 0.32 nmoles injected of each standard solution. The yield of derivatisation was 63.8% as 
estimated by the calibration curve from each standard. 
 
The utilisation of substrates and the formation of products were measured by stopping 
assays  a  different  time  points.  Thus,  assay  mixtures  containing  purified  and 
reconstituted ThiGH, AdoMet, tyrosine and FldA/Fpr/NADPH, were incubated at 37 
ºC  for  0,  15,  30,  60  and  120  minutes.  After  the  removal  of  protein  components, 
supernatants  were  derivatised  if  necessary  and  then  analysed  by  HPLC  with 
fluorescence detection. From the analysis of the HPLC traces it is possible to see the 
increase in glyoxylate derivative through time (figure 3.12). 
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Figure 3.12 HPLC analysis with fluorescent detection of an in vitro assay time course. For 
clarity traces corresponding to incubation at 5, 15, 30, 60 and 90 minutes are offset by 25, 50, 
100, 150, and 200 mV respectively. 
 
For  each  measurement  of  glyoxylate  in  the  in  vitro  assay,  derivatised  glyoxylate 
samples were also analysed. The derivatisation of the assay was always carried out in 
parallel with the derivatisation of the standards to ensure that the same experimental 
conditions were maintained and that the estimated concentrations were rigorous. In 
addition, standard samples of 2-quinoxalinol were analysed in parallel with both assay 
and  glyoxylate  standards  in  order  to  calculate  the  yield  of  derivatisation  for  each 
reaction. 
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Figure 3.13 Time course formation of glyoxylate in a ThiGH assay. The curve shown here is the 
exponential growth and does not relate to the rate of the reaction. Error bars are derived from 
standard deviation of two data sets (table 3.6). 
 
Table 3.6 Time course of glyoxylate formation. SD is standard deviation. 
[glyoxylate]/ M 
Time/min 
sample 1  sample 2  average  SD 
5  44.6  46.7  45.6  1.4 
15  115.0  110.1  112.6  3.5 
30  171.6  200.3  186.0  20.2 
60  183.1  145.1  164.0  26.9 
90  199.4  184.8  192.2  10.4 
120  168.3  129.6  148.9  27.4 
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In order to investigate the kinetics and stoichiometry of the product formation, the 
glyoxylate and the p-cresol (table 3.7) formed in this assay were measured and plotted 
together (figure 3.14). The amounts of p-cresol and glyoxylate produced during a time 
course  experiment  were  calculated  by  comparison  with  standards  of  known 
concentrations measured by HPLC. 
 
Table 3.7 Time course of p-cresol formation. SD is standard deviation. 
[p-cresol]/ M 
Time/min 
sample 1  sample 2  average  SD 
5  23.1  23.4  23.3  0.17 
15  56.5  79.1  67.7  15.9 
30  126.5  115.9  121.2  7.52 
60  167.7  147.7  157.7  14.2 
90  162.1  169.2  165.6  5.04 
120  162.1  182.3  172.2  14.3 
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Figure 3.14 Time course formation of glyoxylate and p-cresol in a ThiGH assay. Error bars are 
derived from standard deviation of two data sets (table 3.4 and 3.5). Glyoxylate (―●),  p-cresol 
(―●). The curves are fit to a first order exponential function.  
The  apparent  first  order  rate  constants  of  p-cresol  and  glyoxylate  formation  were 
calculated. Data from figure 3.14 were fitted, using Origin v 6.0 analysis software, to a 
first-order process to determine and calculate the final concentrations of products and 
the  apparent  first  order  rate  constant  (equation  6.1).  Tyrosine  cleavage  reaction 
produces p-cresol and glyoxylate in an approximate 1:1 ratio over the time course and 
approached  completion  after  1  hour  (table  3.8).  Results  are  shown  with  associated 
standard errors.  
 
Table 3.8 Kinetic parameters for product formation. 
Product  Rate constant [10-2min-1]  Final concentration [ M] 
p-cresol  4.6 ±  0.7  176.2 ± 7.8 
glyoxylate  6.3 ±  1.1  171.6 ± 7.9 
 
 
3.3 Novel proposed mechanism for Thz-P biosynthesis 
 
The  investigations  by  Dr.  M.  Kriek  provided  significant  evidence  about  the 
intermediate and by-product derived from tyrosine cleavage166. These results together 
with  the  HPLC  studies  demonstrate  unequivocally  that  p-cresol  and  glyoxylate  are 
produced from tyrosine during the ThiGH in vitro assay. This allowed the proposal of a 
novel mechanism for tyrosine cleavage in E. coli (scheme 3.4). Reductive cleavage of 
AdoMet generates the highly reactive 5’-deoxyadenosyl radical, which can abstract a 
hydrogen atom from tyrosine 24. The resulting radical 59 can react via two pathways: 
(i) heterolytic pathway leads to dehydroglycine 32 and the stabilised radical anion 67 
↔ 68;  (ii) homolytic cleavage of the Cα-Cβ bond releases the radical intermediate 66 
together with quinone methide 60. To form p-cresol and dehydroglycine by either of 
these pathways requires further electron transfer steps, which can be possible if any of 
these intermediates is in close proximity to the [4Fe-4S] cluster in the active site of   100 
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ThiH.  DFT and ab initio calculations carried out by Dr. A. Croft166, suggest that the 
homolytic  mechanism  [(ii),  scheme  3.4]  is  thermodynamically  more  favourable. 
Increase of polarity improves the relative stability of the heterolytic pathway, but not 
enough for it to be identified as the preferred pathway. Further experimental data is 
required to elucidate this step.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 3.4 Novel proposed mechanism for tyrosine cleavage in E. coli166. 
 
The  mechanism  of  tyrosine  cleavage  by  ThiH  shows  similarities  to  the  mechanism 
catalysed by the glycyl radical enzyme p-hydroxyphenylacetate decarboxylase (HPAD) 
from Clostridium difficile170-172. This organism produces p-cresol by the decarboxylation 
of p-hydroxyphenylacetate by HPAD.  It seems likely that the reactions catalysed by   101 
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ThiH  and  HPAD  use  different  carbon  centred  radicals  to  initiate  mechanistically 
related cleavage reactions (scheme  3.5). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 3.5 Formation of p-cresol by ThiH and HPDA. 
 
3.4 Summary and conclusions 
 
The  development  of  an  in  vitro  assay,  containing  chemically  reconstituted  ThiGH, 
AdoMet, tyrosine and a reducing system (NADPH/Fld/Fpr), allowed the identification 
of  the  reaction  products  formed  upon  tyrosine  cleavage.  The  aromatic  side  chain 
released upon tyrosine cleavage, initially thought to be p-hydroxybenzyl alcohol113, was 
identified as p-cresol. The remaining fragment was hypothesised to be dehydroglycine. 
This intermediate hydrolyses to produce glyoxylate in the absence of Dxp and a sulfur 
donor,  the  products  required  to  biosynthesise  Thz-P.  This  intermediate  was  also 
detected. 
 
The development of an HPLC method using UV-visible detection further confirmed 
the presence of p-cresol and also allowed for its quantification, the retention time was   102 
found to be 16.7 ± 0.5 min. In addition, this method detected AdoH (Rt= 11.8 ± 0.4 min), 
the  product  of  AdoMet  reductive  cleavage  by  the  [4Fe-4S]  cluster;  and  tyrosine 
consumption  was  monitored.  Tyrosine  (initial  concentration  of  160   M)  was  fully 
consumed after 60 min, and 133  M of p-cresol were formed. AdoH was also detected 
and although the maximum expected concentration was 160  M, assuming one molar 
equivalent was generated per mol of tyrosine, the amount of AdoH was higher and 
reached a maximum of 186  M, suggesting some uncoupled turnover. The reaction 
achieved completion after 60 min. 
 
The  intermediate  of  the  tyrosine  cleavage  reaction  was  also  detected  as  glyoxylate. 
Detection and quantification of glyoxylate in the in vitro assays was possible using a 
method devised for the detection of 2-oxoacids, in which glyoxylate is converted to the 
fluorescent 2-quinoxalinol derivative. The retention times were found to be Rt = 11.6 ± 
0.5 min for derivatised glyoxylate, and Rt = 11.6 ± 0.05 min for 2-quinoxalinol. 
 
The development of these two HPLC methods allowed the investigation of the kinetics 
and stoichiometry for the formation of the reaction products formed  upon tyrosine 
cleavage. In addition the rate of consumption of tyrosine was also calculated and final 
concentration found to be 0.0  M as it was expected. Uncoupled turnover of AdoMet 
was confirmed by these calculations. The rate of formation of AdoH seems to be higher 
(0.102 ± 0.033 min-1) than the rate of tyrosine consumption (0.052 ± 0.003 min-1). In 
another  in  vitro  assay  the  rates  of  formation  and  stoichiometry  of  p-cresol  and 
glyoxylate were calculated. The products are formed in an approximate 1:1 ratio over 
time (176.2 ± 7.8  M p-cresol, 171.6 ± 7.9  M glyoxylate), and the reaction is shown to 
achieve  completion  after  60  min,  results  that  are  in  accord  with  the  previous 
experiments. The fitted first order rate constants of formation were found to be 4.6  ±  
0.7  [10-2  min-1]  for  p-cresol,  and  6.3    ±  1.1  [10-2  min-1]  for  glyoxylate.  The  rates  of 
formation of p-cresol seem to be approximately the same in different experiments.   103 
 
CHAPTER 4 
Expression of Microbial ThiH Genes in Escherichia coli 
 
4.1 Introduction 
 
One  of  the  main  goals  of  this  project  is  the  isolation  of  active  holo-ThiH.  The 
optimisation of the expression, purification and chemical reconstitution of ThiH from 
E. coli were described in detail in chapter 2. While these studies were in progress, other 
methods for the expression of holo-ThiH were being carried out in parallel, in particular 
the expression from different organisms. These studies are described in this chapter. 
 
The production of ThiH from different microbes can be especially valuable because 
whilst the active site of a protein might be conserved throughout different species, the 
exterior structure may vary; the surface residues of the protein play an important role 
in  protein-protein  interactions173.  This  may  be  of  particular  importance  in 
crystallisation studies, as during crystallisation these protein-protein interactions and 
the aggregation state of the protein are critical. While surveying for microorganisms 
containing the thiamine biosynthetic  operon two factors were taken in account, the 
operon structure and the thermostability of the organism. 
 
The  operon  structure  can  vary  greatly across  different  types  of  organisms  and  this 
diversity affects the regulation of gene expression174. During evolution, organisms are 
thought  to  adapt  in  order  to  be  more  efficient  in  their  biosynthetic  functions.  The 
expression of ThiH from organisms containing a different thiamine operon structure 
might produce protein with different characteristics. 
 
The stability of an individual protein is greatly influenced by the thermophilicity of the 
source  microorganism175-177.  Hyperthermophiles  grow  optimally  at  temperatures   104 
between  80  and  110  ºC.  Enzymes  from  these  organisms  have  developed  unique 
structure-function properties of high thermostability and high activity at temperatures 
above  70  °C.  A  number  of  hyperthermophilic  enzymes  have  been  identified  and 
characterised178-181.  Enzymes  from  hyperthermophilic  organisms  can  be  efficiently 
purified after expression in a mesophilic host, such as E. coli. Studies on lipoyl synthase 
(LipA), a ‘radical AdoMet’ enzyme, by M. Kriek (unpublished results) showed that 
Sulfolobus solfataricus LipA is far more stable then E. coli LipA, which has a marked 
tendency to precipitate (unpublished results). These observations reinforce the theory 
that  ThiH  expressed  from  a  hyperthermophile  might  be  more  stable,  since  E.  coli 
presents similar stability characteristics to E. coli LipA. 
 
Thermophilic  enzymes  are  often  considered  to  be  advantageous  for  crystallisation 
studies, when compared to their mesophilic orthologs, due to their intrinsic stability 
and  high  solubility176.  Moreover,  due  to  their  weak  catalytic  activity  at  low 
temperatures, enzyme-substrate complexes may have a sufficiently high lifetime for X-
ray  analysis181.  The  X-ray  structures  of  a  variety  of  enzymes  expressed  from 
hyperthermophilic  organisms  has  been  determined.  Examples  include  the  proteins 
from  the  histidine  biosynthetic  pathway  such  as  the  cyclase  of  imidazolglycerol 
phosphate  synthase  and  N’-((5’-phosphoribosyl)-formimino)-5-aminoimidazol-4-
carboxamid  ribonucleotide  isomerase,  both  derived  from  Thermotoga  maritima181;  the 
iron  hydrogenase  maturase  HydE  from  T.  maritima182 and  the  IscU  scaffold  protein 
from  the  hyperthermophile  Aquifex  aeolicus183.  Extending  this  logic  to  proteins  from 
thiamine biosynthesis, the isolation of stable holo-ThiH from a hyperthermophile might 
assist in the determination of the crystal structure.  
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4.2 Results and discussion 
 
4.2.1 Selection of microbial ThiH genes of interest 
 
The structural motifs and elements of proteins are conserved in the genomic encoded 
sequence and across different genomes. The amino acid sequence of an enzyme can 
provide valuable mechanistic information and conserved catalytic residues; it can also 
reveal  evolutionary  relationships  between  enzymes,  which  can  be  revealed  by  a 
sequence alignment184. Therefore, a survey was carried out for organisms containing 
the thiamine biosynthetic operon (table 4.1). The sequence similarity between ThiH’s 
was investigated through alignment of the sequences. All sequences used are listed in 
Appendix C. Sequence alignment allows the comparison of the degree of similarity 
between amino acids that occupy a particular position in the sequence of the protein.  
 
Table 4.1 Microorganisms containing the thiH gene. 
Organism 
Operon 
structure* 
Growth temperature  Respiration 
Escherichia coli  CEFSGH  37 ºC  facultative aerobe 
Vibrio vulnificus  CEFSGH  43 ºC  facultative aerobe 
Desulfovibrio vulgaris  SGHFE  37 ºC  obligate anaerobe 
Thermotoga maritima  H  80 ºC  obligate anaerobe 
Moorella thermoacetica  H  57 ºC  obligate anaerobe 
Chlorobium tepidum  SGHF  47 ºC  obligate anaerobe 
Campylobacter jejuni  SFGH  42 ºC  microaerophilic 
* operon structure: describes the sequence of thiamine biosynthetic genes found in the 
genome of each organism. The genes reported here are those identified in the BLAST 
Genome Taxa Query Page185. 
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Figure 4.1 Sequence alignment of E. coli ThiH with sequences from V. vulnificus, D. vulgaris, 
C. jejuni, C. tepidum, T. maritima and M. thermoacetica. 
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Table 4.2 Partial view of the alignment of sequence of ThiH from E. coli with V. vulnificus, D. 
vulgaris, C. jejuni, C. tepidum, T. maritima and M. thermoacetica. Cysteine residues of the 
CXXXCXXC motif are in blue.  
Organism  Residues  Sequence 
E. coli  83-94  N L C A N D C T Y C G F 
V. vulnificus  82-93  N L C A N A C T Y C G F 
D.  vulgaris  82-93  N H C T N Q C R Y C G F 
T. maritima  95-106  N D C I N D C V Y C G F 
M. thermoacetica  88-99  D Y C I N N C R Y C G Y 
C. tepidum  57-68  N F C S S G C V Y C G F 
C.  jejuni  93-104  N Y C N S K C V Y C G F 
 
The  sequence  alignment  of  the  ThiH  shows  that  all  selected  organisms  contain  a 
conserved CXXXCXXC motif, characteristic of the ‘radical AdoMet’ family (section 1.4).  
 
Studies  of  expression  and  purification  of  ThiH  were  initiated  using  D.  vulgaris 
(difference in operon structure) and T. maritima (hyperthermophile) and are described 
in the following sections.  
 
4.2.2 Expression and purification of Desulfovibrio vulgaris ThiH 
 
Desulfovibrio vulgaris is a gram-negative, anaerobic sulfur reducing bacteria that can be 
found in soil, animal intestines and fresh salt water186. The most commonly used strain, 
D.  vulgaris  Hildenborough,  was  discovered  in  clay  soil  near  Hildenborough,  Kent, 
United Kingdom, and is used as a model organism for studying energy metabolism of 
sulfate-reducing  bacteria  and  bio-corrosion  of  metal187.  D.  vulgaris  has  an  optimal 
growth temperature of 37 ºC and contains a thiSGH gene (ORF DVU2093). 
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pFM001 D.vulgaris
6377 bp
araBAD   1
MCS   2704
araC
Amp
thiH-His
thiG
thiS
Primer design and plasmid assembly 
 
D. vulgaris thiSGH (2.381 kb) was amplified by polymerase chain reaction (PCR) using 
genomic DNA and two different primers (table 6.10, section 6.6.1). The PCR product 
(thiSGH) was restricted using PciI and SacI and cloned into pRL1020 on a NcoI/SacI 
fragment  (method  6.6.1).  The  resultant  vector  was  named  pFM001  and  the  steps 
describing the amplification of the DNA segment as well as all the methods involved in 
the assembly of the plasmid are described in detail in section 6.6.1.  
 
 
 
 
 
 
 
 
 
 
Figure 4.2 Map of pFM001, encoding for D. vulgaris thiSGH-His. MCS: multiple cloning site. 
araBAD: operon promoter. Image created using pDraw32 DNA analysis software v1.0 145.  
 
A  second  plasmid  additionally  containing  the  E.  coli  isc  operon  (encoding  iscSUA-
hscAB-fdx) downstream from the thiSGH operon, was assembled as these proteins have 
been shown to improve expression of enzymes in the holo- form (method 6.6.1)120-122. 
The co-expression of E. coli ThiH with Isc proteins carried out using E. coli thiamine 
biosynthetic genes and is described in section 2.2.2.  
 
pRL1021,  a  plasmid  bearing  the  iscSUA-hscBA-fdx  operon,  was  restricted  with 
EcoRI/SacI to yield the iscSUA-hscBA-fdx fragment which was inserted into similarly 
restricted pFM001 (method 6.6.1). The resulting plasmid was named pFM101 (figure 
4.3). 
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pFM101 D. vulgaris
11086 bp
araBAD   1
MCS  ( 11 bp)   7413
iscS
iscU
iscA
hscB hscA
fdx
araC
A
m p
thiH-H is
thiG
thiS
 
 
 
 
 
 
 
 
 
 
Figure 4.3 Map of pFM101, encoding for D. vulgaris thiSGH-His and E. coli iscSUA-hscBA-
fdx.  MCS:  multiple  cloning  site.  araBAD:  operon  promoter.  Image  created  using  pDraw32 
DNA analysis software v1.0145.  
 
Expression and purification of D. vulgaris pFM001/BL21(DE3) and pFM101/BL21(DE3) 
 
pFM001  and  pFM101  were  transformed  into  E.  coli  BL21(DE3)  cells  and  grown 
aerobically in 2YT medium (method 6.6.2). Table 4.3 shows a comparison between the 
yield of cells and protein obtained from D. vulgaris (pFM001 and pFM101) and E. coli 
(pRL1020 and pRL1021). 
 
Table 4.3 Yields of cells and protein obtained from E. coli and D. vulgaris plasmids. 
Microorganism  Expression vector  Yield of cells (g/L)  Yield of protein (g/L) 
E. coli  pRL1020  7.6  5.2 
E. coli  pRL1021  7  3.5 
D. vulgaris  pFM001  8  0.5 
D. vulgaris  pFM101  5  1.3 
 
The yield of cells obtained from D. vulgaris expression plasmids (pFM001, pFM101), 
was very similar to the yield obtained using pRl1020 and pRl1021.  
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The  His-tagged  proteins  were  purified  from  pFM001/BL21(DE3)  and 
pFM101/BL21(DE3)  (method  13)  and  SDS-PAGE  analysis  of  the  eluted  fractions 
(method 8) shows that D. vulgaris ThiH-His co-elutes in a complex with ThiG, in a 
manner directly analogous to that observed for the E. coli proteins (figure 4.4 and 4.5). 
The predicted molecular weight of D. vulgaris thiamine proteins is higher then that of 
proteins derived from E. coli (table 4.4).   
 
Table 4.4 Predicted molecular weight for thiamine biosynthetic proteins in E. coli and D. 
vulgaris. 
  Proteins  MW/kDa 
ThiH  43.0  
ThiG  26.9  
ThiS  7.3 
Escherichia coli 
ThiF  27.0  
ThiH  48.0  
ThiG  27.6  
ThiS  7.0  
Desulfovibrio vulgaris 
ThiF  22.3 
 
The yield of soluble ThiGH obtained from D. vulgaris expression plasmids was very 
low, comparing to that obtained from E. coli expression system (pRL1020 and pRL1021) 
(table 4.3).  
 
E. coli can be a highly efficient host for recombinant protein expression and is certainly 
the most studied and optimised. It is widely used for protein expression of a number of 
genes  from  different  organisms.  Nevertheless,  it  has  been  observed  that  the 
expressions  of  foreign  genes  may  interfere  with  the  survival  of  E.  coli  cells  and 
significantly affect the expression capability188-190.  
 
Therefore, an explanation for the low level of expression might be found in the codon 
bias of D. vulgaris. E. coli contains a number of low usage codons (listed in table 4.5),   111 
when expressing genes from different organisms in E. coli, less tRNA is available to 
transfer  the  specific  amino  acids,  limiting  the  rate  of  protein  synthesis,  which  is 
observed  as  low  soluble  expression  level  of  the  protein191.  Modifications  of  culture 
conditions (e.g. low growth temperature, changes in media composition, etc.) could 
potentially  shift  the  codon  usage  bias  enough  to  alleviate  some  codon  usage-based 
expression problems. It has been reported however that the levels of most of the tRNA 
isoacceptors  corresponding  to  rare  codons  remain  unchanged  at  different  growth 
rates191,192. Table 4.5 lists the frequency of usage of rare codons in D. vulgaris, showing 
that this organism uses some of the rare codons present in E. coli, in particular arginine 
(codons: AGG and CGG). A complete list of the codon bias is listed in Appendix C. A 
method that can potentially overcome this problem is the use of a Rosetta host strain. 
This strain has been shown to enhance protein synthesis191.  
 
Table 4.5 Usage of rare codons in D. vulgaris thiH. 
Amino acid  Codon  Frequency per thousand  number 
Arg  AGG  28.4  13 
Arg  AGA  10.9  5 
Arg  CGG  52.5  24 
Arg  CGA  10.9  5 
Gly  GGA  4.4  2 
Ile  AUA  4.4  2 
Leu  CUA  4.4  2 
Pro  CCC  19.7  9 
 
The strength of the promoter is another factor that might have affected the protein 
expression. Studies by R. Leonardi58 using E. coli genes showed that pBAD derived 
plasmids  expressed  higher  level  of  soluble  ThiGH,  comparing  to  pET  derivatives 
(described in detail in section 2.2)58. Nevertheless, most studies using D. vulgaris genes, 
expressed in E. coli host, suggest that T7 RNA polymerase (pET vectors) is a more 
efficient promoter190,193,194. 
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Figure 4.4 Purification of ThiGH-His from D. vulgaris pFM001/BL21(DE3). Coomassie Blue 
stained 15% SDS-PAGE gels of proteins eluted from A: nickel-chelating column and B: gel 
filtration column. P: re-suspended pellet; S: supernatant; M: molecular weight marker; M2: 
purified  ThiGH-His  from  pRL1020/BL21  (DE3).  Fractions  26-32  from  the  nickel-chelating 
column were pooled and gel filtered. The numbers correspond to the fractions eluted from the 
column. 
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Figure 4.5 Purification of ThiGH-His from D. vulgaris pFM101/BL21(DE3). Coomassie Blue 
stained 15% SDS-PAGE gels of proteins eluted from A: nickel-chelating column and B: gel 
filtration column. P: re-suspended pellet; S: supernatant; M: molecular weight marker; M2: 
purified  ThiGH-His  from  pRL1020/BL21  (DE3).  Fractions  34-40  from  the  nickel-chelating 
column were pooled and gel filtered. The numbers correspond to the fractions eluted from the 
column. 
 
The iron content of the purified ThiGH samples was determined by the method of Fish 
(method 14). An increase in iron content was observed in purified samples of ThiGH 
expressed from D. vulgaris: pFM001 yield 2 mol of Fe per mol of ThiH and pFM101 
yield 4.5 mol of Fe per mol of ThiH. However, as it was observed with other plasmids 
containing the isc operon (section 2.2.2), ThiGH co-eluted with YqJI (23 kDa) (figure 
4.5) and the presence of this protein has an effect on the overall iron measured from 
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these samples. Nevertheless, the increase of iron observed in ThiGH samples expressed 
from pFM001, suggests that the expression of ThiGH from this organism might result 
in a high proportion of holo-enzyme. Future expression studies are required to optimise 
the expression of ThiGH from D. vulgaris and determine if this expression system is a 
better source of holo protein.  
 
4.2.3 Expression and purification of Thermotoga maritima ThiH 
 
Thermotoga maritima is a rod-shaped bacteria belonging to the order Thermotogales, it 
can be found in heated sea floors and volcanoes. T. maritima was originally isolated at 
Volcano, Italy but it can also be found in the Portuguese island of Azores; it has an 
optimal  growth  temperature of  80  ºC. This  organism metabolises many  simple  and 
complex carbohydrates and has potential as a renewable energy source177,186. Because T. 
maritima contains only a single thiH gene (ORF TM1267) and non of the other thiamine 
biosynthetic genes, there was a possibility that the assignment of TM1267 to be thiH 
was incorrect. 
 
Primer design and plasmid assembly 
 
T. maritima thiH (1.4 kb) was amplified by PCR (method 1), using genomic DNA and 
two  primers  (table  1.12,  section  6.6.4).  The  PCR  product  (thiH)  was  restricted  with 
NcoI/SalI and cloned into pBAD-HisA; on an NcoI/SacI fragment. The steps describing 
the  amplification  of  the  DNA  segment  as  well  as  all  the  methods  involved  in  the 
assembly of the plasmid are described in detail in method 6.6.4. The resulting plasmid 
was named pFM003 (figure 4.6).  
 
 
 
 
 
 
   115 
pFM003 T.maritima
5436 bp
araBAD   1
MCS   1763
TmThiH
araC
Amp
 
 
 
 
 
 
 
 
 
 
Figure 4.6 Map of pFM003, encoding for T. maritima thiH-His. MCS = multiple cloning site. 
araBAD = operon promoter. Image created using pDraw32 DNA analysis software v1.0145.  
 
A second plasmid containing the isc operon (encoding iscSUA-hscAB-fdx) downstream 
from the thiH operon, was assembled. During the planning of the assembly of this 
plasmid it was noticed that the T. maritima PCR product contained a XhoI restriction 
site  (figure  4.7).  This  represented  a  problem  since  the  iscSUA-hscBA-fdx  operon  is 
typically removed using the XhoI/EcoRI restriction sites. Another option to this method 
was the ligation of the PCR product, restricted with NcoI/SalI, to a plasmid restricted on 
a NcoI/XhoI site, since SalI complements the XhoI site (figure 4.7). pMK024, a plasmid 
bearing the isc operon, contained two NcoI sites, one of which would make impossible 
the correct restriction. Therefore mutagenesis on the NcoI site of interest was carried 
out.  The  new  plasmid  was  named  pFM024  (figure  4.7)  (method  6.6.3).  This  made 
possible  the  restriction  of  pFM024  with  NcoI/XhoI  and  insertion  of  the  NcoI/SalI 
restricted PCR product. This resulting plasmid was named pFM103, and due to the 
ligation of SalI and XhoI sites, result in the subtraction annulment of a restriction site 
(figure 4.7).  
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Figure 4.7 Assembly of pFM103 encoding for T. maritima thiH-His and E.coli iscSUA-hscAB-
fdx.  MCS  =  multiple  cloning  site.  araBAD  =  operon  promoter.  The  figure  shows  the 
mutagenesis of the NcoI site of pMK024 to give pFM024 and the sequence of the restriction 
sites. Image created using pDraw32 DNA analysis software v1.0145.    117 
Expression and purification of T. maritima  pFM003/BL21(DE3) and pFM103/BL21(DE3) 
 
pFM003  and  pFM103  were  transformed  into  E.  coli  BL21(DE3)  cells  and  grown 
aerobically in 2YT medium (method 6.6.5). A comparison between the yield of cells 
and protein obtained from T. maritima (pFM003 and pFM103) and E. coli (pRL1020 and 
pRL1021) is shown in table 4.6. The yield of cells obtained from T. maritima expression 
plasmids (pFM003, pFM103), was very similar to the yield obtained using pRL1020 and 
pRL1021.  
 
Table 4.6 Yields of cells and protein obtained from E. coli and T. maritima plasmids. 
Microorganism  Expression vector  Yield of cells (g/L)  Yield of protein (g/L) 
E. coli  pRL1020  7.6  5.2 
E. coli  pRL1021  7.0  3.5 
T. maritima  pFM003  6.0  1.2 
T. maritima  pFM103  6.4  1.0 
 
pFM003/BL21(DE3) and pFM103/BL21(DE3) were purified (method 13) and SDS-PAGE 
analysis of the eluted fractions (method 8) shows that ThiH-His co-elutes with a 28 kDa 
protein, assumed to be E. coli ThiG (figure 4.8 and 4.9). The molecular weight of T. 
maritima ThiH-His is 55.6 kDa. 
 
The  iron  content  of  the  purified  ThiH  samples  was  measured  (method  14)  and  an 
increase was observed; pFM003 yield 2 mol of Fe per mol of ThiH and pFM103 yield 4 
mol of Fe per mol of ThiH. However, as it was observed with plasmids containing the 
isc operon (section 2.2.2), ThiH co-eluted with YqJI (23 kDa) (figure 2.2.2). The presence 
of this protein has an effect on the overall iron measured from these samples.  
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Figure 4.8 Purification of ThiH-His from T. maritima pFM003/BL21(DE3). Coomassie Blue 
stained 15% SDS-PAGE gels of proteins eluted from A: nickel-chelating column and B: gel 
filtration  column.  P:  re-suspended  pellet;  S:  supernatant;  FT:  Flow  through;  M:  molecular 
weight marker. Fractions 16-20 from the nickel-chelating column were pooled and gel filtered. 
The numbers correspond to the fractions eluted from the column. The protein band at ~28kDa 
labelled as unidentified corresponds to the expected molecular weight of ThiG.  
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Figure 4.9 Purification of ThiH-His from T. maritima pFM103/BL21(DE3). Coomassie Blue 
stained 15% SDS-PAGE gels of proteins eluted from A: nickel-chelating column and B: gel 
filtration  column.  P:  re-suspended  pellet;  S:  supernatant;  FT:  Flow  through;  M:  molecular 
weight marker. Fractions 17-22 from the nickel-chelating column were pooled and gel filtered. 
The numbers correspond to the fractions eluted from the column. 
 
The co-elution of what appears to be ThiG with ThiH (figure 4.8 and 4.9) was confusing 
due to the absence of a thiG gene in the expression plasmids. An explanation for this 
might be that ThiH associates with the gene encoding for ThiG present in the E. coli 
chromosome during cell growth and protein expression. 
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The  observed  insolubility  of  ThiH  might  be  caused  by  the  inadequate  choice  of 
promoter  and/or  expression  host  (E.  coli).  Studies  using  hyperthermophiles,  have 
shown that the use of stronger promoters, such as plac, ptac, or T7 RNA polymerase, 
results in higher levels of expression when using host E. coli cells. Another difficulty 
encountered  in  expressing  archeal  genes  in  E.  coli  is  the  difference  of  codon  usage 
between  E.  coli  and  the  expressed  gene,  similar  to  the  D.  vulgaris  experiments. 
Hyperthermophiles in particular tend to adopt different strategies for stability of the 
proteins amongst them are: CG-rich codons; ratio of charged amino acids compared to 
uncharged amino acids; ionic interactions and amino acid preferences175. Table 4.7 lists 
the frequency of usage of rare codons in T. maritima, showing that this organism uses 
arginine,  glycine  and  isoleucine  codons  with  significantly  higher  frequency.  A 
complete  list  of  codons  is  listed  in  Appendix  C.  A  method  that  can  potentially 
overcome this problem is the use of a Rosetta host strain191. 
 
Table 4.7 Rare codon usage in T. maritima thiH. 
Amino acid  Codon  Frequency per thousand  Number 
Arg  AGG  21.1  10 
Arg  AGA  52.7  25 
Arg  CGG  0  0 
Arg  CGA  0  0 
Gly  GGA  31.6  15 
Ile  AUA  29.5  14 
Leu  CUA  2.1  1 
Pro  CCC  10.5  5 
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4.3 Relationship between ThiH and HydG 
 
It was later  noticed that the  T.  maritima  genomic  DNA  (ORF  TM1269)  used  in our 
studies and originally assigned in the databases as ThiH195 was identified by Rubach 
and co-workers196 to be the iron only hydrogenase maturation enzyme HydG.  
 
Hydrogenases  are  enzymes  that  catalyse  the  reversible  reduction  of  protons  to 
molecular hydrogen (H2). These enzymes enable the organism to use either H2 as a 
reducing source, or protons as terminal electron acceptors for the electrons produced 
during  metabolism.  Over  recent  years,  there  has  been  significant  interest  in 
hydrogenases, since they have the potential to generate hydrogen as a bio fuel194. 
 
There  are  three  phylogenetically  unrelated  types  of  hydrogenases:  [NiFe]-
hydrogenases.  [FeFe]  hydrogenases  and  [Fe]-hydrogenase197.  All  of  these  enzymes 
contain  unique  active  sites  with  iron  coordinated  to  cyanide  or  carbon  monoxide 
ligands198.  
 
The assembly of the cofactor found in the iron only hydrogenase (HydA), shown in 
figure 4.10, is proposed to require a chaperone (HydF) and two enzymes HydE and 
HydG,  which  show  sequence  similarity  to  the  ‘radical  AdoMet’  superfamily  of 
enzymes (discussed in section 1.4).   
 
HydE shows similarity to the sulfur insertion enzymes BioB and LipA, which may hint 
that this enzyme is involved in the biosynthesis of the bridging dithiolane ligand199. 
The crystal structure of HydE from T. maritima was recently elucidated by Nicolet and 
co-workers182, although the nature of the substrate remains unknown. 
 
The second protein, HydG, shows a high degree of sequence similarity to ThiH. We 
hypothesise that HydG catalyses a reaction closely related to ThiH, cleaving tyrosine 
and forming p-cresol and dehydroglycine. However, the proposed pathways diverge at 
this point, as dehydration of this dehydroglycine would yield the cyanide and carbon 
monoxide required for the HydA cofactor (scheme 4.1).   122 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 4.1 Proposed mechanism for the formation of the HydA cofactor.  
 
The dehydration of dehydroglycine could potentially to be initiated by HydG via the 
radical-anion 66 (section 3.3, scheme 3.3), or another active site residue acting as a base 
to catalyse the dehydration reaction.  
 
Preliminary studies on the activity of HydG have been undertaken within the Roach 
group. Working with recombinant HydG, Mr. M. Challand has detected the presence 
of p-cresol in HydG samples (results not shown). 
 
The  microorganisms  listed  in  table  4.1  were  aligned  (figure  4.1),  and  from  the 
phenogram (figure 4.10) it is possible to identify to closely related families. HydG and 
ThiH were re-assigned to each of these organisms.  
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Figure 4.10 Phenogram representing sequence homology between ThiH and HydG for selected 
organisms. Image created using Multialin200 
 
4.4 Summary and conclusions 
 
In  order to  study  novel methods  for the production  of holo-ThiH,  several  plasmids 
were  assembled  using  genomic  DNA  from  two  microorganisms,  D.  vulgaris  and  T. 
maritima.  The  selection  of  these  organisms  was  based  on  the  difference  in  operon 
structure (D. vulgaris) and thermostability of the organism (T. maritima). 
 
Studies using D. vulgaris plasmid pFM001, encoding for ThiSGH-His, resulted in a low 
level of soluble ThiGH, judging from the yield of protein obtained. This indicates that 
either  the  expression  system  was  not  appropriate,  i.e.  the  chosen  host  (E.  coli)  was 
unsuitable for the expression of these genes; or that the strength of the promoter was 
not appropriate. The co-expression of thiSGH-His from D. vulgaris with the E. coli isc 
operon  was  also  investigated,  but  these  studies  proved  to  be  ineffective  since  the 
protein YqJI co-eluted with the ThiGH complex. This had been previously observed in   124 
studies using E. coli (section 2.2). However, the increase of iron content observed in 
ThiGH expressed from pFM001, suggests that the D. vulgaris operon might produce 
more stable form of holo-ThiGH.  
 
The investigations using T. maritima produced unexpected results. Initial assignment of 
T. maritima (TM1269) strain indicated the presence of a thiH gene. Therefore, a plasmid 
was assembled encoding for T. maritima thiH-His, pFM003, and expressed in E. coli 
BL21(DE3) cells. The co-elution of ThiH with a second protein, which appears to be 
ThiG was confusing since the thiG gene was not present in the expression plasmid. An 
explanation for this result might be that ThiH associates with ThiG present in the E. coli 
cells during in vivo production. The co-expression with the Isc proteins, pFM003, was 
unsuccessful, since ThiH co-eluted with YqJI. This was also observed in studies using 
D. vulgaris and E. coli. The low solubility of ThiH might be associated with unsuitable 
choice of promoter, but most likely is caused by the significant difference of codon 
usage that exists between T. maritima and E. coli. The use of Rosetta cells, which contain 
rare  codons,  to  express  T.  maritima  genes,  might  produce  a  better  yield  of  soluble 
protein. 
 
The T. maritima (ORF TM1267) gene initially assigned as thiH was later found to be an 
iron only hydrogenase maturation protein, HydG, suggested to be a member of the 
‘radical AdoMet’ family. Finally, a mechanism was proposed in which this enzyme 
participates in a reaction very similar to that catalysed by ThiH (described in chapter 3) 
resulting in the formation of p-cresol.  Preliminary studies by Mr. M. Challand have 
identified  p-cresol  as  a  product  from  HydG  assays,  lending  strong  support  to  this 
hypothesis.  
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CHAPTER 5 
Conclusions  
 
Investigations  on  thiazole  biosynthesis  (Thz-P),  a  thiamine  precursor,  were 
initiated  by  expressing  and  isolating  the  enzymes  involved  in  this  reaction.  The 
isolation of active holo-ThiH, an enzyme required for thiazole synthesis, was essential 
for the reconstitution of in vitro activity. ThiH has been classified as a member of the 
‘radical-AdoMet’  family,  and  contains  an  essential  iron  sulfur  cluster.  Due  to  the 
oxygen  sensitivity  of  this  cluster,  the  isolation  of  this  enzyme  in  the  holo-form  is 
challenging. 
 
Studies  on  the  development  of  novel  expression  and  purification  techniques  were 
carried out with the aim of improving in vivo production of ThiH. Expression studies 
confirmed  that  pRL1020,  a  plasmid  assembled  by  R.  Leonardi,  remains  the  best 
expression  system  for  the  production  of  soluble  ThiGH.  Studies  using  addition  of 
supplements to the growth medium showed no improvement on the production and 
iron content of ThiGH; and the use of alternative affinity chromatography methods, to 
replace nickel affinity chromatography, proved to be ineffective. Nevertheless, the use 
of  ion  exchange  chromatography  produced  a  relatively  pure  sample  of  monomeric 
ThiH. This technique might potentially be an alternative to affinity chromatography 
purification.  Variations  of  the  buffers  used  during  purification  showed  significant 
improvement on the yield of protein; from 2.2 mg/g cell obtained using Tris buffer to 
5.2  mg/g  cell  using  MOPS  buffer.  The  use  of  MOPS  buffer  and  the  addition  of 
anaerobic  cell  lysis  step  to  the  purification  protocol  produced  very  stable  ThiGH 
complex.  
 
For  the  first time,  successful  in  vitro  chemical  reconstitution of  ThiH  (5.2  ± 1.3 mol 
equivalents of Fe per mol of ThiH) was achieved. Once reconstituted in this manner, it   126 
was possible for the ThiGH complex to be concentrated to ~40 mg/mL and to be used 
for  in  vitro  experiments.  Chemical  reconstitution  and  concentration  procedures 
followed by gel filtration chromatography allowed for the separation of the ThiGH 
complex  from  monomeric  ThiH,  resulting  in  samples  with  high  iron  content.  The 
stability of monomeric holo-ThiH, which could be concentrated to 60 mg/mL, is proof 
of  the  improvement  achieved  by  changing  the  purification  methodology  and  the 
chemical reconstitution procedure. This achievement is likely to prove useful during 
future crystallisation studies of ThiH, which will give detailed information about the 
structure of the active site of this protein, and insights into the mechanism of tyrosine 
cleavage. 
 
The successful production of holo-ThiH assisted the development of a functional in vitro 
assay used to study the mechanism of tyrosine cleavage. The in vitro assay contained 
chemically  reconstituted  ThiGH,  AdoMet,  tyrosine  and  a  reducing  system 
(NADPH/Fld/Fpr). The aromatic side chain released upon tyrosine cleavage, initially 
thought  to  be  p-hydroxybenzyl  alcohol,  was  identified  as  p-cresol.  The  remaining 
fragment  was  identified  as  glyoxylate,  the  in  vitro  hydrolysis  product  of 
dehydroglycine.  
 
The development of an HPLC method using UV-visible detection further confirmed 
the presence of p-cresol and also allowed for its quantification, the retention time was 
found to be 16.7 ± 0.5 min. In addition, this method detected AdoH (Rt= 11.8 ± 0.4 min), 
the  product  of  AdoMet  reductive  cleavage  by  the  [4Fe-4S]  cluster;  and  tyrosine 
consumption was also monitored by this method. The intermediate produced by the 
tyrosine  cleavage  reaction,  dehydroglycine,  is  thought  to  undergo  rapid  hydrolysis 
upon release from the ThiGH complex, but the hydrolysis product, glyoxylate was also 
detected. Quantification and detection of glyoxylate in the in vitro assays was achieved 
using  a  method  for  devised  for  the  detection  of  2-oxoacids,  in  which  glyoxylate  is 
converted to the fluorescent 2-quinoxalinol derivative. The retention times were found 
to be Rt = 11.6 ± 0.5 min for derivatised glyoxylate, and Rt = 11.6 ± 0.05 min for 2-
quinoxalinol. 
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The development of these two HPLC methods allowed the investigation of the kinetics 
and stoichiometry for the formation of the reaction products formed  upon tyrosine 
cleavage.  In  addition  the  rate  of  consumption  of  tyrosine  was  also  calculated. 
Uncoupled  turnover  of  AdoMet  was  observed,  with  1.3  mol  equivalents  of  AdoH 
being  produced  relative  to  p-cresol.  The  rate  of  formation  of  AdoH  is  found  to  be 
higher (0.102 ± 0.033 min-1) than the rate of tyrosine consumption (0.052 ± 0.003 min-1). 
In  another  in  vitro  assay  the  rates  of  formation  and  stoichiometry  of  p-cresol  and 
glyoxylate  were  calculated.  These  tyrosine  derived  products  are  formed  in  an 
approximate 1:1 ratio over time (176.2 ± 7.8  M p-cresol, 171.6 ± 7.9  M glyoxylate), 
and the reaction is shown to reach completion after 60 min. The fitted first order rate 
constants of formation were found to be 4.6  ±  0.7 [10-2 min-1] for p-cresol, and 6.3  ± 1.1 
[10-2 min-1] for glyoxylate. The rates of formation of p-cresol seem to be approximately 
the same in different experiments. To explain these observations, a novel mechanism 
for tyrosine cleavage was proposed. Further studies using tyrosine analogues might 
provide information on the kinetics of this reaction and give further information about 
the mechanism of Thz-P formation. 
 
In  order to  study  novel methods  for the production  of holo-ThiH,  several  plasmids 
were  assembled  using  genomic  DNA  from  two  microorganisms,  D.  vulgaris  and  T. 
maritima.  The  selection  of  these  organisms  was  based  on  the  difference  in  operon 
structure (D. vulgaris) and thermostability of the organism (T. maritima). Studies using 
D. vulgaris resulted in a low level of soluble ThiH but slightly higher iron content (in 
comparison with  ThiH produced from  E.  coli). Careful  analysis  of the codon  usage 
from D. vulgaris genes suggest that the use of Rosetta host cells might assist in the 
production of ThiH.  Despite its original assignment as a ThiH, the sequence from T. 
maritima (ORF TM1267) has subsequently been proposed to form part of the iron only 
hydrogenase  cluster  biosynthesis  pathway.  During  these  studies,  T.  maritima  HydG 
was  expressed  and  isolated  and  future  experiments  will  investigate  the  reaction 
catalysed by this enzyme. Due to the sequence similarities between ThiH and HydG, a 
mechanism  sharing  many  common  steps  has  been  proposed  for  HydG.    The 
observation of Mr. M. Challand of p-cresol formation in HydG assays supports this 
model.    128 
____________________________________________ 
CHAPTER 6 
Experimental Methods 
 
6.1 Materials 
 
The following table (table 6.1) summarises all materials and reagents used throughout 
this project.   
 
Table 6.1 Materials and Reagents.  
Materials  Supplier 
Reagent grade chemicals (unless otherwise stated)  Sigma-Aldrich 
Molecular biology reagents  Promega or Qiagen 
Restriction Enzymes 
Promega or 
New England Biolabs 
Taq DNA polymerase 
T4 DNA ligase 
Molecular weight markers for DNA electrophoresis 
Promega 
Pfu Turbo DNA polymerase 
QuikChange® Multi Site-Directed Mutagenesis Kit  
Stratagene 
dNTPs  MBI Fermentas 
Oligonucleotides  Sigma-Genosys 
Electrophoresis grade agarose  Bio-Rad 
Yeast-extract 
Bacto tryptone  
Bacteriological agar 
Oxoid (Fisher) 
β-(+)-L-arabinose 
K3[Fe(CN)6] 
Avocado 
Molecular weight markers for SDS-PAGE 
Acetic acid  
BDHMerck   129 
Potassium acetate 
Potassium dihydrogen phosphate 
Dipotassium hydrogen phosphate 
TLC  plates  (aluminium  backed  silica  Gel-60  (F-254, 
250 m) and RP-18 F254)  
Ampicillin  Melford Laboratories 
Anhydrous FeCl3   Acros 
Perchloric acid (20%)  Fluka 
Polyacrylamide-bis polyacrylamide (30% w/v, 37 :5 :1)  Amresco 
Glycerol 
HPLC grade solvents 
Fisher Scientific 
L-[U-14C]tyrosine  
S-adenosyl-L-[methyl-14C] methionine 
PD-10 and NAP-10  gel filtration columns 
GE Healthcare 
Q and S- Sepharose High Performance 
Superdex 75 (S-75) 
Superdex 200 (S-200) 
Chelating Sepharose Fast Flow resins 
AP Biotech 
Pressure cells (10, 50 and 250 mL)   Amicon 
PM30 and PM10 ultrafiltration membranes 
Biomax Ultrafree filter membranes (5k NMWL) 
Sterile 0.22 um filters 
Millipore 
Analytical and semi-preparative HPLC columns 
Roche, Fisher Scientific and 
Phenomenex 
pBAD-HisA  
E. coli One Shot cells  
Invitrogen 
E. coli BL21(DE)3  Novagen 
pFLAV and pFLDR201 
Gift from Dr. K. S. Hewitson  
(Oxford University)  
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6.2 Equipment 
 
Centrifugation: Samples (2-250 mL) were centrifuged at 4 ºC in an Avanti J-25 centrifuge 
(Beckman). For samples of a volume less than 2 ml a microCentrifugette 4221 (ALC) at 
room temperature or a Biofuge Fresco (Heraeus) at 4 ºC were used. 
 
Determination of pH: Mettler Delta 340 pH meter connected to a Mettler Toledo Inlab 
413 Combination Electrode was used for pH determination and adjustment. The pH 
meter was calibrated at pH 7.0 and 10.0 before use and stored in a saturated solution of 
KCl. 
 
PCR, Sterilisation and Incubation: A Progene Thermal Cycler (Techne) was used for PCR 
amplifications.  Media  and  heat  stable  solutions  required  for  microbiological 
experiments were sterilised in a PriorClave steam autoclave (Priorclave Ltd) at 121 ºC 
for  25  min.  Bacterial  cultures  (solid  and  liquid)  were  incubated  in  an  Innova  4400 
Incubator  Shaker  (New  Brunswick  Scientific)  or  in  an  Innova  4230  Refrigerated 
Incubator Shaker (New Brunswick Scientific).  
 
Cell Lysis by Sonication: Cells suspensions were lysed by sonication in ice/cold water 
baths using either a Soniprep 150 sonicator (Sanyo) or a VC130 sonicator (Sonics and 
Materials, Newtown, CT). Cell lysates were cleared in 250-mL gas-tight polycarbonate 
centrifuge bottles (Beckman-Coulter, High Wycombe, UK). 
 
Anaerobic  Purifications,  protein  reconstitutions  and  assays:  all  experiments  requiring 
anaerobic conditions were carried out under a nitrogen atmosphere in an anaerobic 
glove box with less than 2 ppm of O2 (Belle Technology, Portesham, UK). The glove 
box was maintained at 19 ºC in a temperature controlled laboratory. 
 
UV-visible Spectroscopy: absorbance readings and UV spectra were recorded aerobically 
on  a  Lamba  2  spectrophotometer  (Perkin-Elmer)  and  anaerobically  using  a  Ocean 
Optics (Duiven, The Netherlands) USB2000 spectrophotometer equipped with a light   131 
Mini-D2-GS  source  connected  by  P-400-2-UV/SR  optical  fibers  to  a  cuvette  holder 
inside the glove box.   
 
NMR:  1H and  13C NMR spectra were recorded on a Bruker DXP 300 operating at 75 
MHz. For the samples extracted into organic solvents, the supernatants were extracted, 
combined and the organic phase was analysed by 13C NMR spectrometry on a Bruker 
DPX 400 operating at 100 MHz.  
 
FPLC, HPLC and LC-MS: A Pharmacia-LKB fast performance liquid chromatography 
(FPLC) unit was used for aerobic purifications at 4 ºC; an Amersham Biosciences Acta 
fast protein liquid chromatograph was used for anaerobic protein purifications at 19 
ºC.  
 
A Gilson 321 HPLC work centre equipped with a dual wavelength UV-visible detector 
and  a  Shimadzu  RF-10Axl  fluorescence  detector  was  used  for  analytical  HPLC 
methods;  chromatograms  were  collected  and  analyzed  using  the  Gilson  Unipoint 
software  (Gilson).  Mass  spectrometry  analysis  was  carried  out  using  one  of  three 
systems:  (1)  Gilson  HPLC  coupled  to  a  Thermo  Finnigan  Surveyor  MSQ  single 
quadrupole mass spectrometer with electrospray ionization. The data were collected 
and processed using the XCalibur software system, and multiple charged species were 
analyzed by Promass Deconvolution (Thermo, Altrincham, UK); (2) VG Platform single 
quadrupole; (3) Waters ZMD quadrupole mass spectrometer.  
 
Gel Densitometry Analysis: a Syngene Gene Genius imaging system and related software 
were used to estimate the relative amounts of proteins analysed by SDS-PAGE and 
revealed by Coomassie staining (appendix B).  
 
6.3 General Experimental Methods 
 
Standard  sterile  techniques  were  applied  throughout  microbiological  experiments. 
Growth media and heat stable solutions were autoclaved, whilst heat labile solutions 
were filter sterilised through 0.22  m filters. Unless otherwise stated, growth media   132 
were supplemented with ampicillin (100  g/mL) and protein expression was induced 
by the addition of arabinose [20 % (w/v), 10 mL/L].  Assembled plasmids are listed in 
appendix  A.  The  composition  of  media  and  other  relevant  solutions  is  given  in 
appendix B. 
 
Protein purifications and assays were all carried out inside an anaerobic glove box at 
19 ºC. Buffers, solutions, containers (bottles, jars, tubes, beakers etc.) and equipment 
required during the purification were degassed overnight inside the glove box. For the 
optimised  purification  procedure  (method  13),  purification  buffers  were  degassed 
outside the glove box with a nitrogen line tightly connected to the bottles, sealed and 
placed inside the glove box overnight.  
 
Columns  and  the  HPLC  were  placed  outside  the  box  but  the  buffer  lines  were 
introduced in a sealed gastight fashion into the box so that the anaerobic buffers could 
be pumped through the system and used to elute the proteins; the column eluate was 
fed back into the box to permit anaerobic fraction collection. For experiments using, 
FPLC system, the equipment was placed inside the glove box. Protein was fed to the 
column, placed outside the glove box, using gastight lines, and fed back to the box to 
allow anaerobic collection of the protein fractions. Protein elution was monitored at 280 
and 420 nm.  
 
Method 1: PCR amplification of genes of interest 
 
Polymerase chain reactions (PCR; 50  L) were set up in sterilised tubes (200  L) using 
the conditions reported in table 6.2; however, in order to minimise the extension of 
partially  annealed  primers  to  non-specific  sites  on  the  genomic  DNA,  the  DNA 
polymerase was added only after 3 min incubation at 95 ºC (table 6.3).  
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Table 6.2 Conditions for PCR reaction.  
Component  Stock concentration  Volume  Total quantity 
Pfu turbo buffer  10 ×  2.5  L  1 × 
dNTPs  2 mM  10  L  20 nmol 
DNA template (pRL1020)  10 or 100 ng/ L  1  L  10 or 100 ng 
Primers   10  M  2.5  L/each  0.025 nmol 
Pfu turbo DNA polymerase  0.25 U/ L  5  L  1.25 U 
+/- DMSO    5  L   
Sterile H2O    to 50  L   
* Two reaction mixtures containing different amounts of DNA template (100 and 10 ng) 
were prepared for the amplification of target genes.   
 
PCR reactions were processed in a thermocycler as reported in table 6.3, then analysed 
on 1 % agarose gels by gel electrophoresis.  
 
Table 6.3 PCR amplification reaction cycle conditions. 
Nº of cycles  T/ºC  Time/min 
95  3 
1  80 
(addition of the  polymerase) 
3 
95 
(denaturation) 
1 
50 
(annealing) 
1 
30 
72 
(elongation) 
1-1.5/kb 
72  10 
1 
4  as required* 
   *At the end of the last cycle, reaction mixtures were stored at 4 ºC until removed. 
 
PCR  products  were  purified  using  Wizard
  PCR  Preps  DNA  Purification  System 
(Promega),  as  per  manufacturer’s  instructions.  Plasmid  DNA  was  isolated  using   134 
QIAprep  Spin  Miniprep  Kit  (Quiagen),  as  per  manufacturer’s  instructions.  Sterile 
water (25-45  L) was used to elute the purified plasmid DNA.  
 
Method 2:  Preparation of Competent Cells and Transformation 
 
E. coli competent cells were either purchase (One Shot) or prepared by the rubidium 
chloride  method202.  Purchased  competent  cells  were  transformed  according  to  the 
manufacturer  instructions  and  in  the  case  of  the  competent  cells  prepared  in  our 
laboratory the following general method as been employed successfully. 
 
Aliquots of competent cells (50-200  L) contained in 1.5 mL microcentrifuge tubes were 
defrosted on ice for 10 min before adding, with gentle mixing, 6-10  L of a ligation 
reaction (method 7) or 1  L of purified plasmid DNA. The tubes were then incubated 
on ice for 30 min and then heat-shocked for 45 seconds in a bath maintained at 42 ºC. 
Cells were returned to the ice for 2 min, and room temperature SOC medium (800-950 
 L) was added. The resulting cell suspensions were incubated at 37 ºC (230 rpm) for 1 
hour before being plated on selective 2YT or supplemented DM agar plates (appendix 
B). These plates were incubated overnight at 37 ºC. Positive colonies (those containing 
the  correct  construct)  were  identified  as  follows:  well  isolated  single  colonies  were 
picked  from  plates  with  a  10   L  sterile  tips  and  placed  into  a  50  mL  falcon  tube 
containing 10 mL of 2YT medium supplemented with ampicillin (100  g/mL). Cells 
were grown overnight at 37 ºC for further investigation or storage. 
 
Method 3: Glycerol freeze preparation 
 
Well  isolated  single  colonies  were  picked  from  plates  with  a  10   L  sterile  tip  and 
placed into a 50 mL falcon tube containing 10 mL of 2YT medium supplemented with 
ampicillin (100  g/mL). The cell culture was incubated overnight at 37 ºC. Glycerol (125 
 L) was added to the cell culture (500  L), mixed vigorously, and stored at -80 ºC. 
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Method 4:  Plasmid DNA isolation 
 
Plasmid DNA was isolated using Wizard Plus  Minipreps DNA Purification System 
(Promega), following manufacturer instructions. 
 
Method 5: Restriction digestion (analytical and preparative) 
 
Analytical restriction digestion of plasmid DNA isolated from 5 mL bacterial culture 
(method 10) used the following conditions: 
 
Table 6.4 Conditions for analytical plasmid DNA restriction digestion.*  
Component  Concentration  Volume  Total quantity 
Plasmid  50-75 ng/ L  5  L  250-375 ng 
Buffer 4  10 ×  1  L  1 × 
BSA  1 mg/mL  1  L  1  g 
Enzyme 1  10 U/ L  0.5  L  5 U 
Enzyme 2  10 U/ L  0.5  L  5 U 
Sterile H2O    2  L   
* Total volume: 10  L. 
Preparative restriction digestion of plasmid DNA (25  L, 100-300 ng/ L) isolated from 
10 mL bacterial culture (method 10) used the following conditions: 
 
Table 6.5 Conditions for preparative plasmid DNA restriction digestion.  
Component  Concentration  Volume  Total quantity 
Plasmid  20  L  25  L  2-6  g 
Buffer 4  10 ×  5  L  1 × 
BSA  1 mg/mL  5  L  10  g 
Enzyme 1  10 U/ L  2.5  L  40 U 
Enzyme 2  10 U/ L  2.5  L  40 U 
Sterile H2O    10  L     136 
Reaction mixtures were incubated at 37 ºC for 1-2.5 h and then analysed on a 1 % 
agarose gel by gel electrophoresis.  
 
Method 6: Purification of digested fragments 
 
Completed preparative digestion reactions (63  L) were loaded onto a 1 % low melting 
point  agarose  gel  to  separate  the  fragments  of  interest.  The  required  bands  were 
excised and the DNA recovered from the agarose using the QIAquick Gel Extraction 
Kit (Quiagen), as per manufacturer’s instructions. Agarose gel electrophoresis analysis 
was used to estimate the concentration of the purified fragments by comparison with 
DNA markers of known concentration. 
 
Method 7: Ligation into an expression vector 
 
Samples  of  suitably  restricted  and  purified  plasmid  and  insert  DNA  were  ligated 
under the following conditions: 
 
Table 6.6 Conditions for the ligation of a DNA fragment into an expression vector.* 
Component  Concentration  Volume  Total quantity 
Ligase buffer  10 ×  5  L  1 × 
Plasmid  50 ng/ L  1  L  50 ng 
Insert  25 – 100 ng/ L  x  L*   
T4 DNA ligase  3 U/ L  1  L  3 U 
H2O    to 10  L   
* x varied according to the size of both the vector and the insert, and was calculated to 
give 3:1 and 1:3 insert:vector molar ratios. 
 
Ligation reactions were incubated overnight at 4 ºC and then used to transform TOP10 
competent cells (method 2). Positive colonies were then identified by PCR screening 
and plasmid DNA isolation followed by analytical restriction digestion.    137 
Method 8: SDS-PAGE analysis203 
 
Protein  purity  was  determined  by  analysis  of  15  %  SDS-PAGE  gels  revealed  by 
Coomassie  blue  staining  (appendix  B).  For  each  sample,  small  amounts  (20   L)  of 
cleared lysate and re-suspended cell pellets, were mixed with 2 X SDS-PAGE loading 
buffer  (20   L,  appendix  B),  heated  at  90  ºC  for  5  min  to  ensure  the  proteins  were 
denatured and then a sample loaded onto a SDS-PAGE gel. 
 
Method 9: Estimation of protein concentration204 
 
Protein concentration was routinely determined by the method of Bradford. Briefly, 
Bradford reagent (1 mL) was added to a protein sample (20  L) and incubated at room 
temperature for 5 min, and then the A595 was measured using water as a control. The 
sample was diluted if A595 exceeded 1.0. Appropriate correction factors for proteins of 
unknown concentration were obtained from calibration curves constructed with BSA 
standards.  
 
Method 10: Small scale expression experiments 
 
Cells from glycerol freezes [pRL1020/BL21(DE3) or pRL1021/BL21(DE3)] were used to 
inoculate small scale cultures in 2YT medium (10 mL) supplemented with ampicillin 
(100  g/mL), which were incubated overnight at 37 ºC. This culture was then used as a 
1% inoculum for 200 mL of 2YT growth media containing 200  L of ampicillin (100 
 g/mL). Cells were grown aerobically in an orbital shaker (37 ºC, 180 rpm) and when 
the  OD600  reached  ~0.6,  protein  expression  was  induced  by  the  addition  of  a filter-
sterilised arabinose solution [20 % (w/v), 10 mL/L] and returned to the shaker at 27 ºC. 
After 5 hours the cell cultures were harvested by centrifugation (12000 rpm, 15 min). 
Cell paste was weighed and re-suspended in lysis buffer [50 mM Tris-HCl pH 8.0, 
Glycerol 20% (w/v)] into 50 mL falcon tubes and stored at -80 ºC until further use.  
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Method 11: Aerobic large scale expression experiments 
 
Cells from a glycerol stock were used to inoculate starter cultures in 2YT medium (5×10 
mL) supplemented with ampicillin (100  g/mL), which were incubated overnight at 37 
ºC.  These  cultures  were  then  used  as  1%  inoculum  into  fresh  2YT  medium  (5  L) 
aliquoted in 4 L flasks (∼ 1.25 L of medium/flask), and cells grown at 37 ºC. When the 
OD600  reached  0.4-0.6,  protein  expression  was  induced  by  the  addition  of  a  filter-
sterilised arabinose solution [20 % (w/v), 10 mL/L], after which cells were transferred to 
a shaker at 27 ºC. Cell growth continued until the OD600 = 1.8-2.3, cells were harvest by 
centrifugation (JA-14 rotor, 12000 rpm for 20 min at 4ºC) and cell pellet stored at -80  ºC 
until further use. 
 
Method 12: Initial anaerobic purifications of ThiGH-His58 
 
ThiH was anaerobically purified using the following buffers: A - 50  mM Tris-HCl pH 
8.0, 200 mM NaCl, 50 mM imidazole, 12.5% (w/v) glycerol; B - 50 mM Tris-HCl pH 8.0, 
500 mM NaCl, 50 mM imidazole, 12.5% (w/v) glycerol; C - 50 mM Tris-HCl pH 8.0, 200 
mM NaCl, 500 mM imidazole, 12.5% (w/v) glycerol; D - 50 mM Tris-HCl pH 8.0, 5 mM 
DTT, 12.5% (w/v) glycerol.  
 
To the still frozen cell paste (27-30 g), lysozyme (0.1 mg/mL), benzonase (10 U/mL) and 
PMSF (100 mM stock solution in i-PrOH, 1 mM final concentration) were added under 
aerobic  conditions;  the  cells  were  then  introduced  inside  the  glove  box  and  re-
suspended  in  anaerobic  buffer  A  (90  mL)  stirring  continuously  for  ~30  min.  The 
suspension was then withdrawn from the anaerobic box and rapidly lysed, on ice, by 
sonication (15-20 times 30 second bursts, 30 second rest between each burst). The lysate 
was returned to the box, allowed to degas (10 min), and after the addition of PEI (0.2 % 
v/v) cleared by centrifugation in gastight centrifuge tubes (JA-14 rotor, 12000 rpm, 30-
40 min). The brown supernatant was applied to a Chelating Sepharose column (25 mL) 
previously charged with nickel sulfate (25 mL, 0.2 M) and equilibrated with anaerobic 
buffer  A  (10  column  volumes).  The  column  was  washed  with  buffer  B  (4  column 
volumes), then buffer A (2 column volumes) and proteins were eluted at 5 mL/min   139 
with  an  increasing  gradient  of  buffer  C  from  0  to  50%  over  4  column  volumes, 
collecting  5  ml  fractions.  High  molecular  weight  impurities  were  normally  eluted 
within the first 60-65 mL of the gradient, whilst the ThiGH-His complex was eluted in 
a  broad  peak  between  45  and  200  ml  (towards  the  end  of  the  gradient).  To  avoid 
protein precipitation, the most concentrated and brown fractions (typically fractions 
15-20), were immediately pooled and applied (up to 30-35 mL) to an S-75 gel filtration 
column (3 cm I.D. x 15 cm), previously equilibrated with anaerobic buffer D. Proteins 
were  eluted  isocratically  at  2  mL/min  and  collected  in  10  mL  fractions.  The  most 
concentrated  fractions  were  pooled,  glycerol  added  to  a  final  concentration  of  25% 
(w/v) and proteins concentrated by ultrafiltration (30 kDa MWCO) to 5-6 mg/mL, as 
the ThiGH-His complex precipitates above 7 mg/mL. Proteins were stored at -80 ºC in 
this buffer (buffer E).  
 
Aliquots  of  protein  (50  L)  were  removed  from  the  fractions  collected  during  the 
elution  from  the  nickel-chelating  and  the  gel  filtration  columns,  and  subsequently 
analysed  by  SDS-PAGE  (method  8).  Due  to  the  excellent  reproducibility  of  this 
purification procedure, highly pure ThiGH-His was routinely obtained, in spite of the 
fact that the purity was not checked prior to pooling and concentrating the fractions. 
This was judged to be necessary to allow the highly unstable complex to be rapidly 
exchanged into a buffer in which it was more stable. 
 
Method 12a: Introduction of anaerobic cell lysis  
 
To the still frozen cell paste (27-30 g), lysozyme (0.1 mg/mL), benzonase (10 U/mL) and 
PMSF (100 mM stock solution in i-PrOH, 1 mM final concentration) were added under 
aerobic  conditions;  the  cells  were  then  introduced  inside  the  glove  box  and  re-
suspended  in  anaerobic  buffer  A  (90  mL)  stirring  continuously  for  ~30  min.  The 
suspension was then lysed, on ice, by sonication (30 min, amplitude: 70, pulser: 2 sec), 
and after the addition of PEI (0.2 % v/v) cleared by centrifugation in gastight centrifuge 
tubes (JA-14 rotor, 12000 rpm, 30-40 min). The purification protocol is described above 
(method 12) 
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Method 13: Optimised anaerobic purifications of ThiGH-His 
 
Cells were grown on a large scale as described in method 11. ThiGH was anaerobically 
purified using the following buffers: A - 50 mM Mops pH 7.7, 200 mM NaCl, 50 mM 
imidazole,  10%  (w/v)  glycerol;  B  -  50  mM  Mops  pH  7.7,  500  mM  NaCl,  50  mM 
imidazole,  10%  (w/v)  glycerol;  C  -  50  mM  Mops  pH  7.7,  200  mM  NaCl,  500  mM 
imidazole, 10% (w/v) glycerol; D - 50 mM Mops pH 7.7, 200 mM NaCl, 5 mM DTT, 10% 
(w/v) glycerol.  
 
To the still frozen cell paste (27-30 g), lysozyme (0.1 mg/mL), benzonase (10 U/mL) and 
PMSF (100 mM stock solution in i-PrOH, 1 mM final concentration) were added under 
aerobic  conditions;  the  cells  were  then  introduced  inside  the  glove  box  and  re-
suspended  in  anaerobic  buffer  A  (90  mL)  stirring  continuously  for  ~30  min.  The 
suspension was then lysed, on ice, by sonication (30 min, amplitude: 70, pulser: 2 sec), 
and after the addition of PEI [final concentration: 0.2 % (v/v); pH 8.0, adjusted with 
HCl] cleared by centrifugation in gastight centrifuge tubes (JA-14 rotor, 12000 rpm, 30-
40 min). The brown supernatant was applied to a Chelating Sepharose column (25 mL) 
previously charged with nickel sulfate (25 mL, 0.2 M) and equilibrated with anaerobic 
buffer  A  (10  column  volumes).  The  column  was  washed  with  buffer  B  (4  column 
volumes), then buffer A (2 column volumes) and proteins were eluted at 5 mL/min 
with  an  increasing  gradient  of  buffer  C  from  0  to  50  %  over  4  column  volumes, 
collecting  5  mL  fractions.  High  molecular  weight  impurities  were  normally  eluted 
within the first 60-65 mL of the gradient, whilst the ThiGH-His complex was eluted in 
a broad peak between 45 and 200  mL  (towards  the  end of  the  gradient). To  avoid 
protein precipitation, the most concentrated and brown fractions (typically fractions 
15-20), were immediately pooled and applied (up to 30-35 mL) to a S-75 gel filtration 
column (3 cm I.D. x 15 cm), previously equilibrated with anaerobic buffer D. Proteins 
were stored at -80 ºC. Aliquots of protein (50  L) were removed from the fractions 
collected during the elution from the nickel-chelating and the gel filtration columns, 
and subsequently analysed by SDS-PAGE (method 8). The elution of ThiGH from the 
columns, using this purification method, was highly reproducible  so it allowed the 
rapid transfer of protein samples to the next purification step without SDS-Page gel   141 
analysis.  This  rapid  purification  is  highly  advantageous  as  ThiGH  complex  shows 
great tendency to precipitate in buffers other than the final storage buffer. 
 
Method 14: Iron analysis137 
 
The amount of iron present in purified ThiGH was analysed by the methods of Fish 
and was determined in triplicate. For the iron analysis, the following solutions were 
prepared: reagent A, 0.142 M KMnO4 in 0.6 N HCl, obtained by mixing equal volumes 
of 1.2 M HCl and 0.284 M KMnO4 in H2O (445 mg in 10 mL), and reagent B, 6.5 mM 
ferrozine, 13.1 mM neocuproine, 2 M ascorbic acid, 5 M ammonium acetate in H2O, 
prepared by first dissolving the ammonium acetate (4.85 g) and ascorbate (4.4 g) in 
H2O (12.5 mL) followed by ferrozine and neocuproine (40 mg each). Reagent A was 
freshly prepared every time, whilst reagent B was stored in the dark and was used for 
no longer than 3 weeks. Standard solutions were prepared on a range of concentrations 
(0 – 72 nmoles Fe2+) from a stock solution of FeSO4⋅7 H2O in water (500  g in 10 mL, 180 
 M). This dilution method has been previously described by Leonardi58. 
 
ThiGH-His  samples  (300   L,  5-6  mg/mL)  were  diluted  to  1  mL  with  water  and 
incubated, together with the standards, for 2 h at 60 ºC after the addition of reagent A 
(500  L). At the end of the 2 hour incubation, samples were allowed to cool down to 
room  temperature  before  adding  reagent  B  (100   L).  When  the  purple  colour  was 
completely developed (15-20 min) the A562 of the samples was measured. If necessary, 
protein precipitate was removed by centrifugation before reading the absorbance. The 
amount  of  iron  present  in  the  ThiGH-His  samples  was  estimated  from  standard 
calibration curves constructed in parallel (figure 6.1). 
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Figure 6.1 Iron standard curve. Data fitted using Sigmaplot to a linear function (y=ax+y0): 
R=0.9985, y0=1.094E-2, a=1.730E-2.  
 
6.4 Experimental for chapter 2 
 
6.4.1 Small scale anaerobic expression experiments using pRL1020 
 
Cells from glycerol freezes (pRL1020/BL21(DE3)) were used to inoculate small scale 
cultures in 2YT medium (10 mL) supplemented with ampicillin (100  g/mL), incubated 
overnight at 37 ºC. This culture was used as a 1% inoculum for 1 L of growth medium 
[(1) Glycerol Minimal Medium; (2) 2YT Medium; (3) 2YT Medium supplemented with 
sodium nitrate (40 mM, NaNO3) and sodium nitrite (5 mM, NaNO2) depending on the 
experiment]. To each of them 1 mL of ampicillin (100  g/mL) was added. Cells were 
grown aerobically in an orbital shaker (37 ºC, 180 rpm) and when the OD600 reached 
~0.6  (or  ~0.3  when  glycerol  minimal  medium  was  used),  protein  expression  was 
induced by the addition of a filter-sterilised arabinose solution [20 % (w/v), 10 mL/L] 
and returned to the shaker at 27 ºC. After 1 hour, growth media was transferred into 
gas tight bottles and placed inside the glove box to degas for ~30 min. The bottles were   143 
then withdrawn from the box and left stirring overnight in a cold room at 4 ºC. The 
following morning  bottles were  returned to  the  glove box  and  the  cell culture was 
anaerobically  transferred  into  gas  tight  centrifuge  bottles.  Cells  were  harvest  by 
centrifugation (JA-14 rotor, 12000 rpm, 20 min, 4 ºC). Cell paste was placed inside the 
glove box, weighed, re-suspended in lysis buffer [50 mM Tris-HCl pH 8.0, Glycerol 
20% (w/v)] into 50 mL falcon tubes and immediately frozen in liquid nitrogen. The cell 
suspension was stored at -80 ºC until further use.  
 
6.4.2 Small scale anaerobic expression experiments using pRL1021 
 
Cells from glycerol freezes (pRL1021/BL21(DE3)) were used to inoculate small scale 
cultures in 2YT medium (10 mL) supplemented with ampicillin (100  g/mL), incubated 
overnight at 37 ºC. This culture was then used as a 1% inoculum for 1 L of 4 different 
growth medium: (1) 2YT medium; (2) 2YT supplemented with tyrosine (2 mM); (3) 2YT 
supplemented with ferrous sulfate (FeSO4, 0.3 mM) and (3) 2YT supplemented with 
tyrosine (2 mM) and iron sulfate (FeSO4, 0.3 mM); to each of them 1 mL of ampicillin 
(100  g/mL) was also added. Cells were grown aerobically in an orbital shaker (37 ºC, 
180 rpm) and when the OD600 reached ~0.6 (or ~0.3 when glycerol minimal medium 
was  used),  protein  expression  was  induced  by  the  addition  of  a  filter-sterilised 
arabinose solution [20 % (w/v), 10 mL/L] and returned to shaker at 27 ºC. After 1 hour, 
growth media was transferred into gas tight bottles and placed inside the glove box to 
degas for ~30 min. The bottles were then withdrawn from the box and left stirring 
overnight in a cold room at 4 ºC. The following morning bottles were returned to the 
glove box and the cell culture was anaerobically transferred into gas tight centrifuge 
bottles. Cells were harvest by centrifugation (JA-14 rotor, 12000 rpm, 20 min, 4 ºC). Cell 
paste was placed inside the glove box, weighed, re-suspended in lysis buffer [50 mM 
Tris-HCl pH 8.0, Glycerol 20% (w/v)] into 50 mL falcon tubes and immediately frozen 
in liquid nitrogen. The cell suspension was stored at -80 ºC until further use.  
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6.4.3 Large scale anaerobic expression experiments using pRL1021 
 
Cells from the glycerol freeze of interest were used to inoculate starter cultures in 2YT 
medium (5×10 mL) supplemented with ampicillin (100  g/mL), incubated aerobically 
overnight  at  37  ºC.  These  cultures  was  then  used  as  1  %  inoculum  into  fresh  2YT 
medium (3 L) 2YT supplemented with tyrosine (2 mM) and ferrous sulfate (FeSO4, 0.3 
mM) and placed in a fermentor; cells were grown at 37 ºC, and constantly purged with 
nitrogen to provide an anaerobic atmosphere. When the OD600 reached 0.4-0.6, protein 
expression was induced by the addition of a filter-sterilised arabinose solution [20 % 
(w/v), 10 mL/L], cells were cooled down to 27 ºC. Cell growth continued until the OD600 
= 1.8-2.3, and after nitrogen pressure was applied to the air port of the fermentor, and a 
harvest  line was used to  transfer  the  cell  culture to  previously degassed centrifuge 
bottles inside an anaerobic glove box. The cells were harvest by centrifugation (JA-14 
rotor, 12000 rpm for 8 min at 4 ºC), transferred to the glove box and cell pellet collected 
and immediately stored at -80 ºC. 
 
6.4.4 Small scale anaerobic purifications of ThiGH 
 
ThiGH was anaerobically purified from cell past (~3 g cells) using a purposely made 
small nickel column (figure 6.2) at 19 ºC. The purification buffers were: A - 50 mM Tris-
HCl pH 8.0, 12.5% (w/v) glycerol; B - 50 mM Tris-HCl pH 8.0, 0.5 M NaCl, 10 mM 
imidazole,  12.5%  (w/v)  glycerol;  C  -  50  mM  Tris-HCl  pH  8.0,  0.5  M  NaCl,  20  mM 
imidazole,  12.5%  (w/v)  glycerol;  D  -  50  mM  Tris-HCl  pH  8.0,  0.5  M  NaCl,  50  mM 
imidazole, 12.5% (w/v) glycerol; E - 50 mM Tris-HCl pH 8.0, 0.5 M NaCl, 500 mM 
imidazole, 12.5% (w/v) glycerol. 
 
Nickel columns were prepared by transferring 4 mL of Chelating Sepharose Fast Flow 
resin into a small column (figure 6.2); excess buffer was removed and the resin was 
charged by re-suspending 8 ml of nickel sulfate (0.2 M). The column was then washed 
with buffer A (3× 2 mL). Meanwhile the frozen cell paste (3 g) was introduced inside 
the glove box and re-suspended in 9 mL of anaerobic buffer A and left to stir for 15 
min.  The  suspension  was  then  lysed,  on  ice,  by  sonication  (20  min,  amplitude:  70,   145 
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pulser: 2 sec), and cleared by centrifugation in  microcentrifuge tubes (30 min). The 
brown supernatant was applied to the column and left to stand for 10 min. The flow 
through was collected and re-applied to the column repeating the previous step. The 
column  was then washed  with increasing  gradient  of imidazole  buffer B, C  and D 
(2×10 mL each). Washings were collected. The protein was eluted by the addition of 
6×1 mL of high imidazole buffer E, mixing well each time and left to stand for 5 min 
before collecting. From each fraction collected during the purification aliquots (50  L) 
were removed and subsequently analysed by SDS-PAGE (method 8).  
 
 
 
 
 
 
 
 
 
 
 
Figure 6.2 Design of the small nickel column used in small scale purifications.  
 
6.4.5 Assembly of pFM700 and pFM707 
 
Unless otherwise specified all genes were amplified using Pfu turbo DNA polymerase 
(method 1) and an appropriate pair of oligonucleotide primers.   
 
The following general strategy was employed to assemble all the expression plasmids 
mentioned in chapters 2 and 4. The genes of interest were amplified by PCR (method 1) 
and  cloned  either into  pBAD-HisA or pBAD  derivative plasmid.  Reaction mixtures 
were then transformed into E. coli TOP10 One Shot competent cells (method 2) and 
plated  onto  selective  2YT  solid  medium.  Positive  clones  were  identified  by  DNA 
isolation followed by analytical restriction digestion (method 5). Once isolated, positive   146 
clones were stored as glycerol freezes (method 3), and their plasmid DNA isolated and 
transformed into E. coli BL21 (DE3) expression strains. 
ThiH-StrepTag (1.2 kb) was amplified by PCR (method 1) using two different sets of 
primers: ThiH-StrepTag F and ThiH-StrepTag R to introduce the Strep-tag to the C-
terminal end of ThiH. The sequences for the oligonucleotides used in this reaction are 
listed in table 6.7. 
 
Table 6.7 Sequences of oligonucleotides used in polymerase chain reaction.* 
Primers  Sequence 5’ → 3’ 
ThiH-StrepTag F*  CGT CAA CAT GGC GAA GGC AT 
ThiH-StrepTag R*  CCC TCT CGA GTC ACT TTT CGA ATT GTG GAT GAC TCC 
AAA CTA GTC TTT GCG AGG CGC 
*Primers for PCR amplification were synthesised by Shannon Campbell (Southampton 
University, UK). ThiH-StrepTag F: forward primer; ThiH-StrepTag R: reverse primer. 
 
The PCR product (ThiH-Stag) was restricted with RsrII/XhoI and cloned into pRL1020 
on a RsrII/XhoI fragment. Both digested pRL1020 and PCR product were loaded onto a 
1% agarose gel (appendix A) and analysed by gel electrophoresis (figure 6.3). 
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Figure 6.3 Identification of restriction digestion of PCR product and pRL1020. Lane 1: ThiH-
Streptag (1238 bp); Lane 2: pRL1020 restricted with RsrII/XhoI (1260 bp: ThiH-His, 5636 bp: 
pRL1020 backbone (ThiFSG section), 6896 bp: pRL1020 linearised with XhoI); M: molecular 
weight marker. 
 
The PCR product was ligated into pRL1020 backbone (ThiFSG section) using T4 ligase 
(method  7).  Ligation  reactions  were  incubated  overnight  at  4  ºC  and  then  used  to 
transform  E.  coli  TOP10  competent  cells  (method  2).  Positive  colonies  were  then 
identified by analytical restriction digestion using StuI and BstBI (figure 6.4, method 5). 
The resultant vector was named pFM700. 
 
 
 
 
 
 
 
 
 
 
Figure 6.4 Identification of positive clones containing pFM700 by plasmid DNA isolation and 
restriction. Lanes 1-8 and 10-13: restriction of pFM700 with StuI/BstBI (5584, 749 and 489 
bp); lane 9: pRL1020 restriction with StuI/BstBI (5584, 749 and 563 bp); M: molecular weight 
marker. 
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pRL1021,  a  plasmid  bearing  the  iscSUA-hscBA-fdx  operon,  was  restricted  with 
RsrII/XhoI to remove the ThiH-His fragment and the ThiH-Streptag fragment, equally 
restricted with RsrII/XhoI, inserted (method 7). The ligation reactions were incubated 
overnight at 4 ºC and then used to transform E. coli TOP10 competent cells (method 2). 
Positive  colonies  were  identified  by  analytical  restriction  digestion  using 
XhoI/BstBI/NcoI (figure 6.5, method 5). The restriction site BstBI is unique for this new 
vector which was named pFM707.  
 
 
 
   
 
 
 
 
 
 
 
Figure 6.5 Identification of positive clones containing pFM707 by plasmid DNA isolation and 
restriction. Lane 1: restriction with NcoI (6685, 4929 bp); lane 2: restriction with BstBI (6822, 
4792 bp); lane 3: restriction with XhoI (linearised plasmid DNA); M: molecular weight marker. 
 
6.4.6 Expression and purification of pFM700 and pFM707 
 
pFM700 and pFM707 were transformed into E. coli BL21(DE3) competent cells (method 
2)  and cells were grown on a large scale (method 11). 
 
ThiH was anaerobically purified in a glove box at 19 ºC using the following buffers: A -  
50 mM Tris-HCl, pH 8.0, 200 mM NaCl, 12.5 % (w/v) glycerol; B - buffer A + 2.5 mM 
DTB; C - Buffer A+ 1 mM HABA; D - Buffer A+ 1 mM EDTA 
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To  the  still  frozen  cell  paste  (2  g),  was  introduced  inside  the  glove  box  and  re-
suspended  in  anaerobic  buffer  A  (5  mL)  stirring  continuously  for  ~15  min.  The 
suspension was then lysed, on ice, by sonication (10 min, amplitude: 70, pulser: 2 sec), 
and  cleared  by  centrifugation  in  microcentrifuge  tubes  (20  min).  The  brown 
supernatant was applied to the StrepTactin column (4.5 mL) previously equilibrated 
with anaerobic buffer A (5 column volumes). The column was washed with buffer A (5 
column  volumes),  and  proteins  were  eluted  at  1  mL/min  with  buffer  B  (4  column 
volumes),  collecting  0.5  mL  fractions.  Proteins  were  stored  at  -80  ºC  in  this  buffer 
(buffer B). The column was then regenerated with buffer C (5 column volumes, strong 
orange  colour)  and  washed  with  buffer  D  (storage  buffer)  until  the  orange  colour 
disappear, generally 5 column volumes. Protein samples (50  L) were removed from 
the fractions collected during the wash and elution from the column, and subsequently 
analysed by SDS-PAGE (method 8). 
 
6.4.7 Anaerobic purifications of ThiGH with Q-Sepharose  
 
pRL1020 was transformed into E. coli BL21(DE3) (method 2) and cells were grown on a 
large scale as described in method 11. ThiGH was anaerobically purified in a glove box 
at 19 ºC using the following buffers: Lysis buffer - 50 mM Tris-HCl pH 8.0, 10% (w/v) 
glycerol; A - 50 mM Tris-HCl pH 8.0, 10% (w/v) glycerol; B - 50 mM Tris-HCl pH 8.0, 
0.5 M NaCl, 10% (w/v) glycerol. 
 
To the still frozen cell paste (15 g), lysozyme (0.1 mg/mL), benzonase (10 U/mL) and 
PMSF (100 mM stock solution in i-PrOH, 1 mM final concentration) were added under 
aerobic  conditions;  the  cells  were  then  introduced  inside  the  glove  box  and  re-
suspended in anaerobic lysis  buffer (50  mL) stirring  continuously  for ~30 min.  The 
suspension was then lysed, on ice, by sonication (30 min, amplitude: 70, pulser: 2 sec), 
and  after  the  addition  of  PEI  [0.2  %  (v/v);  pH  8.0,  adjusted  with  HCl]  cleared  by 
centrifugation  in gastight centrifuge tubes  (JA-14  rotor,  12000  rpm, 30-40 min).  The 
brown  supernatant  was  applied  to  the  Q-Sepharose  column  (80  mL)  previously 
equilibrated with anaerobic buffer A (4 column volumes). The column was washed 
with  buffer A  (4  column  volumes), and proteins were  eluted  at  2 mL/min with  an   150 
increasing gradient of buffer B from 0 to 100% over 2 column volumes and isocratically 
with  buffer  B  over  1  column  volume,  collecting  5  mL  fractions.  To  avoid  protein 
precipitation, glycerol was added to a final concentration of 20% (w/v). All fractions 
were  stored  at  -80  ºC.  Protein  samples  (50   L)  were  removed  from  the  fractions 
collected during the wash and elution from column, and subsequently analysed by 
SDS-PAGE (method 8).  
 
6.4.8 Anaerobic purifications of ThiGH with S-Sepharose 
Fraction  48  eluted  from  Q-Sepharose  (method  described  above)  was  anaerobically 
purified in a glove box at 19 ºC using the following buffers: Adjusting buffer - 50mM 
Bis-Tris-HCl  pH  6.2,  10%  (w/v)  glycerol;  A:  50mM  Bis-Tris-HCl  pH  6.7,  10%  (w/v) 
glycerol; B: 50mM Bis-Tris-HCl pH 6.2, 0.5 M NaCl, 10% (w/v) glycerol. 
 
Fraction eluted from Q-Sepharose (6 mL), was adjusted to pH 6.7 and applied to a S-
Sepharose column (5 mL) previously equilibrated with anaerobic buffer A. In the case 
of  the  experiment  at  pH  6.7,  6  mL  of  adjusting  buffer  were  added  to  the  protein 
sample. The column was washed with buffer A (10 column volumes), and proteins 
were eluted at 1 mL/min with an increasing gradient of buffer B from 0 to 100 % over 2 
column volumes and isocratically with buffer B over 1 column volume, collecting 0.5 
mL fractions. All fractions were stored at -80 ºC. Protein samples (50  L) were removed 
from  the  fractions  collected  during  the  wash  and  elution  from  column,  and 
subsequently analysed by SDS-PAGE (method 8). 
  
6.4.9 Effect of pH and additives  
 
A set of purification experiments were carried out using modified buffers, i.e. variation 
of the pH, addition of dithionite, AdoMet and/or tyrosine. In all experiments ThiGH 
was expressed from pRL1020/BL21(DE3) (method 2 and 11) and purified using method 
13, the modification were applied to the buffers described in this method. 
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Table 6.8 lists all the modifications made to the purification buffers. AdoMet, tyrosine 
and  dithionite solutions  were prepared  and  added  to  the buffers  anaerobically.  pH 
variations  were carried out  aerobically  and after  buffers  were degassed  and  placed 
inside an anaerobic glove box. 
 
Table 6.8 Buffers used for purification of ThiGH-His from pRL1020/BL21(DE3). 
 
Buffer  pH  Additives  Final concentration/ mM  Solvent 
-  -  - 
Tris  8.0 
-  -  - 
-  -  - 
Dithionite  1.0  Water 
AdoMet  0.5  Water 
AdoMet 
Tyrosine 
0.5 
1.0 
Water 
HCl, 100 mM 
7.7 
Tyrosine  1.0  HCl, 100 mM 
7.4  Tyrosine  2.0  HCl, 100 mM 
7.0  -  -  - 
MOPS 
6.5  -  -  - 
 
6.4.10 Quantification of AdoMet in SAM-e
® tablets by HPLC 
 
In  order  to  quantify  the  amount  of  AdoMet  present  in  SAM-e®  tablets  by  HPLC a 
program  was  developed  and  optimised  by  using  standard  solutions  of  AdoMet.  A 
range  of  concentrations  of  standards  (0.3   M  to  30  mM)  were  used  to  construct  a 
calibration  curve  to  estimate  the  concentration  of  AdoMet  present  in  the  samples. 
Figure 6.5 shows the AdoMet calibration curve. 
 
In order to extract pure AdoMet, SAM-e® tablets (55 mg) were powdered, dissolved in 
assay buffer (2 mL, 50 mM MOPS pH 7.7, 100 mM NaCl, 10 % glycerol) and cleared by 
centrifugation (12,000 rpm, 10 min). The samples were then diluted (10 fold dilutions) 
in assay buffer and analysed by RP-HPLC (UV-visible detection at 254 nm) using a C18   152 
RP column (Phenomenex Prodigy 5 , 250 x 5.0 mm) pre-equilibrated in solvent A (25 
mM acetic acid with 8 mM sodium octanesulfonate, 2 mL/min). An aliquot (40  L) was 
injected onto the column eluted with solvent A for 3 min followed by a gradient to 
100% solvent B (50% acetonitrile, 50% solvent A) over 15 min, kept at 100% solvent B 
for 2 min, reversed to 0% solvent B over 2 min and re-equilibrated for 10 min. The 
retention time (Rt) for AdoMet standards and SAM-e® extracted samples was 26 min. 
Each tablet contained 35% of pure AdoMet. The extracted samples were added to the 
purification buffers in order to achieve a final concentration of 0.5 mM. 
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Figure 6.6 Calibration curve for AdoMet standard solutions. Data fitted using Sigmaplot to a 
linear function (y=ax+y0): R=0.99, yo=-3.16E+5, a=1.3E+6. 
 
6.4.11 Reconstitution and concentration of ThiGH 
 
DTT solution in buffer D (50 mM MOPS, 100 mM NaCl, 10% (w/v) glycerol; 25  L; 200 
mM) was added to a sample of purified ThiGH complex (1 ml, 83  M) and gently 
mixed. After 15 min, 5 mol eq of FeCl3 in water (40  L, 10 mM) were added carefully in 
small aliquots (5  L), and after a further 10 min, 5 mol eq of Na2S in water were added 
likewise (total added 40  L, 10 mM). The protein solution was incubated for another 2 
hours, and then the precipitated iron sulfide was removed by applying the solution to   153 
a NAP-10 gel filtration column pre-equilibrated and eluted with buffer D. The iron 
content was analyzed by the method of Fish (method 14). Reconstituted ThiGH could 
be  concentrated  to  a  maximum  concentration  of  40  mg/mL  using  a  Biomax  5000 
molecular weight cut-off Ultrafree 0.5-mL centrifugal filter. 
 
6.4.12 UV-visible spectra of ThiGH 
 
UV-visible spectra of purified ThiGH were recorder by using an Ocean Optics USB2000 
spectrophotometer, connected to a cuvette holder placed inside an anaerobic glove box. 
The protein samples were defrosted inside the glove box, diluted to 1 mg/mL with 
anaerobic  buffer  D  and  recorded  at  the  range  250-700  nm,  against  buffer  D.  For 
reconstituted protein, the iron excess removed from samples by centrifugation (2 min, 
12,000 rpm) and protein spectra recorded. 
 
6.4.13 Analytical gel filtration of ThiGH-His complex 
 
Purified ThiGH-His samples (fractions 4-6 from two different purifications, method 13) 
were pooled, chemically reconstituted and concentrated to 40 mg/mL (methods 6.4.11). 
The  resulting  protein  sample  was  applied  to  a  S-200  column  (33  ×  750  mm)  pre-
equilibrated with buffer D [ 50 mM MOPS pH 7.7, 200 mM NaCl, 5 mM DTT, 10% 
(w/v) glycerol]. The protein was eluted at 2 mL/min with this buffer, collecting 10 mL 
fractions. Protein elution was monitored at 280 nm. Eluted proteins were stored at -80 
ºC. Aliquots of each fraction (50  L) were analysed by SDS-PAGE (method 8) and iron 
content  of  fractions  containing  either  ThiGH  complex  or  monomeric  ThiH  was 
measure (method 14). ThiH-His fractions eluted from the S-200 were concentrated to 60 
mg/mL without protein precipitation. 
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6.4.14 Initial studies on the crystallisation of ThiH 
 
ThiGH complex and monomeric ThiH were expressed and separated using method 13 
and 6.4.13. The iron content of the protein samples was measured (table 2.7).  
 
Protein  samples  from  the  S200  column  were  placed  inside  an  anaerobic  glove  box; 
fractions  24-26  of  ThiGH  complex  were  pooled  and  concentrated  using  a 
microcentrifuge (45 min, 9,000 rpm) to 28.3 mg/mL. Fraction 34 containing monomeric 
ThiH was concentrated to 60 mg/mL using a microcentrifuge (60 min, 9,000 rpm). All 
crystallisation experiments were carried out under strict anaerobic environment, in a 
controlled temperature room (18ºC). All solutions used for the experiment were filter 
sterilised. 
  
ThiGH-His  was  expressed  from  pRL1020/BL21(DE3),  purified  (method  13), 
reconstituted, concentrated to 40 mg/mL. An analytical gel filtration chromatography 
was carried out under strictly anaerobic conditions (method 6.4.13) to separate ThiGH 
complex from monomeric ThiH. The iron content of the protein samples was measured 
(table 2.7). Fractions 24-26 of ThiGH complex were pooled and concentrated to 28.3 
mg/mL. Fraction 34 of monomeric ThiH was concentrated to 60 mg/mL. These protein 
samples  were  then  used  to  set  up  the  crystallisation  trial  experiments.  All 
crystallisation experiments were carried out under strict anaerobic environment, inside 
a glove box, in a controlled temperature room. 
  
Screening for optimal crystal growth conditions of ThiGH and monomeric ThiH were 
prepared  in  24  well  plates.  Precipitant  solutions  (table  6.9)  were  prepared  and 
dispensed  onto  the  plate  (1000   L  each)  using  a  pippeting  robot  (Beckman 
workstation).  To  each  precipitant  stock  solution  glycerol  was  added  to  25%  final 
concentration. The plates were then transferred to the glove box port compartment and 
degassed four times  (four cycles of 3 min purge/15 min rest) and then transferred 
inside the glove box and allowed to degas for a further 24 hours. 
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Table 6.9 Precipitant solutions used for crystallisation screening 
Tube  Precipitant  Volume added  Final concentration 
1  Ammonium sulphate, 3.5 M  5.71  2.0 M 
2  Ammonium sulphate, 3.5 M  7.14  2.5 M 
3  Ammonium sulphate, 3.5 M  8.57  3.0 M 
4  Lithium sulphate, 2.0 M  9.00  1.8 M 
5  Lithium sulphate, 2.0 M  7.50  1.5 M 
6  Lithium sulphate, 2.0 M  6.00  1.2 M 
7  Sodium formate, 4.0 M  8.75  3.5 M 
8  Sodium formate, 4.0 M  6.25  2.5 M 
9  Sodium formate, 4.0 M  5.00  2.0 M 
10  100% PEG 400  1.50  15 % 
11  100% PEG 400  2.00  20 % 
12  100% PEG 400  3.00  30 % 
13  50% w/v PEG 1500  3.00  15 % 
14  50% w/v PEG 1500  4.00  20 % 
15  50% w/v PEG 1500  6.00  30 % 
16  50% w/v PEG 4000  3.00  15 % 
17  50% w/v PEG 4000  4.00  20 % 
18  50% w/v PEG 4000  6.00  30 % 
19  50% w/v PEG 8000  3.00  15 % 
20  50% w/v PEG 8000  4.00  20 % 
21  50% w/v PEG 8000  6.00  30 % 
22  25% w/v PEG 20000  3.00  15 % 
23  25% w/v PEG 20000  4.00  20 % 
24  25% w/v PEG 20000  6.00  30 % 
25  100% Isopropanol  0.20  2 % 
26  100% Isopropanol  0.50  5 % 
27  100% Isopropanol  1.00  10 % 
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Stock solutions (10 mM) of additives (tyrosine, AdoMet and Dxp), and buffers (Tris pH 
8.8, 100mM and MOPS pH 7.7, 100 mM) were prepared aerobically, placed inside the 
glove box and allowed to degas.  
 
Protein  solutions  were  completed  by  the  addition  of  further  reagents  (AdoMet, 
tyrosine or Dxp). Drops were prepared by placing drops of protein solution (1.5  L) 
onto cover slips (22 mm diameter) and then adding precipitant solution from the well 
(1.5  L). The cover slip was then carefully inverted to cover the rim of each well of the 
plate. Table 6.10 shows the protein, buffer and additives on each tray. 
 
Table 6.10 Protein, additives and buffers used for crystallisation screening 
Tray nº 
Protein/ 
volume added 
Additives*/ 
volume added 
Buffer 
1  ThiGH/30  L 
AdoMet/3.5  L 
Dxp/1.75  L 
Tyrosine/1.75  L 
MOPS pH 7.7 
2  ThiGH/90  L 
AdoMet/9.0  L 
Dxp/4.5  L 
Tyrosine/4.5  L 
Tris pH 8.8 
3  ThiH/45  L 
AdoMet/4.5  L 
Dxp/2.25  L 
Tyrosine/2.25  L 
MOPS pH 7.7 
* Stock solutions of 10 mM. 
 
6.5 Experimental for chapter 3 
 
Flavodoxin (FldA) and Flavodoxin reductase (Fpr) was supplied by Dr. Kriek in our 
laboratory  purification  procedure  is  described  in  detail  in  reference160.  EPR, 
radiochemical assays, TP course formation, LC-MS and modelling of the cleavage of 
tyrosyl radical are described in references135,160,166.  
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6.5.1 Standard ThiGH Activity Assay 
 
The following proteins and reagents were added, anaerobically, to a reaction mixture 
in  the  following  order  (with  final  concentrations):  reconstituted  and  concentrated 
ThiGH (255  M), tyrosine (0.51 mM), AdoMet (0.74 mM), NADPH (0.67 mM), FldA (62 
 M), Fpr (10  M). Negative control experiments were prepared using same reagents 
but  lacking  tyrosine.  FldA,  Fpr  and  NADPH were  mixed  and  left  for  15  min  until 
solution turned blue. ThiGH, AdoMet and tyrosine solutions were mixed and after the 
reductant mixture was added. The reactions (7×200  L aliquots) were incubated at 37 
ºC for 5, 15, 30, 60, 90, and 120 min and subsequently stored at -80 ºC.  
 
A standard method was developed for the analysis of these supernatants as follows. 
Samples were thawed and proteins were immediately precipitated with 20% perchloric 
acid  (12   L)  and  then  cleared  by  centrifugation  (14,000  rpm,  15  min),  and  the 
supernatants were analysed by HPLC using two different methods: AdoMet, tyrosine, 
and DOA (40  L) analysed by direct UV-visible detection (λex= 223 nm, λem= 280 nm). 
and glyoxylate (40  L) derivatised using 2-oxoacid method169 and analysed by HPLC 
using fluorescent detection (λexc= 340 nm, λem= 420 nm). 
 
6.5.2 
13C NMR spectra of ThiGH assays  
 
Two complete ThiGH assays (each of 277 μL) were prepared as described previously, 
except  that  where  possible  materials  were  prepare  in  sodium  phosphate  buffer  (50 
mM, pH 7.5). Thus assays contained (at final concentrations): reconstituted ThiGH (444 
μM), L-[U-13C]-tyrosine (357 μM), AdoMet (hydrochloride salt, 655 μM), FldA (50 μM), 
Fpr  (9  μM)  and  NADPH  (540  μM).  Two  assays  lacking  the  reducing  system  were 
prepared  as  negative  controls.  Solutions  were  kept  in  sealed  Eppendorf  vials  and 
incubated for 2 hours at 37 ºC. To the each solution was added perchloric acid [15 μL, 
20%  (v/v)]  and  after  30  min  in  air,  the  precipitated  protein  was  removed  by 
centrifugation (15 min, 13000 rpm). The corresponding supernatants were combined 
and the volume adjusted to 550 μL with D2O.  13C NMR spectra (10240 scans) were 
recorded on a Bruker DXP 300 operating at 75 MHz. For the samples extracted into   158 
organic solvents, the supernatants of ten assays were extracted with CDCl3 (500 μL per 
assay) and the combined organic phase was analysed by  13CNMR spectrometry on a 
Bruker DPX 400 operating at 100 MHz. 
 
HO
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Glyoxylate p-hydroxybenzyl alcohol p-cresol
O
O
H
O
 
 
Glyoxylate:  13C  NMR  (75  MHz;  aqueous  phosphate  buffer)  δ 173.7  (COO),  86.8 
(COHOH). 
 
4-Hydroxybenzylalcohol: 13C NMR (75 MHz; MeOD) δ 57.4 (COH, C-4), 133.0 (CCH2, C-
1), 129.3 (2CH), 115.6 (2CH), 64.6 (CH2OH). 
 
p-Cresol: 13C NMR (100 MHz; CDCl3) δ 153.6 (COH), 130.5 (2CH), 130.2 (CCH3), 115.6 
(2CH), 20.9 (CH3). 
 
Organic extract [U-13C]-p-cresol: 13C NMR (100 MHz; CDCl3) δ 153.2 (t, J = 66 Hz, COH), 
130.1 (m, 2CH, CCH3), 115.0 (m, 2CH), 20.4 (m, CH3). 
 
Spectrum of assays after protein precipitation includes hydrated [U-13C]-glyoxylate: 13C NMR 
(75 MHz; sodium phosphate buffer, 50 mM, pH 7.5) δ 173.4 (d, Jcc = 69 Hz, COO), 86.4 
(d, Jcc = 69 Hz, C(OH)2). 
 
Spectrum of negative control assays after protein precipitation contains L-[U-13C]-tyrosine: 
13C NMR (75 MHz; sodium phosphate buffer, 50 mM, pH 7.5) δ 174.2 (COO, d, J = 53 
Hz, C1), 155.1 (COH, t, J = 64 Hz, C-7), 130.8 (2CH, t, J = 54 Hz, C-5 and C-9), 127.1 
(CCH2 (m, J = 54 Hz, C-4), 115.9 (2CH, t, J = 64, C-6 and C-8), 56.3 (CN, dd, J= 53 Hz, J = 
33 Hz, C-2), 35.6 (CH2, t, J = 38 Hz, C-3). 
.  
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Figure 6.7 NMR spectra of organic extract of a ThiGH assay showing formation of 13C labelled 
p-cresol 
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Figure 6.8 NMR spectra of cleared aqueous supernatant from active ThiGH Assay showing the 
formation of 13C glyoxylate (hydrated form).   161 
 
 
 
Figure 6.9 NMR spectra of cleared aqueous supernatant from negative control assay. 
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6.5.3 GC-MS analysis of ThiGH Assays 
 
The  organic  extract  prepared  for  13C  NMR  analysis  was  also  analysed  by  GC-MS, 
essentially as described by Luo et al.205.  
 
GC-MS analysis data was obtained on a Thermo TraceMS equipped with an AS800 
auto sampler and a PE-Wax (30 m x 0.25 mm x 0.25  m) column. Helium was used as a 
carrier gas (flow 1 mL/min) and samples (1.0  L) were injected with a speed of 10 
(JL/s).  The  initial  temperature  of  the  column  oven  was  40  ºC  for  4  min.  This 
temperature was increased to 240 ºC at a speed of 20 ºC / min and maintained at this 
level for another 6 min. The detector was set at 70 eV EI-MS, the source temperature at 
200 ºC with a trap current 150 JA and using the full scan acquisition mode (2 scans/s 
from 20-500 amu). 
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Figure 6.10 GC-MS Traces from p-Cresol analysis. Top: p-cresol standard. Bottom: organic 
extract of a ThiGH assay. 
 
p-Cresol  standards:  calculated  for  C7H7OH  [M+H]:  108.14;  found  108.2.  EI  m/z  (%): 
107.1(100),  108.2(72),  77.1(30),  28.2(30),  79.1(26),  43.1(18),  57.1(17),  55.1(16),  51.1(15), 
80.2(12), 53.1(12), 49.9(12), 39.1(12), 32.1(11), 109.2 (8.9). 
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13C p-cresol from assay: calculated for 13C7H7OH [M+H]: 115.14; found 115.2. EI m/z (%) : 
114.1(100),  115.2(55),  83.1(53),  85.2(45),  55.2(45),  57.2(33),  28.2(29),  86.2(28),  54.1(28), 
56.2(27),  42.2(23),  43.2(22),  29.2(21),  41.1(19),  84.2(18),  68.2(16),  67.1(12),  69.2(11), 
97.2(10), 71.2(10). 
 
6.5.4 Quantification of p-cresol, AdoH and tyrosine by HPLC 
 
Method 1 
RP-HPLC analysis was carried out using a wavelength detector set to 280 nm and a 
C18 column (Hypersil, 5μ, 150 x 4.6 mm) equilibrated in solvent A (0.1% acetic acid). 
The column was eluted at 0.8 ml/min for 6 min with solvent A, followed by a gradient 
to 100% solvent B (0.1% acetic acid in MeOH) over 18 min, kept at 100% solvent B for 2 
min and returned to starting condition in 3 min and then re-equilibrated for 10 min. 
The  following  retention  times  were  observed  for  standards:  p-cresol,  Rt  =14.0  min; 
hydroxybenzyl alcohol, Rt = 11.4 min.  
 
Method 2 
RP-HPLC analysis was carried out using a dual wavelength detector set to 230 nm and 
280 nm and a C18 column (Phenomenex Prodigy 5μ, ODS-2, 150 x 4.6 mm) equilibrated 
in solvent A (0.1% trifluoroacetic acid). The column was eluted at 0.8 ml/min for 6 min 
with solvent A, followed by a gradient to 100% solvent B (0.1% trifluoroacetic acid in 
Acetonitrile) over 27 min, kept at 100% solvent B for 1 min and then re-equilibrated for 
8  min.  The  following  retention  times  were  observed  for  standards:  hydroxybenzyl 
alcohol, Rt = 21 min, tyrosine, Rt = 16.5 min, AdoH, Rt = 17.4 min.  
 
Method 3 
RP-HPLC analysis was carried out using a dual wavelength detector set to 215 and 260 
nm using a Synergy Polar-RP column (4 , 150 x 4.6 mm) pre-equilibrated in solvent A 
(water with 0.1% formic acid). The flow rate was maintained at 0.8 mL/min using a 
binary solvent mixture. An aliquot (40  L) was injected onto the column eluted with 
solvent A for 6 min followed by a gradient to 100% solvent B (50% acetonitrile, 50% 
solvent A) over 20 min, followed by a 5-min gradient to 10% solvent A, 5 min isocratic   165 
at 10% solvent A, and a 4-min gradient to 100% solvent A, and re-equilibrated for 15 
min isocratic at 100% solvent A. This method did not resolve the reaction products. 
 
Method 4 
RP-HPLC analysis was carried out using a dual wavelength detector set to 215 nm and 
260 nm and a C18 column (Phenomenex Prodigy 5μ, ODS-3, 250 x 4.6 mm) equilibrated 
in  solvent  A  (0.1%  TFA).  The  column  was  eluted  at  0.8  ml/min  with  solvent  B 
(Acetonitrile, 0.1% trifluoroacetic acid), using the same elution profile as method 3. The 
following retention times were observed for standards: tyrosine, Rt = 17 min, AdoH, Rt 
= 17.4 min.  
 
Method 5 
RP-HPLC  (UV-visible  detection  at  254  nm)  using  a  C18  RP  column  (Phenomenex 
Prodigy 5 , 250 x 5.0 mm) pre-equilibrated in solvent A (25 mM acetic acid with 8 mM 
sodium octanesulfonate, 2 mL/min). An aliquot (40  L) was injected onto the column 
eluted  with  solvent  A  for  3  min  followed  by  a  gradient  to  100%  solvent  B  (50% 
acetonitrile, 50% solvent A) over 15 min, kept at 100% solvent B for 2 min, reversed to 
0% solvent B over 2 min and re-equilibrated for 10 min. The retention time (Rt) for 
AdoMet was 26 min.  
 
Method 6 
An aliquot of supernatant (40 μL) was analysed by HPLC using a dual wavelength 
detector set to 223 nm and 280 nm and a C18 RP column (Phenomenex Prodigy 5μ, 
ODS-2, 150 x 4.6 mm) equilibrated in solvent A (0.1% acetic acid). The column was 
eluted at 0.8 mL/min for 4 min with solvent A, followed by a gradient to 100% solvent 
B  (0.1%  acetic  acid  in  MeOH)  over  18  min,  kept  at  100%  solvent  B  for  2  min  and 
returned  to  starting  condition  in  3  min  and  then  re-equilibrated  for  5  min.  The 
following  retention  times  were  observed  for  standards:  tyrosine,  Rt  =  8.3  min;  5’-
deoxyadenosine  (AdoH),  Rt  =  11.8  min;  p-hydroxybenzyl  alcohol,  Rt  =  12.6  min;  p-
cresol, Rt = 16.7 min. 
A range of concentrations of standards (0-80 nmoles in 40  L) were used to construct 
calibration  curves  (figure  6.11,  6.12  and  6.13)  for  estimating  the  concentrations  of   166 
tyrosine,  AdoH  and  p-cresol.  Concentrations  were  determined  from  experiments 
carried out in duplicate. The data was fitted to an exponential process and the first 
order rate constant and final concentrations calculated using Sigmaplot. 
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Figure 6.11 Calibration curve for p-cresol standards. Data fitted using Sigmaplot to a linear 
function (y=ax+y0): R=0.9782, yo=9.401E+6, a=4.4E+6.   167 
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Figure 6.12 Calibration curve for AdoH  standards. Data fitted using Sigmaplot to a linear 
function (y=ax+y0): R=0.98, y0=2.3E+7, a=4E+6. 
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Figure 6.13 Calibration curve for tyrosine standards. Data fitted using Sigmaplot to a linear 
function (y=ax+y0): R=0.99, y0=-6.3E+6, a=7.5E+6.   168 
6.5.5 Quantification of glyoxylate by HPLC 
 
The glyoxylic acid content of the samples was estimated using a method devised for 
the detection of 2-oxoacids169 in which the 2-oxoacid is converted to the fluorescent 2-
quinoxalinol derivative. 
 
An aliquot of cleared supernatant (10 μL) was mixed with HEPES (40 μL, 50 mM, pH 
7.5)  and  this  sample  was  acidified  with  HCl  (100  μL,  0.5  M)  and  ortho-phenylene 
diamine (50 μL, 10 mg/mL in 0.5 M HCl) was added. The mixture was heated to 95 ºC 
for 10 min in a heat-block, left at room temperature for 2 min and NaOH (120 μL, 1.25 
M) was added. A calibration was obtained by derivatisation of 0.5 mM glyoxylic acid 
(0; 2.5; 5; 7.5; 10; 15 and 20 μL) diluted in 50 mM HEPES (pH 7.5) to a constant volume 
(50 μL) as described for the samples above.  
 
Derivatised samples were analysed by HPLC using a Hypersil BDS C8 (5μ, 150 x 4.6 
mm)  column  pre-equilibrated  in  solvent  C  (100  mM  ammonium  bicarbonate,  1 
ml/min). An aliquot (40 μL) was injected onto the column eluted with solvent C for 5 
min before a gradient to 80% solvent D (acetonitrile) over 15 min was applied. The 
gradient was reversed to 0% Solvent D over 5 min, and the column was re-equilibrated 
for  10  min  before  the  next  injection. The  2-quinoxalinol  (Rt  11.8  min)  was detected 
using fluorescent detection (λex 340 nm, λem 420 nm).  
 
A range of concentrations of standards (0-40  M) were used to construct calibration 
curves  for  estimating  the  concentrations  of  glyoxylate.  The  standards  used  were  2-
quinoxalinol  (figure  6.14)  and  derivatised  glyoxylate  (figure  6.15),  using  method 
described  above.  By  using  this  calibration  it  was  possible  to  determine,  for  each 
experiment,  the  yield  of  the  derivatisation  reaction  and  concentrations  were 
determined  from  experiments  carried  out  in  duplicate.  The  data  were  fitted  to  an 
exponential process and the first order rate constant and final concentrations calculated 
using Sigmaplot.   169 
nmoles injected
0.0 0.2 0.4 0.6 0.8 1.0
A
r
e
a
0.0
2.0e+5
4.0e+5
6.0e+5
8.0e+5
1.0e+6
1.2e+6
1.4e+6
1.6e+6
1.8e+6
 
Figure 6.14 Calibration curve for 2-quinoxalinol standards. Data fitted using Sigmaplot to a 
linear function (y=ax+y0): R=0.99, y0=5.6E+3, a=1.5E+6. 
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Figure 6.15 Calibration curve for derivatised glyoxylate standards. Data fitted using Sigmaplot 
to a linear function (y=ax+y0):  R=0.97, y0=1.34E+4, a=9.78E+5. 
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6.6 Experimental for chapter 4 
 
6.6.1 Assembly of pFM001 and pFM101 
 
D. vulgaris thiSGH (2.381 kb) was amplified by PCR (method 1) using genomic DNA 
from Desulfovibrio vulgaris and two different sets of primers: ThiS Fwd/ThiS Rev. The 
sequences for the oligonucleotides used in this reaction are listed in table 6.11. 
 
The PCR product (thiSGH) was restricted with PciI/SacI and cloned into pRL1020 on a 
NcoI/SacI fragment. Both, digested pRL1020 and PCR product were loaded onto a 1% 
agarose gel (appendix B) and analysed by gel electrophoresis (figure 6.16). The PCR 
product was then ligated into pRL1020 backbone using T4 ligase (method 7). Ligation 
reactions were incubated overnight at 4 ºC and then used to transform E. coli TOP10 
competent  cells  (method  2).  Positive  colonies  were  then  identified  by  analytical 
restriction  digestion  using  XhoI  (figure  6.17,  method  5).  The  resultant  vector  was 
named pFM001. 
 
Table 6.11 Sequences of oligonucleotides used in polymerase chain reaction. 
Primers  Sequence 5’ → 3’ 
ThiS Fwd*  CTA GCT AGC AAC ATG TTG ACG ATA GTT GTG AAC GGT  
ThiS Rev*  GGA ATT CGA GCT CTC AAT GGT GGT GAT GGT GGT GTC 
GGG CCT CGC ATC GGA C  
* primers used to assemble plasmid encoding for ThiSGH-His 
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Figure  6.16  Identification  of  restriction  digestion  of  PCR  product  and  pRL1020.  Lane  1: 
pRL1020 restricted with NcoI/SacI (4015 bp: pRL1020 backbone, 2881 bp: ThiSGH-His section 
of  pRL1020);  Lane  2  and  3:  PCR  of  thiSGH-His  restricted  with  PciI/SacI  (2362  bp);  M: 
molecular weight marker. 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.17 Identification of positive clones containing pFM001 by plasmid DNA isolation and 
restriction.  Lanes  1-16:  restriction  of  pFM001  with  XhoI  (4637,  1225  and  515  bp);  M: 
molecular weight marker. 
 
pRL1021,  a  plasmid  bearing  the  iscSUA-hscBA-fdx  operon,  was  restricted  with 
EcoRI/SacI  to  insert  the  iscSUA-hscBA-fdx  fragment  into  equally  restricted  pFM001 
(method 7). The ligation reactions were incubated overnight at 4 ºC and then used to 
transform  TOP10  competent  cells  (method  2).  Positive  colonies  were  identified  by 
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analytical restriction digestion using PstI/NdeI (figure 6.18, method 5). The new vector 
was named pFM101.  
 
 
 
 
   
 
 
 
 
 
Figure 6.18 Identification of positive clones containing pFM101 by plasmid DNA isolation and 
restriction. Lanes 1-9: restriction of pFM101 with PstI/NdeI (5960 bp, 5126 bp);   M: molecular 
weight marker. 
 
Table 6.12 contains a list of all the plasmids that were assembled. All the plasmid maps 
are in appendix A. 
 
Table 6.12 List of assembled plasmids using D. vulgaris genes. 
Name  Insert  Parental plasmid 
pFM001  PciI/ SacI, thiSGH  pRL1020  
pFM101  NotI/ EcoRI, iscSUA-hscBA-fdx  pFM001 
 
6.6.2 Expression and purification of pFM001 and pFM101 
 
pFM001/BL21(DE3)  was  cultured  aerobically  on  a  large  scale  (method  11),  induced 
with arabinose and grown at 27 ºC for 4 hours before being harvested. The cell paste 
was weight and stored at -80 ºC until further use. 
 
5960 bp 
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ThiH  was  isolated  using  optimised  purification  method  (method  13)  and  resultant 
fractions analysed by SDS-Page gel analysis (method 8). pFM101 was expressed and 
purified using the same procedures. 
  
6.6.3 Mutagenesis of pMK024  
 
pMK024  was  mutated  at  the  NcoI  site  using    QuikChange®  Multi  Site-Directed 
Mutagenesis Kit from Stratagene, the resulting plasmid was named pFM024. 
 
Table 6.13 Sequences of oligonucleotides used in the NcoI site mutagenesis. 
Primers  Sequence 5’ → 3’ 
Forward   AG ATG AGT GTG GTT GCG GCG 
Reverse  GTA ATC CAT CGT TAA TTA CTC CTG TTA CT  
 
6.6.4 Assembly of pFM003 and pFM103 
 
Two plasmids were assembled using genomic DNA from Thermotoga maritima.  
 
T. maritima ThiH (1.4 Kb) was amplified by PCR (method 1) using two different sets of 
primers:  ThiH  Fwd  and  ThiH  Rev  in  order  to  replace  the  E.  coli  ThiH  present  in 
pRL1020. The oligonucleotides sequences are listed in table 6.14. 
 
Table 6.14 Sequences of oligonucleotides used in polymerase chain reaction. 
Primers  Sequence 5’ → 3’ 
ThiH Fwd*  GGC GGC GCC ATG GGC TGT ATG TAT GTG TTT GTG 
ThiH Rev*  GCC GCC GTC GAC TTA GTG GTG GTG GTG GTG GTG AAA 
TCT GAC ATC CCT CTC 
   174 
The PCR product was loaded onto a 1% agarose gel (appendix B) and analysed by gel 
electrophoresis (figure 6.19). D. vulgaris thiSGH PCR amplification was carried out as a 
positive control. 
 
  
 
 
 
 
 
Figure 6.19 Identification of restriction digestion of PCR product and pRL1020. Lane 1-6: T. 
maritima ThiH (1445 bp); Lane 7: D. vulgaris ThiSGH PCR product (2362 bp); M: molecular 
weight marker. 
 
The PCR product (ThiH) was restricted with NcoI/SalI, cloned into pBAD-HisA and 
pFM024 on a NcoI/XhoI fragment. Restricted pBAD-HisA, pFM024 and PCR product 
were analysed by gel electrophoresis (figure 6.20). 
 
 
 
 
 
 
 
 
 
 
Figure 6.20 Identification of restriction digestion of PCR product, pBAD-HisA and pFM024. 
Lane 1: pFM024 restricted with NcoI/XhoI (backbone: 8699 bp, LipA section: 879 bp); Lane 2: 
pBAD-HisA  restricted  with  NcoI/XhoI  (backbone:  8699  bp,  113  bp);  Lane  3:  PCR  ThiH 
restricted with NcoI/SalI (1445 bp); M: molecular weight marker. 
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The PCR product was ligated into pBAD-HisA and pFM024 using T4 ligase (method 
7). Ligation reactions were incubated overnight at 4 ºC and then used to transform E. 
coli  TOP10  competent  cells  (method  2).  Positive  colonies  were  then  identified  by 
analytical  restriction  digestion.  Potential  colonies  containing  the  thiH  operon  were 
restricted using PciI/EcoRI, EcoRI/NcoI or just EcoRI (figure 6.21, method 5). To identify 
colonies containing the T. maritima thiH-isc operon colonies were restricted using EcoRI 
and EagI/NcoI (figure 6.22, method 5). The resultant vectors were named pFM003 and 
pFM103. Table 6.15 contains a list of all the plasmids that were assembled. All the 
plasmid maps are in appendix A. 
 
Table 6.15 List of assembled plasmids using T. maritima genes. 
Name  Insert  Parental plasmid 
pFM003  NcoI/SalI, thiH  pBAD-HisA  (NcoI/XhoI) 
pFM103  NcoI/SalI, thiH  pFM024 (NcoI/XhoI) 
 
 
 
 
 
 
 
 
 
 
Figure 6.21 Identification of positive colonies containing pFM003. Lane 1: pFM003 restricted 
with EcoRI (5436 bp); Lane 2: pFM003 restricted with NcoI/EcoRI (1473 bp, 3963 bp); Lane 3: 
pFM003 restricted with PciI/EcoRI (2206 bp, 3230 bp); M: molecular weight marker. 
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Figure 6.22 Identification of positive colonies containing pFM103. Lane 1-3: pFM103 restricted 
with EcoRI (10145 bp); Lane 4-7: pFM103 restricted with EagI/NcoI (4055 bp, 6090 bp); M: 
molecular weight marker. 
 
6.6.5 Expression and purification of pFM003 and pFM103 
 
pFM003/BL21(DE3)  was  cultured  aerobically  on  a  large  scale  (method  11),  induced 
with arabinose and grown at 27 ºC for 4 hours before being harvested. The cell paste 
was weight and stored at -80 ºC until further use. 
 
ThiH  was  isolated  using  optimised  purification  method  (method  13)  and  resultant 
fractions analysed by SDS-Page gel analysis (method 8). pFM103 was expressed and 
purified using the same procedures. 
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Maps of plasmids used throughout this project. Restriction sites of interest are 
indicated in blue for unique restriction sites or red for multiple restriction sites. 
 
pBAD/HisA
4104 bp
araBAD   2
NcoI   318   C'CATG_G
MCS   430
SacI   432   G_AGCT'C
araC
Amp
 
 
pRL1020
6896 bp
araBAD   1
NcoI   317   C'CATG_G
RsrII   1962   CG'GwC_CG
SacI   3198   G_AGCT'C
XhoI   3222   C'TCGA_G
MCS   3223
araC
Amp
thiF
thiS
th i G
thiH-His
   2 
pRL1021
11605 bp
araBAD   1
RsrII   1962   CG'GwC_CG
EcoRI   3188   G'AATT_C
SacI   3198   G_AGCT'C
XhoI   3222   C'TCGA_G
MCS   7932
EcoRI   7959   G'AATT_C
A
m p
araC
iscS
iscU
iscA
hscB
hscA
fdx
thiF thiSthiGthiH -H
i
s
 
 
pFM700
6905 bp
araBAD   1
StuI   1942   AGG'CCT
RsrII   1962   CG'GwC_CG
StuI   2691   AGG'CCT
BstBI   3180   TT'CG_AA
XhoI   3231   C'TCGA_G
MCS   3232
BstBI   3263   TT'CG_AA
araC
Amp
thiF
thiS
th iG
ThiH-StrepTag
 
 
 
 
 
 
 
 
   3 
 
pFM707
11614 bp
araBAD   1
NcoI   317   C'CATG_G
BstBI   3180   TT'CG_AA
XhoI   3231   C'TCGA_G
NcoI   5246   C'CATG_G
MCS   7941
BstBI   7972   TT'CG_AA
A
m p
araC
iscS
iscU
iscA
hscB
hscA
fdx
thiF thiS thiG  (-69 bp)
(
- 7 0 2  
b p
)
   
t hi
G ThiH-S trep T
a
g
 
 
 
pFM001 D. vulgaris
6377 bp
araBAD   1
XhoI   963   C'TCGA_G
XhoI   1478   C'TCGA_G
SacI   2679   G_AGCT'C
XhoI   2703   C'TCGA_G
MCS   2704
PciI   4938   A'CATG_T
araC
Amp
thiH
thiG
thiS
 
 
   4 
pFM101 D. vulgaris
11086 bp
araBAD   1
SacI   2679   G_AGCT'C
PstI   4700   C_TGCA'G
MCS  ( 11 bp)   7413
EcoRI   7440   G'AATT_C
NdeI   9826   CA'TA_TG
iscS
iscU
iscA
hscB hscA
fdx
araC
A
m p
thiH
thiG
thiS
 
 
pFM003 T. maritima
5436 bp
araBAD   1
NcoI   317   C'CATG_G
MCS   1763
EcoRI   1790   G'AATT_C
PciI   3997   A'CATG_T
TmThiH
araC
Amp
 
 
 
 
   5 
pMK024
9578 bp
araBAD   1
NcoI   317   C'CATG_G
XhoI   1195   C'TCGA_G
NcoI   3210   C'CATG_G HscB
HscA
Fdx
Isc U
IscA
IscS
LipASulfHis
A m p
rrnB t erm
AraC
pMB1 ori
 
pFM024
9578 bp
araBAD   1
NcoI   317   C'CATG_G
XhoI   1195   C'TCGA_G
HscB
HscA
Fdx
Isc U
IscA
IscS
LipASulfHis
A m p
rrnB t erm
AraC
pMB1 ori
   6 
pFM103 T. maritima
10145 bp
araBAD   1
NcoI   317   C'CATG_G
EagI   4372   C'GGCC_G
EcoRI   6499   G'AATT_C
TMThiH-His
HscB
HscA
Fdx
IscU
IscA
Is c S
A
m p
rrnB ter m
AraC
pMB1 ori
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   7 
 
 
 
 
 
 
 
 
 
 
 
Appendix B 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   8 
 
1. Agarose gel electrophoresis  
 
50 X Running buffer solution, 50 X TAE (per litre): 
Tris base            242 g  
Glacial acetic acid          57.1 mL 
0.5 M EDTA             100 mL 
Adjusted to pH 8.0 with HCl. 
 
1 % Agarose gel (per gel): 
Agarose             0.4 g 
TAE buffer, 1 X           40 mL 
 
The suspension was heated at top power rating in a microwave until the agarose had 
dissolved, poured and allowed to solidify at 4 ºC. 
 
6 X Gel electrophoresis loading buffer: 
Glycerol             30 % (v/v) 
Bromophenol blue           0.25 % (w/v) 
 
Electrophoresis gel stain: 
Ethidium bromide           1  g/mL 
 
2. Sodium Dodecyl Sulphate Polyacrylamide Gel Electrophoresis (SDS-PAGE) 
 
5 X Running buffer (per litre):   
Tris base            15 g 
Glycine             94 g 
SDS               5 g 
 
 
   9 
SDS-PAGE gel  
15 % resolving gel (5 mL per gel): 
H2O               1.1 mL 
30 % (w/v) Acrylamide/bis-acrylamide (37.5:1)  2.5 mL 
1.5 M Tris-HCl, pH 8.8         1.3 mL 
10 % (w/v) SDS            50  L 
10 % (w/v) Ammonium persulphate,     50  L 
TEMED             2  L 
 
3 % stacking gel (2 mL per gel): 
H2O               1.4 mL 
30 % (w/v) Acrylamide/bis-acrylamide (37.5:1)  0.33 mL 
1.0 M Tris, pH 6.8           0.25 mL 
10 % (w/v) SDS          20  L 
10 % (w/v) Ammonium persulphate     20  L 
TEMED             2  L 
 
Freshly prepared ammonium persulfate and TEMED were added just prior to pouring 
the gels. 
 
2 X SDS-PAGE loading buffer 
Tris-HCl             50 mM, pH 6.5 
Bromophenol Blue           0.1 % (w/v) 
SDS              2 % (w/v) 
Glycerol             10 % (w/v) 
DTT               100 mM 
SDS-PAGE gel stain (per litre): 
Acetic acid             100 mL 
Methanol             450 mL 
H2O              450 mL 
Coomassie Brilliant Blue         2.5 g 
   10 
SDS-PAGE gel destain (per litre): 
Acetic acid             100 mL 
Methanol             300 mL 
H2O              600 mL 
 
3. Bradford Assay 
 
Bradford Reagent (per litre):  
88 % Phosphoric acid           100 mL 
Ethanol             50 mL 
Coomassie Brilliant Blue         100 mg 
H2O              850 mL 
 
Coomassie Brilliant Blue was first dissolved in ethanol, then phosphoric acid and water 
were added and the solution filtered.  
 
4. Growth Media 
 
2 X Tryptone/Yeast extract (2YT) (per litre): 
Bacto tryptone           16 g 
Yeast extract             10 g 
NaCl               5 g 
 
Glycerol minimal medium (GMM) (per litre): 
5X M9 salts solution          200 mL 
 
The medium (800 mL) was autoclaved, allowed to cool down and the following sterile 
solutions added: 
1 M MgSO4             2  mL 
1 M CaCl2            0.1 mL 
Glycerol (20 %)          20 mL 
   11 
SOC medium (per litre): 
Bacto tryptone           20 g 
Yeast extract             5 g 
NaCl               0.6 g 
 
The medium (970 mL) was autoclaved, allowed to cool down and the following sterile 
solutions added: 
1M MgCl2            10 mL 
1M MgSO4            10 mL 
2M Glucose             10 mL 
MgCl2 and MgSO4  were filter sterilised.  
 
The medium was autoclaved and stored at room temperature until used. Prior to use, 
sterilised 20 % (w/v) glucose was added to a final concentration of 0.2 % (w/v). 
 
2YT agar plates (per litre): 
Bacto tryptone           16 g 
Yeast extract             10 g 
NaCl               5 g 
Agar              15 g 
 
The  solution  was  autoclaved  and  allowed  to  cool  down  to  50  ºC  before  adding 
ampicillin to a final concentration of 100  g/mL. This medium was poured into petri 
dishes, allowed to harden and stored at 4 ºC 
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Sequences of genes used for sequence alignments 
 
Escherichia coli thiH 
MKTFSDRWRQLDWDDIRLRINGKTAADVERALNASQLTRDDMMALLSPAASGYLEQLAQRAQRLTRQRFG
NTVSFYVPLYLSNLCANDCTYCGFSMSNRIKRKTLDEADIARESAAIREMGFEHLLLVTGEHQAKVGMDY
FRRHLPALREQFSSLQMEVQPLAETEYAELKQLGLDGVMVYQETYHEATYARHHLKGKKQDFFWRLETPD
RLGRAGIDKIGLGALIGLSDNWRVDSYMVAEHLLWLQQHYWQSRYSVSFPRLRPCTGGIEPASIMDERQL
VQTICAFRLLAPEIELSLSTRESPWFRDRVIPLAINNVSAFSKTQPGGYADNHPELEQFSPHDDRRPEAV
AAALTAQGLQPVWKDWDSYLGRASQRL 
Desulfovibrio vulgaris thiH 
MSFYDELARWPHETLDALIASSTADDVLRALAATRPGPADLAALLSPAAMPYLEDMAQRAHELTVRHFGR
TIQLFTPLYLANHCTNQCRYCGFNARNHIRRDQLDAERIMAEGRAIASTGLRQLLLLTGDAPRISTVSYI
AEAAHRLRPLFPSIGVEVYAMQVEEYAELVAGGVESLTMFQETYNPGLYAWLHPAGPKRDFRFRLDAPER
GCLGGMRSVGLGALLGLDDWRRDAFYTAMHGAWLQRYYPATEVSFSVPRMRPHTGSFEPQHPVSDRELVQ
ILTAYRIFMPTAGITVSSREAAAFRDNLIPLGVTRMSAGVSTAVGGHAAGGDGNVASTEGAAAAIAASTA
ISSGDATGDLSGRSTKVDMTSGMAHAVTEDLQQGADAGPSQFDISDDRSVEEMVSAITARGYQPVFKDWE
PPQDNVYACGAAGHADGTVRCEAR 
Thermotoga maritima thiH 
MCMYVFVKERVESRSFIPEEKIFELLEKTKNPDPARVREIIQKSLDKNRLEPEETATLLNVEDPELLEEI 
FEAARTLKERIYGNRIVLFAPLYIGNDCINDCVYCGFRVSNKVVERRTLTEEQLKEEVKALVSQGHKRLI 
VVYGEHPNYSPEFIARTIDIVYNTKYGNGEIRRVNVNAAPQTIEGYKIIKSVGIGTFQIFQETYHRETYL 
KLHPRGPKSNYNWRLYGLDRAMMAGIDDVGIGALFGLYDWKFEVMGLLYHTIHLEERFGVGPHTISFPRI 
KPAINTPYSQKPEHVVSDEDFKKLVAIIRLSVPYTGMILTAREPAKLRDEVIKLGVSQIDAGSRIGIGAY 
SHKEDDEDRKRQFTLEDPRPLDQVMRSLLKEGFVPSFCTACYRAGRTGEHFMEFAIPGFVKNFCTPNALF 
TLQEYLCDYATEETRKVGEEVIERELQKMNPKIRERVREGLEKIKRGERDVRF 
Desulfovibrio vulgaris hydG 
MAEMKATWLDDAALEATLERNAQEDAVKAREVIAKARLLGGLDLDDVATLIALRDPELVEEMFQTARDVK
EEIYGNRLVLFAPLYISNLCSNECLYCAFRRSNTELDRKALDMDAIADETRLIVQQGHKRILLVAGESYP
REGFDYVLRAIDAVYSVHEGTGEIRRLNVNVAPLTVEQFRNLKARDIGTYQLFQETYHRGTYAKVHLAGP
KKDFDWRATAMDRAMEAGIDDVGIGPLFGLYDWRFEVLATLRHAQHLEEAFGVGCHTISVPRLEPACGSD
MASNPPRPVSNADFMRLVAILRLAVPYTGIIMSTRESAEMRTQTLALGVSQISAGSRTNPGGYAENEREE
AAQFQLGDHRSLSEVIADVGSMGYIPSFCTACYRMGRTGHDFMDLAKPGLIKQKCGPNALATFKEYLLDY
GTPEARAVGESVIAADLGKLDEKTRRVAERLIARVDEGRRDVFV 
Moorella thermoacetica thiH 
MQHGYRADFINHEEIEGYLEEAKRATRDVAVRIIEKAREAKGLEPYEVAVLLQNDDADVRRRMFTAAREI
KEKIYGQRIVLFAPLYFSDYCINNCRYCGYRRENKFERRRLEPEELEREVRILESLGHKRLALEAGEDPV
HCPLEYTLDVINRIYRITEANGSIRRVNVNIAATTVDAYRQLKAAGIGTYVLFQETYHRPTYAYMHPGGP
KADYDWHTTAMDRAMEGGIDDVGLGVLFGLYDYKFEVMGLLYHARHLEETFGVGPHTISVPRLRPAYNIT
LEKFPYLVDDEDFKKLVAIIRLAVPYTGMIISTRETAELRAELLELGVSQISAGSCTGVGGYGRHYADQE
DDIPQFEIGDHRHPDEVIGDLCRRGYLPSYCTACYRRGRTGDRFMSLAKTGEIQHCCQPNAILTFKEYLL
DYARPATREVGETTIREHLARIPSPAIRAETERRLERIAAGERDLYF 
Vibrio vulnificus thiH 
MSFVEHFNQLNWDDIRLSIYSKTALDVERALSKNKLDLEDFKALISPAAEHYLEAMAQRSYALTRKRFGN 
TLSLYIPLYLSNLCANACTYCGFSMENRLKRRTLTVQEIDAEMAAIKAMKFDSVLLVTGEHEGKVGMNYF 
RQVLPQIKRAFNYLAMEVQPLSQEHYQELKLLGLDAVMVYQETYHPATYAQHHLRGNKTNFNYRLETPDR 
LARAGIDKIGIGALIGLEEWRTDCFYVAAHLDYLERTYWQTRYSISFPRLRPCAGALQPKSVMSDKQLVQ 
LICAYRLFNPEVELSLSTRESALFRDNVLPLGITSMSAASKTQPGGYAMPDVELEQFEISDERSAAEVEQ 
MIRSKGFDPVWRDWHAAYSGARFS 
Chlorobium tepidum thiH 
MIALPAWLTDERLSEDIEPLLRQTDNESLERLAAEAQAVTLRRFGRVISLYTPLYLSNFCSSGCVYCGFA 
SDRRSPRRKLDTDEIEKELLAMKALGVSDVLLLTGERTNSVGFDYLRRAVDIAARHMPRVAVEAFPMSVA 
EYRGLAECGCTGLTIYQETYDPDHYRELHRWGPKQDFLERLETPERAITGGIRSVGIGALLGLSEPVGEA 
LAVLRHARYLCKTYWKAGVTVSFPRIRPQEGGFQPSFTVSDRFLARMIFAFRIGMPDVDLVLSTRESSNF 
RDGMAGLGITRMSIASRTTVGGYVEKETAGASQFEVSDNRSVEAFCAALRAKDLEPVFKNWDAAYNNPLP 
AEECT 
Campylobacter jejuni thiH 
MQDYMQHLPHMQEIKSEILNKVLTQVQSYDESQFSAKDVKNALNQTHLSIEHLKALLSSAAEDFIEELAF 
KSAKVKQKYFGNSISLFTPLYLSNYCNSKCVYCGFQKGNKIARAKLNEAEIHEEMQAIAKSGLEEILMLT 
GEGREFASVEYIANACKIAREYFKVVGVEIYPMNEDEYKILHEKGCDYVTVFQETYNPLKYSKIHLAGEK 
RIFPYRFNAQERALKAGMRGVAFAALLGIDDFRKDALATALHAHFLQQAYSHAEISISVPRLRPIINNAK 
IHPKDVSEKRLLQVLCAYRLFLPFAGITISSRERIGFRDEVIKLGATKMSAGVSVGIGEHKGEKKGDEQF 
EISDDRSVDEILAMLKRSNLQAVMSDSIYVG   14 
 
Codon Bias 
 
D. vulgaris ThiH 
UUU  8.8(     4)  UCU 19.7(     9)  UAU  2.2(     1)  UGU 19.7(     9) 
UUC  8.8(     4)  UCC 19.7(     9)  UAC  2.2(     1)  UGC 37.2(    17) 
UUA  2.2(     1)  UCA 28.4(    13)  UAA  0.0(     0)  UGA 15.3(     7) 
UUG  6.6(     3)  UCG 37.2(    17)  UAG  2.2(     1)  UGG 35.0(    16) 
 
CUU  2.2(     1)  CCU 10.9(     5)  CAU  6.6(     3)  CGU 15.3(     7) 
CUC  8.8(     4)  CCC 19.7(     9)  CAC  6.6(     3)  CGC 28.4(    13) 
CUA  4.4(     2)  CCA 39.4(    18)  CAA  4.4(     2)  CGA 10.9(     5) 
CUG 10.9(     5)  CCG 50.3(    23)  CAG 26.3(    12)  CGG 52.5(    24) 
 
AUU  8.8(     4)  ACU  8.8(     4)  AAU  2.2(     1)  AGU 10.9(     5) 
AUC  8.8(     4)  ACC 43.8(    20)  AAC 10.9(     5)  AGC 24.1(    11) 
AUA  4.4(     2)  ACA 17.5(     8)  AAA  0.0(     0)  AGA 10.9(     5) 
AUG 28.4(    13)  ACG 32.8(    15)  AAG  8.8(     4)  AGG 28.4(    13) 
 
GUU 10.9(     5)  GCU  8.8(     4)  GAU  2.2(     1)  GGU  6.6(     3) 
GUC  6.6(     3)  GCC 15.3(     7)  GAC  6.6(     3)  GGC 35.0(    16) 
GUA  4.4(     2)  GCA 28.4(    13)  GAA  2.2(     1)  GGA  4.4(     2) 
GUG 17.5(     8)  GCG 32.8(    15)  GAG  6.6(     3)  GGG 19.7(     9) 
 
T. maritima (TM1267) 
UUU 14.8(     7)  UCU  6.3(     3)  UAU  6.3(     3)  UGU  6.3(     3) 
UUC 33.8(    16)  UCC 10.5(     5)  UAC 38.0(    18)  UGC 10.5(     5) 
UUA  0.0(     0)  UCA  6.3(     3)  UAA  2.1(     1)  UGA  0.0(     0) 
UUG  4.2(     2)  UCG  6.3(     3)  UAG  0.0(     0)  UGG  4.2(     2) 
 
CUU 19.0(     9)  CCU  6.3(     3)  CAU  0.0(     0)  CGU  2.1(     1) 
CUC 38.0(    18)  CCC 10.5(     5)  CAC 21.1(    10)  CGC  6.3(     3) 
CUA  2.1(     1)  CCA 12.7(     6)  CAA  2.1(     1)  CGA  0.0(     0) 
CUG 16.9(     8)  CCG 21.1(    10)  CAG 23.2(    11)  CGG  0.0(     0) 
 
AUU  6.3(     3)  ACU  6.3(     3)  AAU  6.3(     3)  AGU  0.0(     0) 
AUC 40.1(    19)  ACC 10.5(     5)  AAC 31.6(    15)  AGC  6.3(     3) 
AUA 29.5(    14)  ACA  8.4(     4)  AAA 29.5(    14)  AGA 52.7(    25) 
AUG 19.0(     9)  ACG 25.3(    12)  AAG 38.0(    18)  AGG 21.1(    10) 
 
GUU 16.9(     8)  GCU  4.2(     2)  GAU 12.7(     6)  GGU 19.0(     9) 
GUC 16.9(     8)  GCC 10.5(     5)  GAC 31.6(    15)  GGC 12.7(     6) 
GUA  6.3(     3)  GCA 12.7(     6)  GAA 54.9(    26)  GGA 31.6(    15) 
GUG 31.6(    15)  GCG 21.1(    10)  GAG 52.7(    25)  GGG  2.1(     1) 
 
E. Coli ThiH 
UUU 15.7(     6)  UCU  5.2(     2)  UAU 21.0(     8)  UGU  5.2(     2) 
UUC 21.0(     8)  UCC 15.7(     6)  UAC 15.7(     6)  UGC  7.9(     3) 
UUA 13.1(     5)  UCA 10.5(     4)  UAA  0.0(     0)  UGA  2.6(     1) 
UUG  7.9(     3)  UCG 13.1(     5)  UAG  0.0(     0)  UGG 23.6(     9) 
 
CUU 18.4(     7)  CCU  7.9(     3)  CAU 21.0(     8)  CGU 21.0(     8) 
CUC 10.5(     4)  CCC  2.6(     1)  CAC  7.9(     3)  CGC 36.7(    14) 
CUA 13.1(     5)  CCA  2.6(     1)  CAA 26.2(    10)  CGA  7.9(     3) 
CUG 52.5(    20)  CCG 28.9(    11)  CAG 34.1(    13)  CGG 15.7(     6) 
 
AUU 18.4(     7)  ACU  7.9(     3)  AAU 13.1(     5)  AGU 10.5(     4) 
AUC 13.1(     5)  ACC 15.7(     6)  AAC 13.1(     5)  AGC 13.1(     5) 
AUA  5.2(     2)  ACA  5.2(     2)  AAA 23.6(     9)  AGA  5.2(     2) 
AUG 26.2(    10)  ACG 15.7(     6)  AAG  7.9(     3)  AGG  2.6(     1) 
 
GUU 15.7(     6)  GCU 15.7(     6)  GAU 28.9(    11)  GGU 10.5(     4) 
GUC 10.5(     4)  GCC 39.4(    15)  GAC 34.1(    13)  GGC 31.5(    12) 
GUA  5.2(     2)  GCA  2.6(     1)  GAA 39.4(    15)  GGA  7.9(     3) 
GUG 10.5(     4)  GCG 34.1(    13)  GAG 23.6(     9)  GGG  7.9(     3) 